| (+)-alpha-tocopherol | increases activity | EXP | | 6480464 | alpha-Tocopherol results in increased activity of CYP1A2 protein | CTD | PMID:15665910 |
| (+)-artemisinin | increases expression | ISO | RGD:10438 | 6480464 | artemisinine results in increased expression of CYP1A2 mRNA | CTD | PMID:17962186 |
| (+)-artemisinin | increases expression | EXP | | 6480464 | artemisinine results in increased expression of CYP1A2 mRNA | CTD | PMID:16919048 |
| (+)-artemisinin | decreases activity | ISO | RGD:735711 | 6480464 | artemisinine results in decreased activity of CYP1A2 protein | CTD | PMID:11124226 |
| (-)-cotinine | increases activity | ISO | RGD:735711 | 6480464 | Cotinine results in increased activity of CYP1A2 protein | CTD | PMID:16203240 |
| (-)-cotinine | decreases activity | ISO | RGD:735711 | 6480464 | Cotinine results in decreased activity of CYP1A2 protein | CTD | PMID:15916432 |
| (-)-epigallocatechin 3-gallate | affects binding | EXP | | 6480464 | epigallocatechin gallate binds to CYP1A2 protein | CTD | PMID:23010222 |
| (-)-selegiline | affects metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein affects the metabolism of Selegiline | CTD | PMID:16198659 |
| (2,4-dichlorophenoxy)acetic acid | increases expression | EXP | | 6480464 | 2,4-Dichlorophenoxyacetic Acid results in increased expression of CYP1A2 mRNA | CTD | PMID:10910964 |
| (R)-lipoic acid | multiple interactions | ISO | RGD:10438 | 6480464 | [CYP1A1 protein co-treated with CYP1A2 protein] affects the reaction [[Thioctic Acid results in decreased activity of POR protein] inhibits the reaction [aristolochic acid I results in increased abundance of [7-(deoxyadenosin-N(6)-yl)aristolactam I co-treated with 7-(deoxyguanosin-N(2)-yl)aristolactam I co-treated with 7-(deoxyadenosin-N(6)--yl)aristolactam II]]] | CTD | PMID:21932800 |
| (S)-naringenin | decreases activity | ISO | RGD:735711 | 6480464 | naringenin results in decreased activity of CYP1A2 protein | CTD | PMID:21053930 |
| (S)-nicotine | decreases activity | ISO | RGD:735711 | 6480464 | Nicotine results in decreased activity of CYP1A2 protein | CTD | PMID:15916432 |
| (S)-nicotine | increases expression | ISO | RGD:735711 | 6480464 | Nicotine results in increased expression of CYP1A2 protein | CTD | PMID:11849738 |
| 1,1-bis(2-aminoethyl)-2-hydroxy-3-oxotriazane | decreases activity | EXP | | 6480464 | 2,2'-(hydroxynitrosohydrazono)bis-ethanamine results in decreased activity of CYP1A2 protein | CTD | PMID:15542068 |
| 1,1-dichloroethene | decreases expression | EXP | | 6480464 | vinylidene chloride results in decreased expression of CYP1A2 protein | CTD | PMID:10547960 |
| 1,2,4,5-tetrachlorobenzene | increases expression | EXP | | 6480464 | 1,2,4,5-tetrachlorobenzene results in increased expression of CYP1A2 protein | CTD | PMID:10696772 |
| 1,2,4-trichlorobenzene | increases oxidation | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased oxidation of 1,2,4-trichlorobenzene | CTD | PMID:7747284 |
| 1,2-dichlorobenzene | increases oxidation | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased oxidation of 2-dichlorobenzene | CTD | PMID:7747284 |
| 1,2-dichloroethene | affects expression | EXP | | 6480464 | 1,2-dichloroethylene affects the expression of CYP1A2 protein | CTD | PMID:9493318 |
| 1,2-dichloroethene | decreases activity | EXP | | 6480464 | 1,2-dichloroethylene results in decreased activity of CYP1A2 protein | CTD | PMID:9671540 |
| 1,2-dimethylnaphthalene | decreases activity | ISO | RGD:735711 | 6480464 | 1,2-dimethylnaphthalene results in decreased activity of CYP1A2 protein | CTD | PMID:15916432 |
| 1,4-dichlorobenzene | increases oxidation | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased oxidation of 4-dichlorobenzene | CTD | PMID:7747284 |
| 1,4-dimethylnaphthalene | decreases activity | ISO | RGD:735711 | 6480464 | 1,4-dimethylnaphthalene results in decreased activity of CYP1A2 protein | CTD | PMID:15916432 |
| 1,4-naphthoquinone | increases expression | ISO | RGD:735711 | 6480464 | 1,4-naphthoquinone results in increased expression of CYP1A2 mRNA | CTD | PMID:18602459 |
| 1,4-naphthoquinone | increases abundance | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased abundance of 1,4-naphthoquinone | CTD | PMID:16243959 |
| 1,7-dimethylxanthine | affects metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein affects the metabolism of 1,7-dimethylxanthine | CTD | PMID:1302044 |
| 1,7-dimethylxanthine | increases hydroxylation | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased hydroxylation of 1,7-dimethylxanthine | CTD | PMID:15980104 |
| 1,7-dimethylxanthine | increases chemical synthesis | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased chemical synthesis of 1,7-dimethylxanthine | CTD | PMID:1302044 |
| 1,7-phenanthroline | multiple interactions | EXP | | 6480464 | 1,7-phenanthroline inhibits the reaction [[Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CYP1A2 protein] | CTD | PMID:17967931 |
| 1,7-phenanthroline | increases expression | EXP | | 6480464 | 1,7-phenanthroline results in increased expression of CYP1A2 protein | CTD | PMID:17967931 |
| 1-benzofuran | decreases activity | ISO | RGD:735711 | 6480464 | benzofuran analog results in decreased activity of CYP1A2 protein | CTD | PMID:15916432 |
| 1-methyl-7H-xanthine | decreases activity | ISO | RGD:735711 | 6480464 | 1-methylxanthine results in decreased activity of CYP1A2 protein | CTD | PMID:11465391 |
| 1-methylnaphthalene | decreases activity | ISO | RGD:735711 | 6480464 | 1-methylnaphthalene results in decreased activity of CYP1A2 protein | CTD | PMID:15916432 |
| 1-naphthol | increases abundance | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased abundance of 1-naphthol | CTD | PMID:16243959 |
| 1-naphthol | decreases activity | ISO | RGD:735711 | 6480464 | 1-naphthol results in decreased activity of CYP1A2 protein | CTD | PMID:15916432 |
| 1-naphthyl isothiocyanate | multiple interactions | EXP | | 6480464 | [1-Naphthylisothiocyanate co-treated with 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine] results in decreased expression of CYP1A2 protein; more ... | CTD | PMID:15598703 |
| 1-naphthyl isothiocyanate | increases expression | EXP | | 6480464 | 1-Naphthylisothiocyanate results in increased expression of CYP1A2 mRNA | CTD | PMID:20551477 |
| 1-naphthyl isothiocyanate | decreases expression | EXP | | 6480464 | 1-Naphthylisothiocyanate results in decreased expression of CYP1A2 protein | CTD | PMID:15598703 |
| 17alpha-ethynylestradiol | increases hydroxylation | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased hydroxylation of Ethinyl Estradiol | CTD | PMID:15304426 |
| 17alpha-ethynylestradiol | decreases activity | ISO | RGD:735711 | 6480464 | Ethinyl Estradiol results in decreased activity of CYP1A2 protein | CTD | PMID:18816299 |
| 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:735711 | 6480464 | [Ethinyl Estradiol co-treated with norgestimate] results in decreased activity of CYP1A2 protein | CTD | PMID:16291717 |
| 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:735711 | 6480464 | [Ethinyl Estradiol co-treated with Gestodene] results in decreased activity of CYP1A2 protein; more ... | CTD | PMID:16198659 |
| 17beta-estradiol | multiple interactions | ISO | RGD:735711 | 6480464 | Chlorpyrifos inhibits the reaction [CYP1A2 protein results in increased metabolism of Estradiol]; more ... | CTD | PMID:16790556 |
| 17beta-estradiol | multiple interactions | ISO | RGD:735711 | 6480464 | [Estradiol binds to ESR2 protein] which results in increased expression of CYP1A2 mRNA | CTD | PMID:20404318 |
| 17beta-estradiol | increases expression | ISO | RGD:735711 | 6480464 | Estradiol results in increased expression of CYP1A2 mRNA | CTD | PMID:19619570 |
| 17beta-estradiol | multiple interactions | ISO | RGD:735711 | 6480464 | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of CYP1A2 mRNA | CTD | PMID:19619570 |
| 17beta-estradiol | increases metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased metabolism of Estradiol | CTD | PMID:16790556 |
| 17beta-estradiol | increases hydroxylation | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased hydroxylation of Estradiol | CTD | PMID:15961252 |
| 2'-deoxyguanosine | multiple interactions | ISO | RGD:735711 | 6480464 | CYP1A2 protein promotes the reaction [Aflatoxin B1 binds to Deoxyguanosine]; more ... | CTD | PMID:21907773 |
| 2,2',4,4',5,5'-hexachlorobiphenyl | decreases response to substance | ISO | RGD:10438 | 6480464 | CYP1A2 results in decreased susceptibility to 2,4,5,2',4',5'-hexachlorobiphenyl | CTD | PMID:21571617 |
| 2,2',4,4',5,5'-hexachlorobiphenyl | increases expression | ISO | RGD:10438 | 6480464 | 2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of CYP1A2 mRNA | CTD | PMID:21851831 |
| 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | EXP | | 6480464 | [3,4,5,3',4'-pentachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl] results in increased activity of CYP1A2 protein | CTD | PMID:17160104 |
| 2,2',4,4',5,5'-hexachlorobiphenyl | increases expression | EXP | | 6480464 | 2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of CYP1A2 protein | CTD | PMID:3302669 |
| 2,2',4,4',5,5'-hexachlorobiphenyl | increases activity | EXP | | 6480464 | 2,4,5,2',4',5'-hexachlorobiphenyl results in increased activity of CYP1A2 protein | CTD | PMID:16835634 |
| 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | EXP | | 6480464 | [2,4,5,2',4',5'-hexachlorobiphenyl co-treated with 3,4,5,3',4'-pentachlorobiphenyl] results in increased activity of CYP1A2 protein | CTD | PMID:16835634 |
| 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | ISO | RGD:10438 | 6480464 | 2,4,5,2',4',5'-hexachlorobiphenyl promotes the reaction [AHR protein results in increased expression of CYP1A2]; more ... | CTD | PMID:20961953 |
| 2,2',5,5'-tetrachlorobiphenyl | increases expression | ISO | RGD:735711 | 6480464 | 2,5,2',5'-tetrachlorobiphenyl results in increased expression of CYP1A2 mRNA | CTD | PMID:21703328 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:735711 | 6480464 | 1-nitropyrene inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein]; more ... | CTD | PMID:18493746 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of and results in increased activity of CYP1A2 protein | CTD | PMID:11585058 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA | CTD | PMID:10568693 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | arsenite inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of and results in increased activity of CYP1A2 protein]; more ... | CTD | PMID:22159698 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases activity | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein | CTD | PMID:12062927 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA | CTD | PMID:10568693 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:10438 | 6480464 | [Tetrachlorodibenzodioxin results in increased localization of AHR protein] which results in increased expression of CYP1A2 mRNA | CTD | PMID:8215422 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:10438 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CYP1A2 mRNA | CTD | PMID:15034205 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:10438 | 6480464 | AHR protein inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of CYP1A2 mRNA] | CTD | PMID:15034205 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:10438 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 protein | CTD | PMID:17997381 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:10438 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of and results in increased activity of CYP1A2 protein | CTD | PMID:2512931 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:10438 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA | CTD | PMID:11043581 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:735711 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA | CTD | PMID:11064004 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:735711 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA | CTD | PMID:11064004 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA | CTD | PMID:10910964 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:10438 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA | CTD | PMID:11043581 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:10438 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA | CTD | PMID:11043581 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:735711 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA | CTD | PMID:11064004 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | Tetrachlorodibenzodioxin inhibits the reaction [CYP1A2 protein results in decreased methylation of 7-methoxyresorufin] | CTD | PMID:12635099 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:735711 | 6480464 | N-(2-(3H-indol-3-yl)ethyl)-9-isopropyl-2-(5-methyl-3-pyridyl)purin-6-amine inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | CTD | PMID:21493753 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA | CTD | PMID:10910964 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA | CTD | PMID:10910964 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 protein | CTD | PMID:12361703 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:10438 | 6480464 | Tetradecanoylphorbol Acetate inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | CTD | PMID:1313028 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:10438 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA | CTD | PMID:11043581 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:735711 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA | CTD | PMID:11064004 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:735711 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 protein | CTD | PMID:11370663 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases activity | ISO | RGD:735711 | 6480464 | Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein | CTD | PMID:16426572 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:10438 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA | CTD | PMID:11043581 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:10438 | 6480464 | sodium arsenite inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | CTD | PMID:22535251 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA | CTD | PMID:10910964 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 protein | CTD | PMID:12361703 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA | CTD | PMID:10910964 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases activity | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein | CTD | PMID:12062927 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of CYP1A2 mRNA | CTD | PMID:22298810 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:735711 | 6480464 | Tetrachlorodibenzodioxin affects the expression of CYP1A2 mRNA | CTD | PMID:22298810 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:10438 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 protein | CTD | PMID:17997381 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:10438 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA | CTD | PMID:11043581 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases activity | ISO | RGD:10438 | 6480464 | Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein | CTD | PMID:10986007 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:10438 | 6480464 | Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to CYP1A2 promoter] | CTD | PMID:21889950 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:10438 | 6480464 | ARNT affects the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | CTD | PMID:11043581 PMID:20935161 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:735711 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA | CTD | PMID:11064004 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases activity | ISO | RGD:735711 | 6480464 | Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein | CTD | PMID:16426572 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:735711 | 6480464 | [Tetrachlorodibenzodioxin co-treated with AHR mRNA] affects the expression of CYP1A2 mRNA | CTD | PMID:20619336 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 protein | CTD | PMID:12606150 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA | CTD | PMID:19692669 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases activity | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein | CTD | PMID:20705892 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:735711 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA | CTD | PMID:15056799 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:10438 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 protein | CTD | PMID:17997381 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases activity | ISO | RGD:10438 | 6480464 | Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein | CTD | PMID:22579925 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:10438 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA | CTD | PMID:18372398 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | affects abundance | ISO | RGD:10438 | 6480464 | CYP1A2 protein affects the abundance of Tetrachlorodibenzodioxin | CTD | PMID:9240455 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:10438 | 6480464 | ARNT affects the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | CTD | PMID:20935161 PMID:11043581 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases activity | ISO | RGD:735711 | 6480464 | Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein | CTD | PMID:20188822 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 protein | CTD | PMID:12606150 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA | CTD | PMID:18796159 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases activity | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein | CTD | PMID:12062927 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:10438 | 6480464 | Mercury promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA]; more ... | CTD | PMID:22579925 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:735711 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA | CTD | PMID:7554073 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases activity | ISO | RGD:735711 | 6480464 | Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein | CTD | PMID:18493746 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:10438 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA | CTD | PMID:21095216 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:10438 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 protein | CTD | PMID:9875294 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases activity | ISO | RGD:10438 | 6480464 | Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein | CTD | PMID:9443932 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 protein | CTD | PMID:9144388 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:10438 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 protein | CTD | PMID:21095216 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA | CTD | PMID:19497421 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases activity | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein | CTD | PMID:16835633 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:10438 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA | CTD | PMID:9443932 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | affects abundance | ISO | RGD:10438 | 6480464 | CYP1A2 protein affects the abundance of Tetrachlorodibenzodioxin | CTD | PMID:19695277 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases activity | ISO | RGD:735711 | 6480464 | Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein | CTD | PMID:17183067 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | affects response to substance | ISO | RGD:10438 | 6480464 | CYP1A2 affects the susceptibility to Tetrachlorodibenzodioxin | CTD | PMID:21095216 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:735711 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA | CTD | PMID:17785579 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases activity | ISO | RGD:10438 | 6480464 | Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein | CTD | PMID:10986007 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:735711 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA | CTD | PMID:12107646 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases activity | ISO | RGD:735711 | 6480464 | Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein | CTD | PMID:20705892 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 protein | CTD | PMID:12606150 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA | CTD | PMID:19497421 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases activity | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein | CTD | PMID:16835633 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:10438 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 protein | CTD | PMID:9875294 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:10438 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA | CTD | PMID:16929009 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:10438 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 protein | CTD | PMID:17997381 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:10438 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA | CTD | PMID:16929009 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases activity | ISO | RGD:10438 | 6480464 | Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein | CTD | PMID:9443932 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | affects abundance | ISO | RGD:10438 | 6480464 | CYP1A2 protein affects the abundance of Tetrachlorodibenzodioxin | CTD | PMID:10448125 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:735711 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 protein | CTD | PMID:16258175 PMID:16426572 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:735711 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA | CTD | PMID:16527260 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:735711 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of and results in increased activity of CYP1A2 protein | CTD | PMID:16426572 PMID:14709624 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases activity | ISO | RGD:735711 | 6480464 | Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein | CTD | PMID:17183067 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 protein | CTD | PMID:16966094 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA | CTD | PMID:17690134 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases activity | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein | CTD | PMID:16781091 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of and results in increased activity of CYP1A2 protein | CTD | PMID:9707506 PMID:11585058 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 protein | CTD | PMID:16966094 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin results in increased expression of and results in increased activity of CYP1A2 protein] which results in increased activity of 2-amino-3,4-dimethylimidazo(4,5-f)quinoline | CTD | PMID:11585058 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA | CTD | PMID:19497421 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases activity | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein | CTD | PMID:20705892 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of and results in increased activity of CYP1A2 protein | CTD | PMID:11585058 PMID:9707506 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases activity | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased activity of CYP1A2 protein | CTD | PMID:15659567 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | Tetrachlorodibenzodioxin promotes the reaction [CYP1A2 protein affects the metabolism of bromodichloromethane] | CTD | PMID:12062927 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with 2,3,4,7,8-pentachlorodibenzofuran co-treated with 3,4,5,3',4'-pentachlorobiphenyl] results in increased activity of CYP1A2 protein | CTD | PMID:17342195 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | Drugs, Chinese Herbal promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | CTD | PMID:16901605 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | Dexamethasone promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA]; more ... | CTD | PMID:17690134 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | CYP1A2 protein binds to and affects the abundance of Tetrachlorodibenzodioxin | CTD | PMID:16966094 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | 1-nitropyrene inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein]; more ... | CTD | PMID:18493746 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA | CTD | PMID:15664428 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 | CTD | PMID:15993909 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:10438 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 protein | CTD | PMID:9875294 PMID:17997381 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:10438 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA | CTD | PMID:17949056 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:10438 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 | CTD | PMID:15722456 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases activity | ISO | RGD:10438 | 6480464 | Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein | CTD | PMID:9443932 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:10438 | 6480464 | Tetrachlorodibenzodioxin inhibits the reaction [Butyrates results in increased expression of CYP1A2 mRNA]; more ... | CTD | PMID:15252868 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:10438 | 6480464 | [Tetrachlorodibenzodioxin co-treated with AHR protein] results in increased expression of CYP1A2 mRNA | CTD | PMID:21534955 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:10438 | 6480464 | Tetrachlorodibenzodioxin affects the expression of CYP1A2 mRNA | CTD | PMID:20819909 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:10438 | 6480464 | Iron-Dextran Complex inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | CTD | PMID:9443932 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects response to substance | ISO | RGD:10438 | 6480464 | CYP1A2 protein affects the susceptibility to Tetrachlorodibenzodioxin | CTD | PMID:16636061 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:10438 | 6480464 | [CYP1A2 protein affects the abundance of Tetrachlorodibenzodioxin] inhibits the reaction [CYP1A1 protein results in increased metabolism of Tetrachlorodibenzodioxin] | CTD | PMID:19695277 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects abundance | ISO | RGD:10438 | 6480464 | CYP1A2 protein affects the abundance of Tetrachlorodibenzodioxin | CTD | PMID:10448125 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:10438 | 6480464 | CYP1A2 protein affects the abundance of and affects the susceptibility to Tetrachlorodibenzodioxin | CTD | PMID:15003330 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:10438 | 6480464 | ARNT affects the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | CTD | PMID:20935161 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:10438 | 6480464 | AHR protein affects the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | CTD | PMID:16214954 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:735711 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 protein | CTD | PMID:16426572 PMID:16258175 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:735711 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA | CTD | PMID:14729655 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:735711 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of and results in increased activity of CYP1A2 protein | CTD | PMID:14709624 PMID:16426572 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases activity | ISO | RGD:735711 | 6480464 | Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein | CTD | PMID:18493746 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases activity | ISO | RGD:735711 | 6480464 | Tetrachlorodibenzodioxin results in decreased activity of CYP1A2 protein | CTD | PMID:15659567 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:735711 | 6480464 | Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to CYP1A2 enhancer] | CTD | PMID:17785579 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:735711 | 6480464 | sodium arsenite inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein]; more ... | CTD | PMID:20188822 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:735711 | 6480464 | salicylamide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA]; more ... | CTD | PMID:14729655 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:735711 | 6480464 | NCX 4040 inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | CTD | PMID:19542225 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:735711 | 6480464 | flavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA]; more ... | CTD | PMID:17090139 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:735711 | 6480464 | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of CYP1A2 mRNA | CTD | PMID:19619570 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:735711 | 6480464 | Plant Extracts inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | CTD | PMID:11064004 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:735711 | 6480464 | resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | CTD | PMID:19376845 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:735711 | 6480464 | Dexamethasone promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA]; more ... | CTD | PMID:19022236 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects response to substance | ISO | RGD:735711 | 6480464 | CYP1A2 protein affects the susceptibility to Tetrachlorodibenzodioxin | CTD | PMID:16636061 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:735711 | 6480464 | Azacitidine promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA]; more ... | CTD | PMID:12927368 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:735711 | 6480464 | anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | CTD | PMID:17959153 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:735711 | 6480464 | 3-(3-methoxyphenyl)-N-(3,4,5-trimethoxyphenyl)acrylamide inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein]; more ... | CTD | PMID:17183067 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:735711 | 6480464 | 2-((2,6-dichlorophenyl)amino)benzeneacetic acid 4-(3H-1,2-dithiol-3-thione-5-yl)phenyl ester inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA]; more ... | CTD | PMID:19276279 |
| 2,4,6-trinitrobenzenesulfonic acid | multiple interactions | EXP | | 6480464 | Trinitrobenzenesulfonic Acid results in decreased activity of and results in decreased expression of CYP1A2 protein | CTD | PMID:18079364 |
| 2,4-dinitrophenol | multiple interactions | ISO | RGD:735711 | 6480464 | 2,4-Dinitrophenol inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | CTD | PMID:18493746 |
| 2,4-dinitrophenol | multiple interactions | EXP | | 6480464 | 2,4-Dinitrophenol inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | CTD | PMID:18493746 |
| 2,6-dimethylnaphthalene | decreases activity | ISO | RGD:735711 | 6480464 | 2,6-dimethylnaphthalene results in decreased activity of CYP1A2 protein | CTD | PMID:15916432 |
| 2-acetamidofluorene | increases hydrolysis | ISO | RGD:735711 | 6480464 | CYP1A2 results in increased hydrolysis of 2-Acetylaminofluorene | CTD | PMID:2334931 |
| 2-acetamidofluorene | increases activity | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased activity of 2-Acetylaminofluorene | CTD | PMID:15450435 |
| 2-acetamidofluorene | affects metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein affects the metabolism of 2-Acetylaminofluorene | CTD | PMID:2655891 |
| 2-acetamidofluorene | increases expression | ISO | RGD:10438 | 6480464 | 2-Acetylaminofluorene results in increased expression of CYP1A2 mRNA | CTD | PMID:16381673 |
| 2-acetamidofluorene | decreases expression | EXP | | 6480464 | 2-Acetylaminofluorene analog results in decreased expression of CYP1A2 protein; more ... | CTD | PMID:15916741 |
| 2-acetamidofluorene | multiple interactions | ISO | RGD:10438 | 6480464 | NR1I2 protein affects the reaction [2-Acetylaminofluorene results in increased expression of CYP1A2 mRNA] | CTD | PMID:16381673 |
| 2-chlorobiphenyl | decreases activity | ISO | RGD:735711 | 6480464 | 2-chlorobiphenyl results in decreased activity of CYP1A2 protein | CTD | PMID:15916432 |
| 2-hydroxy-17beta-estradiol | increases chemical synthesis | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased chemical synthesis of 2-hydroxyestradiol | CTD | PMID:16790556 |
| 2-hydroxy-17beta-estradiol | multiple interactions | ISO | RGD:735711 | 6480464 | Chlorpyrifos inhibits the reaction [CYP1A2 protein results in increased chemical synthesis of 2-hydroxyestradiol]; more ... | CTD | PMID:16790556 |
| 2-methylnaphthalene | decreases activity | ISO | RGD:735711 | 6480464 | 2-methylnaphthalene results in decreased activity of CYP1A2 protein | CTD | PMID:15916432 |
| 2-naphthol | increases abundance | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased abundance of 2-naphthol | CTD | PMID:16243959 |
| 2-naphthol | decreases activity | ISO | RGD:735711 | 6480464 | 2-naphthol results in decreased activity of CYP1A2 protein | CTD | PMID:15916432 |
| 2-naphthylamine | increases activity | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased activity of 2-Naphthylamine | CTD | PMID:15450435 |
| 2-nitroanisole | increases expression | EXP | | 6480464 | 2-nitroanisole results in increased expression of CYP1A2 | CTD | PMID:11409192 |
| 2-nitroanisole | increases expression | EXP | | 6480464 | 2-nitroanisole results in increased expression of CYP1A2 protein | CTD | PMID:16601807 |
| 3,3',4,4',5-pentachlorobiphenyl | increases expression | ISO | RGD:735711 | 6480464 | 3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CYP1A2 mRNA | CTD | PMID:16049271 PMID:19692669 |
| 3,3',4,4',5-pentachlorobiphenyl | increases expression | EXP | | 6480464 | 3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CYP1A2 mRNA | CTD | PMID:16049271 more ... |
| 3,3',4,4',5-pentachlorobiphenyl | multiple interactions | EXP | | 6480464 | 3,4,5,3',4'-pentachlorobiphenyl inhibits the reaction [CYP1A2 protein results in decreased methylation of 7-methoxyresorufin] | CTD | PMID:12635099 |
| 3,3',4,4',5-pentachlorobiphenyl | increases expression | ISO | RGD:10438 | 6480464 | 3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CYP1A2 mRNA | CTD | PMID:20702594 PMID:21335049 |
| 3,3',4,4',5-pentachlorobiphenyl | increases expression | EXP | | 6480464 | 3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CYP1A2 mRNA | CTD | PMID:16049271 PMID:19692669 |
| 3,3',4,4',5-pentachlorobiphenyl | increases expression | ISO | RGD:735711 | 6480464 | 3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CYP1A2 mRNA | CTD | PMID:19692669 PMID:16049271 |
| 3,3',4,4',5-pentachlorobiphenyl | increases expression | EXP | | 6480464 | 3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CYP1A2 mRNA | CTD | PMID:19692669 PMID:16049271 |
| 3,3',4,4',5-pentachlorobiphenyl | increases expression | EXP | | 6480464 | 3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CYP1A2 mRNA | CTD | PMID:16049271 |
| 3,3',4,4',5-pentachlorobiphenyl | multiple interactions | EXP | | 6480464 | [3,4,5,3',4'-pentachlorobiphenyl co-treated with 2,3',4,4',5-pentachlorobiphenyl] results in increased activity of CYP1A2 protein | CTD | PMID:17342196 |
| 3,3',4,4',5-pentachlorobiphenyl | multiple interactions | EXP | | 6480464 | [2,4,5,2',4',5'-hexachlorobiphenyl co-treated with 3,4,5,3',4'-pentachlorobiphenyl] results in increased activity of CYP1A2 protein | CTD | PMID:16835634 |
| 3,3',4,4',5-pentachlorobiphenyl | multiple interactions | ISO | RGD:10438 | 6480464 | 3,4,5,3',4'-pentachlorobiphenyl promotes the reaction [AHR protein results in increased expression of CYP1A2]; more ... | CTD | PMID:20961953 |
| 3,3',4,4',5-pentachlorobiphenyl | increases activity | EXP | | 6480464 | 3,4,5,3',4'-pentachlorobiphenyl results in increased activity of CYP1A2 protein | CTD | PMID:16628245 |
| 3,3',4,4',5-pentachlorobiphenyl | decreases activity | EXP | | 6480464 | 3,4,5,3',4'-pentachlorobiphenyl results in decreased activity of CYP1A2 protein | CTD | PMID:15659567 |
| 3,3',4,4',5-pentachlorobiphenyl | multiple interactions | EXP | | 6480464 | [3,4,5,3',4'-pentachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl] results in increased activity of CYP1A2 protein | CTD | PMID:17160104 |
| 3,3',4,4',5-pentachlorobiphenyl | decreases activity | ISO | RGD:735711 | 6480464 | 3,4,5,3',4'-pentachlorobiphenyl results in decreased activity of CYP1A2 protein | CTD | PMID:15659567 |
| 3,3',4,4',5-pentachlorobiphenyl | increases expression | ISO | RGD:735711 | 6480464 | 3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CYP1A2 mRNA | CTD | PMID:16049271 |
| 3,3',4,4',5-pentachlorobiphenyl | increases expression | ISO | RGD:10438 | 6480464 | 3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CYP1A2 mRNA | CTD | PMID:20702594 |
| 3,3',4,4',5-pentachlorobiphenyl | increases activity | ISO | RGD:10438 | 6480464 | 3,4,5,3',4'-pentachlorobiphenyl results in increased activity of CYP1A2 protein | CTD | PMID:10986007 |
| 3,3',4,4',5-pentachlorobiphenyl | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with 2,3,4,7,8-pentachlorodibenzofuran co-treated with 3,4,5,3',4'-pentachlorobiphenyl] results in increased activity of CYP1A2 protein | CTD | PMID:17342195 |
| 3,3',4,4',5-pentachlorobiphenyl | decreases response to substance | ISO | RGD:10438 | 6480464 | CYP1A2 results in decreased susceptibility to 3,4,5,3',4'-pentachlorobiphenyl | CTD | PMID:21571617 |
| 3,3',4,4'-tetrachlorobiphenyl | decreases response to substance | ISO | RGD:10438 | 6480464 | CYP1A2 results in decreased susceptibility to 3,4,3',4'-tetrachlorobiphenyl | CTD | PMID:21571617 |
| 3,3',4,4'-tetrachlorobiphenyl | multiple interactions | EXP | | 6480464 | 3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [CYP1A2 protein results in decreased methylation of 7-methoxyresorufin] | CTD | PMID:12635099 |
| 3,3',4,4'-tetrachlorobiphenyl | increases expression | ISO | RGD:10438 | 6480464 | 3,4,3',4'-tetrachlorobiphenyl results in increased expression of CYP1A2 mRNA | CTD | PMID:12117779 PMID:19467301 |
| 3,3',4,4'-tetrachlorobiphenyl | increases expression | ISO | RGD:10438 | 6480464 | 3,4,3',4'-tetrachlorobiphenyl results in increased expression of CYP1A2 mRNA | CTD | PMID:12117779 |
| 3,3',4,4'-tetrachlorobiphenyl | multiple interactions | ISO | RGD:10438 | 6480464 | 3,4,3',4'-tetrachlorobiphenyl promotes the reaction [AHR protein results in increased expression of CYP1A2]; more ... | CTD | PMID:20961953 |
| 3,3'-diindolylmethane | increases expression | ISO | RGD:735711 | 6480464 | 3,3'-diindolylmethane results in increased expression of CYP1A2 mRNA | CTD | PMID:15672752 PMID:19770484 |
| 3,3'-diindolylmethane | increases expression | EXP | | 6480464 | 3,3'-diindolylmethane results in increased expression of CYP1A2 protein | CTD | PMID:8384853 |
| 3,3'-diindolylmethane | multiple interactions | ISO | RGD:735711 | 6480464 | [3,3'-diindolylmethane results in increased expression of CYP1A2 mRNA] which results in increased abundance of aflatoxin B1-DNA adduct | CTD | PMID:19770484 |
| 3,3'-diindolylmethane | decreases activity | ISO | RGD:735711 | 6480464 | 3,3'-diindolylmethane results in decreased activity of CYP1A2 protein | CTD | PMID:19770484 |
| 3,3'-diindolylmethane | increases expression | ISO | RGD:735711 | 6480464 | 3,3'-diindolylmethane results in increased expression of CYP1A2 mRNA | CTD | PMID:19770484 PMID:15672752 |
| 3,3'-diindolylmethane | increases expression | ISO | RGD:735711 | 6480464 | 3,3'-diindolylmethane results in increased expression of CYP1A2 mRNA; more ... | CTD | PMID:15672752 |
| 3,3'-diindolylmethane | increases oxidation | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased oxidation of 3,3'-diindolylmethane | CTD | PMID:16544949 |
| 3,3'-diindolylmethane | multiple interactions | ISO | RGD:735711 | 6480464 | Quercetin inhibits the reaction [CYP1A2 protein results in increased oxidation of 3,3'-diindolylmethane]; more ... | CTD | PMID:16544949 |
| 3,4-dichloroaniline | increases expression | ISO | RGD:735711 | 6480464 | 3,4-dichloroaniline results in increased expression of CYP1A2 protein; more ... | CTD | PMID:21784029 |
| 3,4-dihydroxybenzoic acid | multiple interactions | EXP | | 6480464 | protocatechuic acid inhibits the reaction [Methylcholanthrene results in increased activity of CYP1A2 protein] | CTD | PMID:15302093 |
| 3-isobutyl-1-methyl-7H-xanthine | decreases activity | ISO | RGD:735711 | 6480464 | 1-Methyl-3-isobutylxanthine results in decreased activity of CYP1A2 protein | CTD | PMID:11465391 |
| 3-methylcholanthrene | increases activity | ISO | RGD:10438 | 6480464 | Methylcholanthrene results in increased activity of CYP1A2 protein | CTD | PMID:16639589 PMID:4054433 |
| 3-methylcholanthrene | increases expression | ISO | RGD:735711 | 6480464 | Methylcholanthrene results in increased expression of CYP1A2 protein | CTD | PMID:15769886 more ... |
| 3-methylcholanthrene | increases expression | EXP | | 6480464 | Methylcholanthrene results in increased expression of CYP1A2 protein | CTD | PMID:11285323 more ... |
| 3-methylcholanthrene | increases expression | EXP | | 6480464 | Methylcholanthrene results in increased expression of CYP1A2 mRNA | CTD | PMID:10476907 more ... |
| 3-methylcholanthrene | increases expression | ISO | RGD:10438 | 6480464 | Methylcholanthrene results in increased expression of CYP1A2 protein | CTD | PMID:16639589 more ... |
| 3-methylcholanthrene | increases expression | ISO | RGD:10438 | 6480464 | Methylcholanthrene results in increased expression of CYP1A2 mRNA | CTD | PMID:11356909 more ... |
| 3-methylcholanthrene | multiple interactions | ISO | RGD:10438 | 6480464 | AHR protein promotes the reaction [Methylcholanthrene results in increased expression of CYP1A2 mRNA]; more ... | CTD | PMID:6749129 |
| 3-methylcholanthrene | increases expression | ISO | RGD:735711 | 6480464 | Methylcholanthrene results in increased expression of CYP1A2 mRNA | CTD | PMID:12107646 more ... |
| 3-methylcholanthrene | increases expression | ISO | RGD:10438 | 6480464 | Methylcholanthrene results in increased expression of CYP1A2 protein | CTD | PMID:16167840 more ... |
| 3-methylcholanthrene | multiple interactions | EXP | | 6480464 | lead nitrate inhibits the reaction [Methylcholanthrene results in increased expression of CYP1A2 protein] | CTD | PMID:8902619 |
| 3-methylcholanthrene | increases expression | ISO | RGD:735711 | 6480464 | Methylcholanthrene results in increased expression of CYP1A2 mRNA | CTD | PMID:12107646 more ... |
| 3-methylcholanthrene | multiple interactions | ISO | RGD:735711 | 6480464 | Methylcholanthrene promotes the reaction [Nicardipine results in increased expression of CYP1A2 mRNA]; more ... | CTD | PMID:20067464 |
| 3-methylcholanthrene | increases expression | EXP | | 6480464 | Methylcholanthrene results in increased expression of CYP1A2 protein | CTD | PMID:11285323 more ... |
| 3-methylcholanthrene | increases expression | EXP | | 6480464 | Methylcholanthrene results in increased expression of CYP1A2 mRNA | CTD | PMID:10476907 more ... |
| 3-methylcholanthrene | increases expression | ISO | RGD:10438 | 6480464 | Methylcholanthrene results in increased expression of CYP1A2 mRNA | CTD | PMID:11356909 more ... |
| 3-methylcholanthrene | increases expression | ISO | RGD:10438 | 6480464 | Methylcholanthrene results in increased expression of CYP1A2 mRNA | CTD | PMID:11356909 more ... |
| 3-methylcholanthrene | increases expression | EXP | | 6480464 | Methylcholanthrene results in increased expression of CYP1A2 protein | CTD | PMID:11285323 more ... |
| 3-methylcholanthrene | multiple interactions | EXP | | 6480464 | Methylcholanthrene promotes the reaction [Lindane results in increased expression of and results in increased activity of CYP1A2 protein] | CTD | PMID:18486174 |
| 3-methylcholanthrene | increases expression | ISO | RGD:735711 | 6480464 | Methylcholanthrene results in increased expression of CYP1A2 mRNA | CTD | PMID:12107646 more ... |
| 3-methylcholanthrene | increases expression | EXP | | 6480464 | Methylcholanthrene results in increased expression of CYP1A2 mRNA | CTD | PMID:10476907 more ... |
| 3-methylcholanthrene | increases expression | EXP | | 6480464 | Methylcholanthrene results in increased expression of CYP1A2 protein | CTD | PMID:11285323 more ... |
| 3-methylcholanthrene | increases activity | EXP | | 6480464 | Methylcholanthrene results in increased activity of CYP1A2 protein | CTD | PMID:15302093 more ... |
| 3-methylcholanthrene | increases expression | ISO | RGD:735711 | 6480464 | Methylcholanthrene results in increased expression of CYP1A2 mRNA | CTD | PMID:12107646 more ... |
| 3-methylcholanthrene | increases activity | ISO | RGD:735711 | 6480464 | Methylcholanthrene results in increased activity of CYP1A2 protein | CTD | PMID:19022236 more ... |
| 3-methylcholanthrene | increases expression | ISO | RGD:10438 | 6480464 | Methylcholanthrene results in increased expression of CYP1A2 mRNA | CTD | PMID:11356909 more ... |
| 3-methylcholanthrene | increases activity | ISO | RGD:735711 | 6480464 | Methylcholanthrene results in increased activity of CYP1A2 protein | CTD | PMID:19022236 more ... |
| 3-methylcholanthrene | increases expression | EXP | | 6480464 | Methylcholanthrene results in increased expression of CYP1A2 protein | CTD | PMID:16639589 more ... |
| 3-methylcholanthrene | increases expression | EXP | | 6480464 | Methylcholanthrene results in increased expression of CYP1A2 mRNA | CTD | PMID:20226384 more ... |
| 3-methylcholanthrene | increases expression | ISO | RGD:10438 | 6480464 | Methylcholanthrene results in increased expression of CYP1A2 mRNA | CTD | PMID:11549291 more ... |
| 3-methylcholanthrene | increases expression | ISO | RGD:735711 | 6480464 | Methylcholanthrene results in increased expression of CYP1A2 mRNA | CTD | PMID:20171196 more ... |
| 3-methylcholanthrene | increases activity | EXP | | 6480464 | Methylcholanthrene results in increased activity of CYP1A2 protein | CTD | PMID:15590115 more ... |
| 3-methylcholanthrene | increases expression | ISO | RGD:10438 | 6480464 | Methylcholanthrene results in increased expression of CYP1A2 protein | CTD | PMID:19679878 more ... |
| 3-methylcholanthrene | increases expression | EXP | | 6480464 | Methylcholanthrene results in increased expression of CYP1A2 protein | CTD | PMID:9152597 more ... |
| 3-methylcholanthrene | increases expression | EXP | | 6480464 | Methylcholanthrene results in increased expression of CYP1A2 mRNA | CTD | PMID:10772642 more ... |
| 3-methylcholanthrene | increases activity | EXP | | 6480464 | Methylcholanthrene results in increased activity of CYP1A2 protein | CTD | PMID:1617633 more ... |
| 3-methylcholanthrene | increases expression | ISO | RGD:10438 | 6480464 | Methylcholanthrene results in increased expression of CYP1A2 mRNA | CTD | PMID:12117779 more ... |
| 3-methylcholanthrene | increases expression | ISO | RGD:735711 | 6480464 | Methylcholanthrene results in increased expression of CYP1A2 mRNA | CTD | PMID:12107646 more ... |
| 3-methylcholanthrene | increases expression | ISO | RGD:735711 | 6480464 | Methylcholanthrene results in increased expression of CYP1A2 protein | CTD | PMID:9744552 PMID:15769886 |
| 3-methylcholanthrene | increases expression | EXP | | 6480464 | Methylcholanthrene results in increased expression of CYP1A2 protein | CTD | PMID:11999409 more ... |
| 3-methylcholanthrene | increases expression | EXP | | 6480464 | Methylcholanthrene results in increased expression of CYP1A2 mRNA | CTD | PMID:15144902 more ... |
| 3-methylcholanthrene | increases activity | EXP | | 6480464 | Methylcholanthrene results in increased activity of CYP1A2 protein | CTD | PMID:15302093 more ... |
| 3-methylcholanthrene | increases expression | ISO | RGD:10438 | 6480464 | Methylcholanthrene results in increased expression of CYP1A2 protein | CTD | PMID:19679878 more ... |
| 3-methylcholanthrene | increases expression | ISO | RGD:10438 | 6480464 | Methylcholanthrene results in increased expression of CYP1A2 mRNA | CTD | PMID:16639589 more ... |
| 3-methylcholanthrene | increases expression | ISO | RGD:735711 | 6480464 | Methylcholanthrene results in increased expression of CYP1A2 mRNA | CTD | PMID:19022236 more ... |
| 3-methylcholanthrene | increases expression | EXP | | 6480464 | Methylcholanthrene results in increased expression of CYP1A2 protein | CTD | PMID:9152597 more ... |
| 3-methylcholanthrene | increases expression | EXP | | 6480464 | Methylcholanthrene results in increased expression of CYP1A2 mRNA | CTD | PMID:15144902 more ... |
| 3-methylcholanthrene | increases activity | EXP | | 6480464 | Methylcholanthrene results in increased activity of CYP1A2 protein | CTD | PMID:1617633 more ... |
| 3-methylcholanthrene | increases expression | ISO | RGD:10438 | 6480464 | Methylcholanthrene results in increased expression of CYP1A2 mRNA | CTD | PMID:19525444 more ... |
| 3-methylcholanthrene | increases expression | ISO | RGD:10438 | 6480464 | Methylcholanthrene results in increased expression of CYP1A2 protein | CTD | PMID:16639589 more ... |
| 3-methylcholanthrene | increases expression | ISO | RGD:735711 | 6480464 | Methylcholanthrene results in increased expression of CYP1A2 mRNA | CTD | PMID:19135037 more ... |
| 3-methylcholanthrene | increases expression | EXP | | 6480464 | Methylcholanthrene results in increased expression of CYP1A2 protein | CTD | PMID:11999409 more ... |
| 3-methylcholanthrene | increases expression | EXP | | 6480464 | Methylcholanthrene results in increased expression of CYP1A2 mRNA | CTD | PMID:15144902 more ... |
| 3-methylcholanthrene | increases activity | EXP | | 6480464 | Methylcholanthrene results in increased activity of CYP1A2 protein | CTD | PMID:1617633 more ... |
| 3-methylcholanthrene | increases expression | ISO | RGD:10438 | 6480464 | Methylcholanthrene results in increased expression of CYP1A2 mRNA | CTD | PMID:11549291 more ... |
| 3-methylcholanthrene | increases expression | ISO | RGD:10438 | 6480464 | Methylcholanthrene results in increased expression of CYP1A2 protein | CTD | PMID:16639589 more ... |
| 3-methylcholanthrene | increases expression | ISO | RGD:735711 | 6480464 | Methylcholanthrene results in increased expression of CYP1A2 mRNA | CTD | PMID:15769886 more ... |
| 3-methylcholanthrene | increases activity | ISO | RGD:735711 | 6480464 | Methylcholanthrene results in increased activity of CYP1A2 protein | CTD | PMID:19022236 PMID:19135037 |
| 3-methylcholanthrene | multiple interactions | ISO | RGD:735711 | 6480464 | AHR protein affects the susceptibility to [Methylcholanthrene results in increased expression of CYP1A2 mRNA] | CTD | PMID:20171196 |
| 3-methylcholanthrene | multiple interactions | EXP | | 6480464 | protocatechuic acid inhibits the reaction [Methylcholanthrene results in increased activity of CYP1A2 protein] | CTD | PMID:15302093 |
| 3-methylcholanthrene | increases expression | EXP | | 6480464 | Methylcholanthrene results in increased expression of CYP1A2 protein | CTD | PMID:11999409 more ... |
| 3-methylcholanthrene | increases expression | EXP | | 6480464 | Methylcholanthrene results in increased expression of CYP1A2 mRNA | CTD | PMID:15144902 more ... |
| 3-methylcholanthrene | multiple interactions | EXP | | 6480464 | [[Methylcholanthrene results in increased expression of CYP1A1 protein] co-treated with [Methylcholanthrene results in increased expression of CYP1A2 protein]] results in decreased susceptibility to Trp-P-1; more ... | CTD | PMID:11999409 |
| 3-methylcholanthrene | multiple interactions | EXP | | 6480464 | [Methylcholanthrene results in increased activity of CYP1A2 protein] which results in increased oxidation of Uroporphyrinogens | CTD | PMID:1617633 |
| 3-methylcholanthrene | multiple interactions | EXP | | 6480464 | Methylcholanthrene results in increased expression of and results in increased activity of CYP1A2 protein | CTD | PMID:15946133 |
| 3-methylcholanthrene | increases activity | EXP | | 6480464 | Methylcholanthrene results in increased activity of CYP1A2 protein | CTD | PMID:15302093 more ... |
| 3-methylcholanthrene | multiple interactions | EXP | | 6480464 | Methylcholanthrene promotes the reaction [CYP1A2 protein results in increased oxidation of Toluene] | CTD | PMID:1994898 |
| 3-methylcholanthrene | multiple interactions | EXP | | 6480464 | Methylcholanthrene inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | CTD | PMID:18493746 |
| 3-methylcholanthrene | increases expression | ISO | RGD:10438 | 6480464 | Methylcholanthrene results in increased expression of CYP1A2 protein | CTD | PMID:19679878 PMID:16639589 |
| 3-methylcholanthrene | increases expression | ISO | RGD:10438 | 6480464 | Methylcholanthrene results in increased expression of CYP1A2 mRNA | CTD | PMID:16639589 more ... |
| 3-methylcholanthrene | multiple interactions | ISO | RGD:10438 | 6480464 | [Methylcholanthrene binds to and results in increased activity of AHR protein] which results in increased expression of CYP1A2 mRNA | CTD | PMID:21498875 |
| 3-methylcholanthrene | increases activity | ISO | RGD:10438 | 6480464 | Methylcholanthrene results in increased activity of CYP1A2 protein | CTD | PMID:16639589 |
| 3-methylcholanthrene | affects response to substance | ISO | RGD:10438 | 6480464 | CYP1A2 affects the susceptibility to Methylcholanthrene | CTD | PMID:19772856 |
| 3-methylcholanthrene | increases expression | ISO | RGD:735711 | 6480464 | Methylcholanthrene results in increased expression of CYP1A2 protein | CTD | PMID:15769886 PMID:9744552 |
| 3-methylcholanthrene | increases expression | ISO | RGD:735711 | 6480464 | Methylcholanthrene results in increased expression of CYP1A2 mRNA | CTD | PMID:19135037 more ... |
| 3-methylcholanthrene | increases activity | ISO | RGD:735711 | 6480464 | Methylcholanthrene results in increased activity of CYP1A2 protein | CTD | PMID:19135037 PMID:19022236 |
| 3-methylcholanthrene | multiple interactions | ISO | RGD:735711 | 6480464 | Methylcholanthrene inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | CTD | PMID:18493746 |
| 3-methylcholanthrene | multiple interactions | ISO | RGD:735711 | 6480464 | [Dexamethasone co-treated with Mifepristone] promotes the reaction [Methylcholanthrene results in increased activity of CYP1A2 protein]; more ... | CTD | PMID:19022236 |
| 3-methylcholanthrene | multiple interactions | ISO | RGD:735711 | 6480464 | [Celsior co-treated with Methylcholanthrene] results in increased expression of CYP1A2 mRNA | CTD | PMID:15448115 |
| 3-methylcholanthrene | increases expression | ISO | RGD:10438 | 6480464 | Methylcholanthrene results in increased expression of CYP1A2 mRNA | CTD | PMID:11356909 more ... |
| 3-methylquinoline | decreases activity | ISO | RGD:735711 | 6480464 | 3-methylquinoline results in decreased activity of CYP1A2 protein | CTD | PMID:15916432 |
| 3H-1,2-dithiole-3-thione | decreases expression | EXP | | 6480464 | 1,2-dithiol-3-thione results in decreased expression of CYP1A2 mRNA | CTD | PMID:19162173 |
| 4',5,7-trihydroxy-3'-methoxyflavone | multiple interactions | ISO | RGD:735711 | 6480464 | chrysoeriol inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] | CTD | PMID:20553787 |
| 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one | multiple interactions | ISO | RGD:735711 | 6480464 | CYP1A2 protein affects the metabolism of and results in increased activity of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | CTD | PMID:11774366 |
| 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one | increases activity | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased activity of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | CTD | PMID:15728263 |
| 4-chlorobiphenyl | decreases activity | ISO | RGD:735711 | 6480464 | 4-chlorobiphenyl results in decreased activity of CYP1A2 protein | CTD | PMID:15916432 |
| 4-coumaric acid | decreases activity | ISO | RGD:735711 | 6480464 | 4-coumaric acid results in decreased activity of CYP1A2 protein | CTD | PMID:15841493 |
| 4-hydroxynon-2-enal | multiple interactions | ISO | RGD:735711 | 6480464 | [CYP1A2 protein results in increased reduction of 4-hydroxy-2-nonenal] which results in increased chemical synthesis of 1,4-dihydroxy-2-nonene; more ... | CTD | PMID:21766881 |
| 4-nitroaniline | increases activity | EXP | | 6480464 | 4-nitroaniline analog results in increased activity of CYP1A2 protein | CTD | PMID:9545601 |
| 4-nitroaniline | increases expression | EXP | | 6480464 | 4-nitroaniline analog results in increased expression of CYP1A2 mRNA; more ... | CTD | PMID:7553614 PMID:9545601 |
| 4-nitroaniline | increases expression | EXP | | 6480464 | 4-nitroaniline analog results in increased expression of CYP1A2 mRNA; more ... | CTD | PMID:9545601 PMID:7553614 |
| 4-nitrophenol | increases hydroxylation | EXP | | 6480464 | CYP1A2 protein results in increased hydroxylation of 4-nitrophenol | CTD | PMID:11911841 |
| 5,7-dihydroxy-4'-methoxyflavone | decreases activity | ISO | RGD:735711 | 6480464 | acacetin results in decreased activity of CYP1A2 protein | CTD | PMID:21053930 |
| 5-aza-2'-deoxycytidine | increases expression | ISO | RGD:735711 | 6480464 | decitabine results in increased expression of CYP1A2 mRNA | CTD | PMID:19274061 |
| 5-azacytidine | multiple interactions | ISO | RGD:735711 | 6480464 | Azacitidine promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | CTD | PMID:12927368 |
| 5-azacytidine | increases expression | ISO | RGD:735711 | 6480464 | Azacitidine results in increased expression of CYP1A2 mRNA | CTD | PMID:12927368 |
| 7,12-dimethyltetraphene | multiple interactions | ISO | RGD:10438 | 6480464 | [CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene; more ... | CTD | PMID:8961944 |
| 7,12-dimethyltetraphene | increases expression | ISO | RGD:735711 | 6480464 | 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A2 mRNA | CTD | PMID:19276279 PMID:17183067 |
| 7,12-dimethyltetraphene | increases activity | ISO | RGD:735711 | 6480464 | 9,10-Dimethyl-1,2-benzanthracene results in increased activity of CYP1A2 protein | CTD | PMID:17183067 |
| 7,12-dimethyltetraphene | increases expression | ISO | RGD:735711 | 6480464 | 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A2 mRNA | CTD | PMID:17183067 PMID:19276279 |
| 7,12-dimethyltetraphene | multiple interactions | ISO | RGD:735711 | 6480464 | [CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene; more ... | CTD | PMID:8961944 |
| 7,12-dimethyltetraphene | multiple interactions | ISO | RGD:735711 | 6480464 | 3-(3-methoxyphenyl)-N-(3,4,5-trimethoxyphenyl)acrylamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased activity of CYP1A2 protein]; more ... | CTD | PMID:17183067 |
| 7,12-dimethyltetraphene | multiple interactions | ISO | RGD:735711 | 6480464 | 2-((2,6-dichlorophenyl)amino)benzeneacetic acid 4-(3H-1,2-dithiol-3-thione-5-yl)phenyl ester inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A2 mRNA]; more ... | CTD | PMID:19276279 |
| 7,12-dimethyltetraphene | increases activity | ISO | RGD:10438 | 6480464 | CYP1A2 protein results in increased activity of 9,10-Dimethyl-1,2-benzanthracene | CTD | PMID:15606143 |
| 7,12-dimethyltetraphene | increases activity | EXP | | 6480464 | 9,10-Dimethyl-1,2-benzanthracene results in increased activity of CYP1A2 protein | CTD | PMID:16054776 |
| acenaphthene | increases activity | ISO | RGD:10438 | 6480464 | acenaphthene results in increased activity of CYP1A2 protein | CTD | PMID:8001243 |
| acenaphthene | multiple interactions | ISO | RGD:10438 | 6480464 | [acenaphthylene co-treated with acenaphthene co-treated with dibenzofuran co-treated with fluorene co-treated with phenanthrene co-treated with anthracene] results in increased expression of CYP1A2 mRNA | CTD | PMID:7750161 |
| acenaphthylene | increases expression | ISO | RGD:10438 | 6480464 | acenaphthylene results in increased expression of CYP1A2 mRNA; more ... | CTD | PMID:8001243 |
| acenaphthylene | multiple interactions | ISO | RGD:10438 | 6480464 | [acenaphthylene co-treated with acenaphthene co-treated with dibenzofuran co-treated with fluorene co-treated with phenanthrene co-treated with anthracene] results in increased expression of CYP1A2 mRNA | CTD | PMID:7750161 |
| acenaphthylene | increases activity | ISO | RGD:10438 | 6480464 | acenaphthylene results in increased activity of CYP1A2 protein | CTD | PMID:8001243 PMID:10977129 |
| acenaphthylene | increases activity | ISO | RGD:10438 | 6480464 | acenaphthylene results in increased activity of CYP1A2 protein | CTD | PMID:10977129 PMID:8001243 |
| acenocoumarol | affects metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein affects the metabolism of Acenocoumarol | CTD | PMID:11918509 |
| acephate | multiple interactions | ISO | RGD:10438 | 6480464 | [fenarimol co-treated with acephate] affects the expression of CYP1A2 protein; more ... | CTD | PMID:17686559 |
| acetone | multiple interactions | EXP | | 6480464 | Acetone promotes the reaction [Toluene results in increased expression of CYP1A2 protein] | CTD | PMID:8996725 |
| aconitine | multiple interactions | ISO | RGD:735711 | 6480464 | [Fluvoxamine results in decreased activity of CYP1A2 protein] which results in increased chemical synthesis of Aconitine metabolite | CTD | PMID:21277363 |
| actinomycin D | multiple interactions | ISO | RGD:735711 | 6480464 | Dactinomycin inhibits the reaction [15,16-dihydrotanshinone I results in increased expression of CYP1A2 mRNA]; more ... | CTD | PMID:21262253 |
| aflatoxin B1 | increases activity | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased activity of Aflatoxin B1 | CTD | PMID:15988000 |
| aflatoxin B1 | increases expression | ISO | RGD:735711 | 6480464 | Aflatoxin B1 results in increased expression of CYP1A2 mRNA | CTD | PMID:21994236 |
| aflatoxin B1 | increases metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased metabolism of Aflatoxin B1 | CTD | PMID:22743290 |
| aflatoxin B1 | multiple interactions | ISO | RGD:735711 | 6480464 | CYP1A2 protein promotes the reaction [Aflatoxin B1 binds to Deoxyguanosine] | CTD | PMID:21907773 |
| aflatoxin B1 | multiple interactions | ISO | RGD:735711 | 6480464 | [CYP1A2 protein results in increased metabolism of Aflatoxin B1] which results in increased chemical synthesis of aflatoxin B1-2,3-oxide; more ... | CTD | PMID:20707407 |
| aflatoxin B1 | decreases expression | ISO | RGD:10438 | 6480464 | Aflatoxin B1 results in decreased expression of CYP1A2 mRNA | CTD | PMID:19770486 |
| aflatoxin B1 | increases response to substance | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased susceptibility to Aflatoxin B1 | CTD | PMID:11189750 |
| aflatoxin B1 exo-8,9-epoxide | multiple interactions | ISO | RGD:735711 | 6480464 | [CYP1A2 protein results in increased metabolism of Aflatoxin B1] which results in increased chemical synthesis of aflatoxin B1-2,3-oxide | CTD | PMID:20707407 |
| alachlor | increases expression | EXP | | 6480464 | alachlor results in increased expression of CYP1A2 protein | CTD | PMID:11850968 |
| albendazole | increases expression | ISO | RGD:735711 | 6480464 | Albendazole results in increased expression of CYP1A2 mRNA | CTD | PMID:12451431 |
| albendazole | affects metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein affects the metabolism of Albendazole | CTD | PMID:12920490 |
| alizarin | decreases activity | ISO | RGD:735711 | 6480464 | alizarin results in decreased activity of CYP1A2 protein | CTD | PMID:12379470 |
| all-trans-retinoic acid | increases expression | ISO | RGD:735711 | 6480464 | Tretinoin results in increased expression of CYP1A2 mRNA | CTD | PMID:16985168 |
| all-trans-retinoic acid | decreases expression | ISO | RGD:735711 | 6480464 | Tretinoin results in decreased expression of CYP1A2 mRNA | CTD | PMID:16882163 |
| allocryptopine | increases expression | ISO | RGD:735711 | 6480464 | allocryptopine results in increased expression of CYP1A2 mRNA | CTD | PMID:21419197 |
| allyl alcohol | decreases expression | EXP | | 6480464 | allyl alcohol results in decreased expression of CYP1A2 protein | CTD | PMID:10547960 |
| almotriptan | decreases methylation | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in decreased methylation of almotriptan | CTD | PMID:12642466 |
| alpha-linolenic acid | decreases activity | ISO | RGD:735711 | 6480464 | alpha-Linolenic Acid results in decreased activity of CYP1A2 protein | CTD | PMID:16978661 |
| ametryn | multiple interactions | ISO | RGD:735711 | 6480464 | POR protein promotes the reaction [CYP1A2 protein results in increased metabolism of ametryne] | CTD | PMID:8971136 |
| ametryn | increases metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased metabolism of ametryne | CTD | PMID:8971136 |
| amiodarone | decreases activity | ISO | RGD:735711 | 6480464 | Amiodarone results in decreased activity of CYP1A2 protein | CTD | PMID:16449812 |
| amitraz | increases expression | EXP | | 6480464 | amitraz results in increased expression of CYP1A2 protein | CTD | PMID:15350676 |
| amitriptyline | increases metabolic processing | ISO | RGD:735711 | 6480464 | Amitriptyline results in increased metabolism of CYP1A2 protein | CTD | PMID:18359012 |
| amodiaquine | decreases activity | ISO | RGD:735711 | 6480464 | Amodiaquine results in decreased activity of CYP1A2 protein | CTD | PMID:11124226 |
| amphetamine | affects chemical synthesis | ISO | RGD:735711 | 6480464 | CYP1A2 protein affects the chemical synthesis of Amphetamine | CTD | PMID:15294457 |
| andrographolide | decreases expression | ISO | RGD:735711 | 6480464 | andrographolide results in decreased expression of CYP1A2 mRNA | CTD | PMID:19041297 |
| andrographolide | multiple interactions | EXP | | 6480464 | andrographolide affects the reaction [CYP1A2 protein results in increased metabolism of Theophylline] | CTD | PMID:20096675 |
| andrographolide | increases expression | EXP | | 6480464 | andrographolide results in increased expression of CYP1A2 mRNA | CTD | PMID:19041297 |
| andrographolide | multiple interactions | ISO | RGD:10438 | 6480464 | [andrographolide co-treated with beta-Naphthoflavone] results in increased expression of CYP1A2 mRNA | CTD | PMID:19737545 |
| andrographolide | increases expression | ISO | RGD:10438 | 6480464 | andrographolide results in increased expression of CYP1A2 mRNA | CTD | PMID:17825862 |
| andrographolide | multiple interactions | ISO | RGD:10438 | 6480464 | [andrographolide co-treated with benz(a)anthracene] results in increased expression of CYP1A2 mRNA | CTD | PMID:17825862 |
| angelicin | increases expression | ISO | RGD:10438 | 6480464 | angelicin results in increased expression of CYP1A2 protein | CTD | PMID:18692084 |
| aniline | multiple interactions | ISO | RGD:735711 | 6480464 | CYP1A2 protein affects the metabolism of [norharman co-treated with aniline] | CTD | PMID:15279827 |
| aniline | increases expression | EXP | | 6480464 | aniline analog results in increased expression of CYP1A2 mRNA; more ... | CTD | PMID:16639589 |
| aniline | increases activity | EXP | | 6480464 | aniline analog results in increased activity of CYP1A2 protein | CTD | PMID:16639589 |
| anthracen-2-amine | multiple interactions | ISO | RGD:735711 | 6480464 | CYB5 protein promotes the reaction [CYP1A2 protein results in increased activity of 2-anthramine] | CTD | PMID:15728263 |
| anthracen-2-amine | affects metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein affects the metabolism of 2-anthramine | CTD | PMID:2655891 |
| anthracen-2-amine | increases activity | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased activity of 2-anthramine | CTD | PMID:15728263 |
| anthracene | increases activity | ISO | RGD:10438 | 6480464 | anthracene results in increased activity of CYP1A2 protein | CTD | PMID:8001243 |
| anthracene | multiple interactions | ISO | RGD:10438 | 6480464 | [acenaphthylene co-treated with acenaphthene co-treated with dibenzofuran co-treated with fluorene co-treated with phenanthrene co-treated with anthracene] results in increased expression of CYP1A2 mRNA | CTD | PMID:7750161 |
| anthracene | multiple interactions | ISO | RGD:735711 | 6480464 | alyssin inhibits the reaction [anthracene results in increased activity of CYP1A2 protein]; more ... | CTD | PMID:19362136 |
| anthracene | increases activity | ISO | RGD:735711 | 6480464 | anthracene results in increased activity of CYP1A2 protein | CTD | PMID:19362136 |
| apigenin | decreases activity | ISO | RGD:735711 | 6480464 | Apigenin results in decreased activity of CYP1A2 protein | CTD | PMID:21053930 |
| apigenin | decreases activity | ISO | RGD:735711 | 6480464 | Apigenin results in decreased activity of CYP1A2 protein | CTD | PMID:20806393 PMID:21053930 |
| arachidonic acid | decreases activity | ISO | RGD:735711 | 6480464 | Arachidonic Acid results in decreased activity of CYP1A2 protein | CTD | PMID:16978661 |
| aristolochic acid | increases metabolic processing | EXP | | 6480464 | CYP1A2 protein results in increased metabolism of aristolochic acid I | CTD | PMID:21362632 |
| aristolochic acid | increases chemical synthesis | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased chemical synthesis of aristolochic acid I metabolite | CTD | PMID:22086975 |
| aristolochic acid | multiple interactions | ISO | RGD:735711 | 6480464 | [CYP1A2 protein results in increased oxidation of aristolochic acid I] which results in increased chemical synthesis of aristolochic acid I metabolite; more ... | CTD | PMID:22086975 |
| aristolochic acid | increases oxidation | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased oxidation of aristolochic acid I | CTD | PMID:22086975 |
| aristolochic acid | multiple interactions | ISO | RGD:10438 | 6480464 | [[alpha-naphthoflavone results in decreased activity of CYP1A2 protein] co-treated with [alpha-naphthoflavone results in decreased activity of CYP1A1 protein]] inhibits the reaction [aristolochic acid I results in increased abundance of [7-(deoxyadenosin-N(6)-yl)aristolactam I co-treated with 7-(deoxyguanosin-N(2)-yl)aristolactam I co-treated with 7-(deoxyadenosin-N(6)--yl)aristolactam II]]; more ... | CTD | PMID:21932800 |
| aristolochic acid | increases abundance | EXP | | 6480464 | CYP1A2 protein results in increased abundance of aristolochic acid I metabolite | CTD | PMID:21362632 |
| Aroclor 1254 | increases expression | ISO | RGD:735711 | 6480464 | Chlorodiphenyl (54% Chlorine) results in increased expression of CYP1A2 mRNA | CTD | PMID:17851650 more ... |
| Aroclor 1254 | increases expression | EXP | | 6480464 | Chlorodiphenyl (54% Chlorine) results in increased expression of CYP1A2 mRNA | CTD | PMID:11163329 more ... |
| Aroclor 1254 | increases expression | EXP | | 6480464 | Chlorodiphenyl (54% Chlorine) results in increased expression of CYP1A2 mRNA | CTD | PMID:16049271 more ... |
| Aroclor 1254 | increases expression | ISO | RGD:735711 | 6480464 | Chlorodiphenyl (54% Chlorine) results in increased expression of CYP1A2 mRNA | CTD | PMID:16049271 more ... |
| Aroclor 1254 | increases expression | ISO | RGD:735711 | 6480464 | Chlorodiphenyl (54% Chlorine) results in increased expression of CYP1A2 mRNA | CTD | PMID:16934159 more ... |
| Aroclor 1254 | increases expression | EXP | | 6480464 | Chlorodiphenyl (54% Chlorine) results in increased expression of CYP1A2 mRNA | CTD | PMID:8471063 more ... |
| Aroclor 1254 | increases expression | EXP | | 6480464 | Chlorodiphenyl (54% Chlorine) results in increased expression of CYP1A2 mRNA | CTD | PMID:8471063 more ... |
| Aroclor 1254 | increases expression | EXP | | 6480464 | Chlorodiphenyl (54% Chlorine) results in increased expression of CYP1A2 mRNA | CTD | PMID:18178546 more ... |
| Aroclor 1254 | increases expression | ISO | RGD:735711 | 6480464 | Chlorodiphenyl (54% Chlorine) results in increased expression of CYP1A2 mRNA | CTD | PMID:17851650 more ... |
| Aroclor 1254 | increases expression | EXP | | 6480464 | Chlorodiphenyl (54% Chlorine) results in increased expression of CYP1A2 protein | CTD | PMID:8471063 |
| Aroclor 1254 | increases expression | EXP | | 6480464 | Chlorodiphenyl (54% Chlorine) results in increased expression of CYP1A2 mRNA | CTD | PMID:18178546 more ... |
| Aroclor 1254 | increases activity | EXP | | 6480464 | Chlorodiphenyl (54% Chlorine) results in increased activity of CYP1A2 protein | CTD | PMID:8471063 PMID:11713002 |
| Aroclor 1254 | increases expression | ISO | RGD:735711 | 6480464 | Chlorodiphenyl (54% Chlorine) results in increased expression of CYP1A2 protein | CTD | PMID:17851650 |
| Aroclor 1254 | affects response to substance | ISO | RGD:10438 | 6480464 | CYP1A2 affects the susceptibility to Chlorodiphenyl (54% Chlorine) | CTD | PMID:19772856 |
| Aroclor 1254 | increases expression | ISO | RGD:735711 | 6480464 | Chlorodiphenyl (54% Chlorine) results in increased expression of CYP1A2 mRNA | CTD | PMID:16934159 more ... |
| Aroclor 1254 | increases expression | EXP | | 6480464 | Chlorodiphenyl (54% Chlorine) results in increased expression of CYP1A2 mRNA | CTD | PMID:18178546 more ... |
| Aroclor 1254 | increases activity | EXP | | 6480464 | Chlorodiphenyl (54% Chlorine) results in increased activity of CYP1A2 protein | CTD | PMID:11713002 PMID:8471063 |
| arsenite(3-) | multiple interactions | EXP | | 6480464 | arsenite inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA]; more ... | CTD | PMID:22159698 |
| aspartame | increases activity | EXP | | 6480464 | Aspartame results in increased activity of CYP1A2 protein | CTD | PMID:16937917 |
| atrazine | increases activity | EXP | | 6480464 | Atrazine results in increased activity of CYP1A2 protein | CTD | PMID:9711812 |
| atrazine | increases expression | ISO | RGD:735711 | 6480464 | Atrazine results in increased expression of CYP1A2 mRNA | CTD | PMID:22310298 |
| atrazine | increases activity | ISO | RGD:735711 | 6480464 | Atrazine results in increased activity of CYP1A2 protein | CTD | PMID:22310298 |
| azoxystrobin | increases expression | ISO | RGD:735711 | 6480464 | azoxystrobin results in increased expression of CYP1A2 mRNA; more ... | CTD | PMID:21784029 |
| baicalein | increases chemical synthesis | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased chemical synthesis of baicalein | CTD | PMID:19666078 |
| baicalein | decreases activity | ISO | RGD:735711 | 6480464 | baicalein results in decreased activity of CYP1A2 protein | CTD | PMID:21053930 |
| baicalein | multiple interactions | ISO | RGD:735711 | 6480464 | [CYP1A2 protein results in increased metabolism of chrysin] which results in increased chemical synthesis of baicalein | CTD | PMID:19666078 |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of CYP1A2 mRNA | CTD | PMID:17973897 more ... |
| benzo[a]pyrene | multiple interactions | EXP | | 6480464 | lead nitrate inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 protein] | CTD | PMID:8902619 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:10438 | 6480464 | Bucladesine affects the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA]; more ... | CTD | PMID:1849469 |
| benzo[a]pyrene | increases expression | ISO | RGD:10438 | 6480464 | Benzo(a)pyrene results in increased expression of CYP1A2 mRNA | CTD | PMID:11171528 more ... |
| benzo[a]pyrene | decreases expression | ISO | RGD:10438 | 6480464 | Benzo(a)pyrene results in decreased expression of CYP1A2 mRNA | CTD | PMID:15034205 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:10438 | 6480464 | AHR protein inhibits the reaction [Benzo(a)pyrene results in decreased expression of CYP1A2 mRNA] | CTD | PMID:15034205 |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of CYP1A2 protein | CTD | PMID:8902619 |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of CYP1A2 mRNA | CTD | PMID:16510159 more ... |
| benzo[a]pyrene | increases expression | ISO | RGD:735711 | 6480464 | Benzo(a)pyrene results in increased expression of CYP1A2 mRNA | CTD | PMID:12107646 more ... |
| benzo[a]pyrene | increases expression | ISO | RGD:735711 | 6480464 | Benzo(a)pyrene results in increased expression of CYP1A2 mRNA | CTD | PMID:12107646 more ... |
| benzo[a]pyrene | decreases activity | ISO | RGD:735711 | 6480464 | Benzo(a)pyrene results in decreased activity of CYP1A2 protein | CTD | PMID:11162773 |
| benzo[a]pyrene | multiple interactions | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of and results in increased activity of CYP1A2 protein | CTD | PMID:16510159 PMID:22785257 |
| benzo[a]pyrene | increases expression | ISO | RGD:10438 | 6480464 | Benzo(a)pyrene results in increased expression of CYP1A2 mRNA | CTD | PMID:11171528 more ... |
| benzo[a]pyrene | multiple interactions | ISO | RGD:10438 | 6480464 | [Benzo(a)pyrene co-treated with sodium bichromate] results in decreased expression of CYP1A2 mRNA | CTD | PMID:22613061 |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of CYP1A2 mRNA | CTD | PMID:16510159 more ... |
| benzo[a]pyrene | multiple interactions | ISO | RGD:10438 | 6480464 | Lipopolysaccharides inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] | CTD | PMID:22466549 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:735711 | 6480464 | [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of CYP1A2 mRNA; more ... | CTD | PMID:17690111 |
| benzo[a]pyrene | multiple interactions | EXP | | 6480464 | [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of CYP1A2 mRNA; more ... | CTD | PMID:18711122 |
| benzo[a]pyrene | increases activity | EXP | | 6480464 | Benzo(a)pyrene results in increased activity of CYP1A2 mRNA; more ... | CTD | PMID:21505853 |
| benzo[a]pyrene | increases activity | ISO | RGD:735711 | 6480464 | Benzo(a)pyrene results in increased activity of CYP1A2 protein | CTD | PMID:19202560 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:735711 | 6480464 | 2-oxohexyl isothiocyanate inhibits the reaction [Benzo(a)pyrene results in increased activity of CYP1A2 protein]; more ... | CTD | PMID:19202560 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:10438 | 6480464 | [fluoranthene co-treated with pyrene co-treated with benz(a)anthracene co-treated with chrysene co-treated with benzo(b)fluoranthene co-treated with benzo(k)fluoranthene co-treated with Benzo(a)pyrene] results in increased expression of CYP1A2 mRNA | CTD | PMID:7750161 |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of CYP1A2 mRNA | CTD | PMID:16510159 more ... |
| benzo[a]pyrene | increases expression | ISO | RGD:10438 | 6480464 | Benzo(a)pyrene results in increased expression of CYP1A2 mRNA | CTD | PMID:11171528 more ... |
| benzo[a]pyrene | multiple interactions | ISO | RGD:735711 | 6480464 | kaempferol inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA]; more ... | CTD | PMID:21256954 |
| benzo[a]pyrene | increases expression | ISO | RGD:735711 | 6480464 | Benzo(a)pyrene results in increased expression of CYP1A2 mRNA | CTD | PMID:12107646 more ... |
| benzo[a]pyrene | increases expression | ISO | RGD:735711 | 6480464 | Benzo(a)pyrene results in increased expression of CYP1A2 protein | CTD | PMID:11849738 more ... |
| benzo[a]pyrene | multiple interactions | ISO | RGD:735711 | 6480464 | 15,16-dihydrotanshinone I promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA]; more ... | CTD | PMID:21262253 |
| benzo[a]pyrene | increases expression | ISO | RGD:10438 | 6480464 | Benzo(a)pyrene results in increased expression of CYP1A2 mRNA | CTD | PMID:20371670 more ... |
| benzo[a]pyrene | increases activity | ISO | RGD:10438 | 6480464 | Benzo(a)pyrene results in increased activity of CYP1A2 protein | CTD | PMID:15863256 PMID:18321868 |
| benzo[a]pyrene | increases expression | ISO | RGD:10438 | 6480464 | Benzo(a)pyrene results in increased expression of CYP1A2 mRNA | CTD | PMID:14562683 more ... |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of CYP1A2 mRNA | CTD | PMID:16510159 more ... |
| benzo[a]pyrene | increases expression | ISO | RGD:735711 | 6480464 | Benzo(a)pyrene results in increased expression of CYP1A2 protein | CTD | PMID:11849738 PMID:20542099 |
| benzo[a]pyrene | increases expression | ISO | RGD:735711 | 6480464 | Benzo(a)pyrene results in increased expression of CYP1A2 mRNA | CTD | PMID:16545412 more ... |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of CYP1A2 mRNA | CTD | PMID:17973897 more ... |
| benzo[a]pyrene | increases expression | ISO | RGD:10438 | 6480464 | Benzo(a)pyrene results in increased expression of CYP1A2 mRNA | CTD | PMID:19406224 more ... |
| benzo[a]pyrene | increases expression | ISO | RGD:735711 | 6480464 | Benzo(a)pyrene results in increased expression of CYP1A2 protein | CTD | PMID:20542099 more ... |
| benzo[a]pyrene | increases expression | ISO | RGD:735711 | 6480464 | Benzo(a)pyrene results in increased expression of CYP1A2 mRNA | CTD | PMID:15056799 more ... |
| benzo[a]pyrene | increases expression | ISO | RGD:735711 | 6480464 | Benzo(a)pyrene results in increased expression of CYP1A2 protein | CTD | PMID:11849738 more ... |
| benzo[a]pyrene | increases expression | ISO | RGD:735711 | 6480464 | Benzo(a)pyrene results in increased expression of CYP1A2 mRNA | CTD | PMID:12107646 more ... |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of CYP1A2 mRNA | CTD | PMID:19497421 PMID:16510159 |
| benzo[a]pyrene | increases expression | ISO | RGD:10438 | 6480464 | Benzo(a)pyrene results in increased expression of CYP1A2 protein | CTD | PMID:18321868 PMID:17997381 |
| benzo[a]pyrene | increases expression | ISO | RGD:10438 | 6480464 | Benzo(a)pyrene results in increased expression of CYP1A2 mRNA | CTD | PMID:19961161 more ... |
| benzo[a]pyrene | increases expression | ISO | RGD:735711 | 6480464 | Benzo(a)pyrene results in increased expression of CYP1A2 mRNA | CTD | PMID:15056799 more ... |
| benzo[a]pyrene | increases expression | ISO | RGD:10438 | 6480464 | Benzo(a)pyrene results in increased expression of CYP1A2 mRNA | CTD | PMID:19961161 more ... |
| benzo[a]pyrene | increases expression | ISO | RGD:735711 | 6480464 | Benzo(a)pyrene results in increased expression of CYP1A2 mRNA | CTD | PMID:20553787 more ... |
| benzo[a]pyrene | increases expression | ISO | RGD:10438 | 6480464 | Benzo(a)pyrene results in increased expression of CYP1A2 protein | CTD | PMID:17997381 PMID:18321868 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:10438 | 6480464 | Curcumin inhibits the reaction [Benzo(a)pyrene results in increased activity of CYP1A2 protein]; more ... | CTD | PMID:18321868 |
| benzo[a]pyrene | increases expression | ISO | RGD:10438 | 6480464 | Benzo(a)pyrene results in increased expression of CYP1A2 mRNA | CTD | PMID:19896525 more ... |
| benzo[a]pyrene | multiple interactions | ISO | RGD:10438 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in increased expression of CYP1A2 mRNA | CTD | PMID:21715664 |
| benzo[a]pyrene | increases activity | ISO | RGD:10438 | 6480464 | Benzo(a)pyrene results in increased activity of CYP1A2 protein | CTD | PMID:18321868 PMID:15863256 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:735711 | 6480464 | Melatonin inhibits the reaction [CYP1A2 protein results in increased hydrolysis of Benzo(a)pyrene] | CTD | PMID:19919601 |
| benzo[a]pyrene | increases metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased metabolism of Benzo(a)pyrene | CTD | PMID:2791199 |
| benzo[a]pyrene | increases hydrolysis | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased hydrolysis of Benzo(a)pyrene | CTD | PMID:19919601 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:735711 | 6480464 | [CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of Benzo(a)pyrene; more ... | CTD | PMID:8961944 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:735711 | 6480464 | chrysoeriol inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] | CTD | PMID:20553787 |
| benzo[a]pyrene | affects metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein affects the metabolism of Benzo(a)pyrene | CTD | PMID:20542099 |
| benzo[a]pyrene | increases expression | ISO | RGD:735711 | 6480464 | Benzo(a)pyrene results in increased expression of CYP1A2 protein | CTD | PMID:20542099 PMID:11849738 |
| benzo[a]pyrene | increases expression | ISO | RGD:735711 | 6480464 | Benzo(a)pyrene results in increased expression of CYP1A2 mRNA | CTD | PMID:20553787 more ... |
| benzo[a]pyrene | multiple interactions | ISO | RGD:735711 | 6480464 | Benzo(a)pyrene inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | CTD | PMID:18493746 |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of CYP1A2 mRNA | CTD | PMID:16510159 PMID:19497421 |
| benzo[a]pyrene | multiple interactions | EXP | | 6480464 | Benzo(a)pyrene inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | CTD | PMID:18493746 |
| benzo[a]pyrene | multiple interactions | EXP | | 6480464 | atipamezole inhibits the reaction [Dexmedetomidine promotes the reaction [Benzo(a)pyrene results in increased expression of and results in increased activity of CYP1A2 protein]]; more ... | CTD | PMID:16510159 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:10438 | 6480464 | [CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of Benzo(a)pyrene; more ... | CTD | PMID:8961944 |
| benzo[a]pyrene | affects metabolic processing | ISO | RGD:10438 | 6480464 | CYP1A2 protein affects the metabolism of Benzo(a)pyrene | CTD | PMID:16256281 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:735711 | 6480464 | resveratrol inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] | CTD | PMID:10496959 |
| benzo[a]pyrene | increases expression | ISO | RGD:735711 | 6480464 | Benzo(a)pyrene results in increased expression of CYP1A2 mRNA | CTD | PMID:10496959 more ... |
| benzo[b]fluoranthene | increases expression | ISO | RGD:10438 | 6480464 | benzo(b)fluoranthene results in increased expression of CYP1A2 mRNA | CTD | PMID:12117779 |
| benzo[b]fluoranthene | multiple interactions | EXP | | 6480464 | [Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of CYP1A2 mRNA | CTD | PMID:18711122 |
| benzo[b]fluoranthene | increases expression | ISO | RGD:735711 | 6480464 | benzo(b)fluoranthene results in increased expression of CYP1A2 mRNA | CTD | PMID:16269432 PMID:17253728 |
| benzo[b]fluoranthene | multiple interactions | ISO | RGD:735711 | 6480464 | [Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of CYP1A2 mRNA | CTD | PMID:17690111 |
| benzo[b]fluoranthene | decreases activity | ISO | RGD:735711 | 6480464 | benzo(b)fluoranthene results in decreased activity of CYP1A2 protein | CTD | PMID:11162773 |
| benzo[b]fluoranthene | multiple interactions | ISO | RGD:10438 | 6480464 | [fluoranthene co-treated with pyrene co-treated with benz(a)anthracene co-treated with chrysene co-treated with benzo(b)fluoranthene co-treated with benzo(k)fluoranthene co-treated with Benzo(a)pyrene] results in increased expression of CYP1A2 mRNA | CTD | PMID:7750161 |
| benzyl isothiocyanate | increases expression | EXP | | 6480464 | benzyl isothiocyanate results in increased expression of CYP1A2 mRNA | CTD | PMID:22664424 |
| benzyl isothiocyanate | multiple interactions | EXP | | 6480464 | benzyl isothiocyanate results in increased activity of [CYP1A1 protein co-treated with CYP1A2 protein] | CTD | PMID:22664424 |
| benzylideneacetone | increases oxidation | EXP | | 6480464 | CYP1A2 protein results in increased oxidation of benzylideneacetone | CTD | PMID:15863696 |
| berberine | multiple interactions | ISO | RGD:10438 | 6480464 | Berberine inhibits the reaction [beta-Naphthoflavone results in increased expression of CYP1A2 mRNA] | CTD | PMID:22342832 |
| beta-carboline | multiple interactions | ISO | RGD:735711 | 6480464 | CYP1A2 protein affects the metabolism of [norharman co-treated with aniline] | CTD | PMID:15279827 |
| bilirubin | decreases activity | ISO | RGD:10438 | 6480464 | Bilirubin results in decreased activity of CYP1A2 protein | CTD | PMID:16183037 |
| bilobalide | multiple interactions | EXP | | 6480464 | bilobalide results in increased expression of and results in increased activity of CYP1A2 protein | CTD | PMID:18421621 |
| bilobalide | increases expression | EXP | | 6480464 | bilobalide results in increased expression of CYP1A2 mRNA | CTD | PMID:18421621 |
| biochanin A | increases metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased metabolism of biochanin A | CTD | PMID:12814970 |
| biphenyl | decreases activity | ISO | RGD:735711 | 6480464 | diphenyl results in decreased activity of CYP1A2 protein | CTD | PMID:15916432 |
| biphenyl-4-amine | increases activity | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased activity of 4-biphenylamine | CTD | PMID:15450435 |
| biphenyl-4-amine | increases oxidation | EXP | | 6480464 | CYP1A2 protein results in increased oxidation of 4-biphenylamine | CTD | PMID:2908851 |
| biphenyl-4-amine | multiple interactions | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased hydroxylation of and results in increased activity of 4-biphenylamine | CTD | PMID:16988941 |
| biphenyl-4-amine | increases metabolic processing | ISO | RGD:10438 | 6480464 | CYP1A2 protein results in increased metabolism of 4-biphenylamine | CTD | PMID:11376689 |
| biphenyl-4-amine | affects metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein affects the metabolism of 4-biphenylamine | CTD | PMID:2655891 |
| bromobenzene | decreases expression | EXP | | 6480464 | bromobenzene results in decreased expression of CYP1A2 protein | CTD | PMID:10547960 |
| bromodichloromethane | increases metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased metabolism of bromodichloromethane | CTD | PMID:12076521 |
| bromodichloromethane | increases metabolic processing | EXP | | 6480464 | CYP1A2 protein results in increased metabolism of bromodichloromethane | CTD | PMID:11295256 PMID:12076521 |
| bromodichloromethane | increases metabolic processing | EXP | | 6480464 | CYP1A2 protein results in increased metabolism of bromodichloromethane | CTD | PMID:12076521 PMID:11295256 |
| bromodichloromethane | multiple interactions | EXP | | 6480464 | isosafrole inhibits the reaction [CYP1A2 protein affects the metabolism of bromodichloromethane]; more ... | CTD | PMID:12062927 |
| bromodichloromethane | affects metabolic processing | EXP | | 6480464 | CYP1A2 protein affects the metabolism of bromodichloromethane | CTD | PMID:12062927 |
| bromodichloromethane | increases expression | EXP | | 6480464 | bromodichloromethane results in increased expression of CYP1A2 protein | CTD | PMID:11295256 |
| bromodichloromethane | decreases expression | EXP | | 6480464 | bromodichloromethane results in decreased expression of CYP1A2 protein | CTD | PMID:11295256 |
| bucladesine | multiple interactions | ISO | RGD:10438 | 6480464 | Bucladesine affects the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] | CTD | PMID:1849469 |
| C60 fullerene | decreases expression | EXP | | 6480464 | fullerene C60 results in decreased expression of CYP1A2 mRNA | CTD | PMID:19167457 |
| cadmium dichloride | decreases activity | ISO | RGD:735711 | 6480464 | Cadmium Chloride results in decreased activity of CYP1A2 protein | CTD | PMID:11162773 |
| caffeine | affects metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein affects the metabolism of Caffeine | CTD | PMID:15327588 more ... |
| caffeine | multiple interactions | EXP | | 6480464 | Caffeine promotes the reaction [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of CYP1A2 mRNA] | CTD | PMID:12706856 |
| caffeine | multiple interactions | ISO | RGD:735711 | 6480464 | resveratrol promotes the reaction [CYP1A2 protein results in increased metabolism of Caffeine] | CTD | PMID:20716633 |
| caffeine | increases metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased metabolism of Caffeine | CTD | PMID:11907490 PMID:20716633 |
| caffeine | affects metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein affects the metabolism of Caffeine | CTD | PMID:1302044 more ... |
| caffeine | affects metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein affects the metabolism of Caffeine | CTD | PMID:15286053 more ... |
| caffeine | decreases methylation | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in decreased methylation of Caffeine | CTD | PMID:12433797 PMID:11145498 |
| caffeine | affects metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein affects the metabolism of Caffeine | CTD | PMID:15022032 more ... |
| caffeine | affects metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein affects the metabolism of Caffeine | CTD | PMID:15022032 more ... |
| caffeine | multiple interactions | ISO | RGD:735711 | 6480464 | GH1 protein promotes the reaction [CYP1A2 protein results in increased metabolism of Caffeine] | CTD | PMID:11907490 |
| caffeine | multiple interactions | EXP | | 6480464 | CYP1A2 protein binds to and affects the metabolism of Caffeine | CTD | PMID:15659567 |
| caffeine | affects metabolic processing | EXP | | 6480464 | CYP1A2 protein affects the metabolism of Caffeine | CTD | PMID:15619608 |
| caffeine | increases activity | EXP | | 6480464 | Caffeine results in increased activity of CYP1A2 protein | CTD | PMID:15822860 |
| caffeine | decreases methylation | ISO | RGD:10438 | 6480464 | CYP1A2 protein results in decreased methylation of Caffeine | CTD | PMID:11376689 |
| caffeine | multiple interactions | ISO | RGD:735711 | 6480464 | rofecoxib inhibits the reaction [CYP1A2 protein results in increased metabolism of Caffeine] | CTD | PMID:16934051 |
| caffeine | increases metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased metabolism of Caffeine | CTD | PMID:11907490 |
| caffeine | decreases methylation | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in decreased methylation of Caffeine | CTD | PMID:11145498 PMID:12433797 |
| caffeine | affects binding | ISO | RGD:735711 | 6480464 | CYP1A2 protein binds to Caffeine | CTD | PMID:9334905 |
| caffeine | multiple interactions | ISO | RGD:735711 | 6480464 | CYP1A2 protein binds to and affects the metabolism of Caffeine | CTD | PMID:15659567 PMID:15856409 |
| caffeine | affects metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein affects the metabolism of Caffeine | CTD | PMID:14586384 more ... |
| caffeine | multiple interactions | ISO | RGD:735711 | 6480464 | Ciprofloxacin inhibits the reaction [CYP1A2 protein results in decreased methylation of Caffeine] | CTD | PMID:11145498 |
| caffeine | decreases activity | ISO | RGD:735711 | 6480464 | Caffeine results in decreased activity of CYP1A2 protein | CTD | PMID:11465391 |
| caffeine | affects metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein affects the metabolism of Caffeine metabolite | CTD | PMID:1302044 |
| caffeine | multiple interactions | ISO | RGD:735711 | 6480464 | CYP1A2 protein binds to and affects the metabolism of Caffeine | CTD | PMID:15856409 PMID:15659567 |
| caffeine | affects metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein affects the metabolism of Caffeine | CTD | PMID:14586384 more ... |
| canthaxanthin | increases expression | EXP | | 6480464 | Canthaxanthin results in increased expression of CYP1A2 mRNA | CTD | PMID:9271336 |
| canthaxanthin | increases expression | ISO | RGD:10438 | 6480464 | Canthaxanthin results in increased expression of CYP1A2 mRNA | CTD | PMID:9271336 |
| capsaicin | decreases activity | ISO | RGD:735711 | 6480464 | Capsaicin results in decreased activity of CYP1A2 protein | CTD | PMID:22375877 |
| carbamazepine | increases expression | ISO | RGD:735711 | 6480464 | Carbamazepine results in increased expression of CYP1A2 mRNA | CTD | PMID:17112801 |
| carbamazepine | decreases expression | EXP | | 6480464 | Carbamazepine results in decreased expression of CYP1A2 mRNA | CTD | PMID:17381134 |
| carbaryl | multiple interactions | ISO | RGD:735711 | 6480464 | Carbaryl inhibits the reaction [CYP1A2 protein results in increased metabolism of Estradiol]; more ... | CTD | PMID:16790556 |
| carbaryl | increases expression | EXP | | 6480464 | Carbaryl results in increased expression of CYP1A2 protein | CTD | PMID:9858662 |
| carbaryl | decreases activity | ISO | RGD:735711 | 6480464 | Carbaryl results in decreased activity of CYP1A2 protein | CTD | PMID:16790556 |
| carbendazim | increases expression | ISO | RGD:735711 | 6480464 | mecarzole results in increased expression of CYP1A2 mRNA; more ... | CTD | PMID:21784029 |
| carbofuran | increases hydroxylation | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased hydroxylation of Carbofuran | CTD | PMID:15560889 |
| carotenoid | affects response to substance | ISO | RGD:735711 | 6480464 | CYP1A2 protein polymorphism affects the susceptibility to Carotenoids | CTD | PMID:15095308 |
| celecoxib | decreases activity | ISO | RGD:735711 | 6480464 | celecoxib results in decreased activity of CYP1A2 protein | CTD | PMID:18816299 |
| chalcone | increases hydroxylation | EXP | | 6480464 | CYP1A2 protein results in increased hydroxylation of Chalcone | CTD | PMID:15863696 |
| chlorpromazine | multiple interactions | ISO | RGD:735711 | 6480464 | Chlorpromazine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | CTD | PMID:18493746 |
| chlorpromazine | increases oxidation | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased oxidation of Chlorpromazine | CTD | PMID:20615392 |
| chlorpromazine | affects expression | EXP | | 6480464 | Chlorpromazine affects the expression of CYP1A2 mRNA | CTD | PMID:18246545 |
| chlorpromazine | multiple interactions | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased metabolism of and results in increased activity of Chlorpromazine | CTD | PMID:19482014 |
| chlorpromazine | decreases methylation | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in decreased methylation of Chlorpromazine | CTD | PMID:20615392 |
| chlorpyrifos | multiple interactions | ISO | RGD:735711 | 6480464 | Chlorpyrifos inhibits the reaction [CYP1A2 protein results in increased chemical synthesis of 2-hydroxyestradiol]; more ... | CTD | PMID:16790556 |
| chlorpyrifos | increases expression | ISO | RGD:735711 | 6480464 | Chlorpyrifos results in increased expression of CYP1A2 mRNA | CTD | PMID:21784029 PMID:22310298 |
| chlorpyrifos | affects metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein affects the metabolism of Chlorpyrifos | CTD | PMID:15557345 PMID:17079358 |
| chlorpyrifos | affects metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein affects the metabolism of Chlorpyrifos | CTD | PMID:17079358 PMID:15557345 |
| chlorpyrifos | increases expression | ISO | RGD:735711 | 6480464 | Chlorpyrifos results in increased expression of CYP1A2 mRNA | CTD | PMID:21784029 |
| chlorpyrifos | decreases expression | ISO | RGD:735711 | 6480464 | Chlorpyrifos results in decreased expression of CYP1A2 protein | CTD | PMID:21784029 |
| chlorpyrifos | decreases activity | ISO | RGD:735711 | 6480464 | Chlorpyrifos results in decreased activity of CYP1A2 protein | CTD | PMID:16790556 |
| chlorzoxazone | affects metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein affects the metabolism of Chlorzoxazone | CTD | PMID:14586387 |
| chlorzoxazone | affects metabolic processing | EXP | | 6480464 | CYP1A2 protein affects the metabolism of Chlorzoxazone | CTD | PMID:15879494 |
| chlorzoxazone | increases hydroxylation | EXP | | 6480464 | CYP1A2 protein results in increased hydroxylation of Chlorzoxazone | CTD | PMID:11911841 |
| choline | multiple interactions | EXP | | 6480464 | Choline deficiency inhibits the reaction [Acetaminophen results in increased expression of CYP1A2 protein]; more ... | CTD | PMID:18798224 |
| chrysene | increases expression | ISO | RGD:735711 | 6480464 | chrysene results in increased expression of CYP1A2 mRNA | CTD | PMID:12107646 |
| chrysene | increases expression | ISO | RGD:735711 | 6480464 | chrysene results in increased expression of CYP1A2 mRNA | CTD | PMID:12107646 PMID:17253728 |
| chrysene | multiple interactions | ISO | RGD:10438 | 6480464 | [fluoranthene co-treated with pyrene co-treated with benz(a)anthracene co-treated with chrysene co-treated with benzo(b)fluoranthene co-treated with benzo(k)fluoranthene co-treated with Benzo(a)pyrene] results in increased expression of CYP1A2 mRNA | CTD | PMID:7750161 |
| chrysene | multiple interactions | ISO | RGD:10438 | 6480464 | EPHX1 protein promotes the reaction [CYP1A2 protein results in increased metabolism of chrysene]; more ... | CTD | PMID:8961944 |
| chrysene | multiple interactions | ISO | RGD:735711 | 6480464 | [CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of chrysene; more ... | CTD | PMID:8961944 |
| ciglitazone | multiple interactions | ISO | RGD:735711 | 6480464 | [ciglitazone binds to PPARG protein alternative form] which results in increased expression of CYP1A2 mRNA; more ... | CTD | PMID:16197558 |
| cimetidine | decreases activity | ISO | RGD:735711 | 6480464 | Cimetidine results in decreased activity of CYP1A2 protein | CTD | PMID:19909766 |
| cimetidine | multiple interactions | ISO | RGD:735711 | 6480464 | styrofoam analog promotes the reaction [Cimetidine results in decreased activity of CYP1A2 protein] | CTD | PMID:19909766 |
| ciprofibrate | decreases expression | EXP | | 6480464 | ciprofibrate results in decreased expression of CYP1A2 mRNA | CTD | PMID:7676460 |
| ciprofibrate | decreases expression | ISO | RGD:10438 | 6480464 | ciprofibrate results in decreased expression of CYP1A2 mRNA | CTD | PMID:17962186 |
| ciprofibrate | multiple interactions | ISO | RGD:10438 | 6480464 | ciprofibrate inhibits the reaction [Phenobarbital results in increased expression of CYP1A2 mRNA] | CTD | PMID:17962186 |
| ciprofloxacin | decreases activity | ISO | RGD:735711 | 6480464 | Ciprofloxacin results in decreased activity of CYP1A2 protein | CTD | PMID:18816299 more ... |
| ciprofloxacin | decreases activity | ISO | RGD:735711 | 6480464 | Ciprofloxacin results in decreased activity of CYP1A2 protein | CTD | PMID:11145498 more ... |
| ciprofloxacin | decreases activity | ISO | RGD:735711 | 6480464 | Ciprofloxacin results in decreased activity of CYP1A2 protein | CTD | PMID:18816299 more ... |
| ciprofloxacin | decreases activity | ISO | RGD:735711 | 6480464 | Ciprofloxacin results in decreased activity of CYP1A2 protein | CTD | PMID:11145498 more ... |
| ciprofloxacin | multiple interactions | ISO | RGD:735711 | 6480464 | [Ciprofloxacin results in decreased activity of CYP1A2 protein] which results in increased abundance of Clozapine; more ... | CTD | PMID:11151749 |
| ciprofloxacin | multiple interactions | ISO | RGD:735711 | 6480464 | Ciprofloxacin inhibits the reaction [CYP1A2 protein results in decreased methylation of Caffeine] | CTD | PMID:11145498 |
| ciprofloxacin | decreases activity | ISO | RGD:735711 | 6480464 | Ciprofloxacin results in decreased activity of CYP1A2 protein | CTD | PMID:15592331 more ... |
| ciprofloxacin | multiple interactions | ISO | RGD:735711 | 6480464 | Ciprofloxacin inhibits the reaction [CYP1A2 protein affects the metabolism of tizanidine] | CTD | PMID:15592331 |
| cis-ketoconazole | decreases activity | ISO | RGD:735711 | 6480464 | Ketoconazole results in decreased activity of CYP1A2 protein | CTD | PMID:15916432 PMID:15618748 |
| cis-ketoconazole | decreases activity | EXP | | 6480464 | Ketoconazole results in decreased activity of CYP1A2 protein | CTD | PMID:15879494 PMID:12814958 |
| cis-ketoconazole | decreases activity | ISO | RGD:735711 | 6480464 | Ketoconazole results in decreased activity of CYP1A2 protein | CTD | PMID:15618748 PMID:15916432 |
| cis-ketoconazole | decreases activity | EXP | | 6480464 | Ketoconazole results in decreased activity of CYP1A2 protein | CTD | PMID:12814958 PMID:15879494 |
| cis-ketoconazole | multiple interactions | EXP | | 6480464 | Ketoconazole inhibits the reaction [CYP1A2 protein results in increased metabolism of 3-cyano-7-ethoxycoumarin] | CTD | PMID:19858067 |
| cis-ketoconazole | multiple interactions | ISO | RGD:10438 | 6480464 | Ketoconazole inhibits the reaction [CYP1A2 protein results in increased oxidation of Uroporphyrinogens] | CTD | PMID:1567206 |
| cis-ketoconazole | multiple interactions | ISO | RGD:735711 | 6480464 | Ketoconazole inhibits the reaction [CYP1A2 protein results in increased metabolism of Triazines] | CTD | PMID:9305587 |
| cisplatin | multiple interactions | ISO | RGD:735711 | 6480464 | Cisplatin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | CTD | PMID:18493746 |
| cisplatin | multiple interactions | EXP | | 6480464 | Cisplatin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | CTD | PMID:18493746 |
| clarithromycin | multiple interactions | ISO | RGD:735711 | 6480464 | [Ofloxacin co-treated with Clarithromycin] inhibits the reaction [CYP1A2 protein results in increased metabolism of Theophylline] | CTD | PMID:11408986 |
| clenbuterol | multiple interactions | EXP | | 6480464 | Clenbuterol inhibits the reaction [Lipopolysaccharides results in decreased activity of CYP1A2 protein]; more ... | CTD | PMID:15710352 |
| clofibrate | multiple interactions | ISO | RGD:10438 | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of CYP1A2 mRNA; more ... | CTD | PMID:17585979 |
| clofibrate | decreases expression | EXP | | 6480464 | Clofibrate results in decreased expression of CYP1A2 mRNA | CTD | PMID:11328961 more ... |
| clofibrate | decreases expression | EXP | | 6480464 | Clofibrate results in decreased expression of CYP1A2 protein | CTD | PMID:18670166 PMID:17967931 |
| clofibrate | decreases expression | EXP | | 6480464 | Clofibrate results in decreased expression of CYP1A2 mRNA | CTD | PMID:11328961 more ... |
| clofibrate | decreases expression | EXP | | 6480464 | Clofibrate results in decreased expression of CYP1A2 mRNA | CTD | PMID:15033592 more ... |
| clofibrate | decreases expression | EXP | | 6480464 | Clofibrate results in decreased expression of CYP1A2 protein | CTD | PMID:17967931 PMID:18670166 |
| clofibrate | decreases expression | EXP | | 6480464 | Clofibrate results in decreased expression of CYP1A2 mRNA | CTD | PMID:12851107 more ... |
| clofibrate | decreases expression | EXP | | 6480464 | Clofibrate results in decreased expression of CYP1A2 protein | CTD | PMID:17967931 |
| clofibrate | decreases expression | ISO | RGD:10438 | 6480464 | Clofibrate results in decreased expression of CYP1A2 mRNA | CTD | PMID:17585979 |
| clofibric acid | affects expression | EXP | | 6480464 | Clofibric Acid affects the expression of CYP1A2 mRNA | CTD | PMID:17602206 |
| clotrimazole | increases expression | EXP | | 6480464 | Clotrimazole results in increased expression of CYP1A2 protein | CTD | PMID:7986207 |
| clotrimazole | multiple interactions | EXP | | 6480464 | Clotrimazole inhibits the reaction [CYP1A2 protein results in increased metabolism of 3-cyano-7-ethoxycoumarin] | CTD | PMID:19858067 |
| clozapine | affects response to substance | ISO | RGD:735711 | 6480464 | CYP1A2 protein affects the susceptibility to Clozapine | CTD | PMID:12919186 |
| clozapine | affects metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein affects the metabolism of Clozapine | CTD | PMID:15883149 more ... |
| clozapine | affects metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein affects the metabolism of Clozapine | CTD | PMID:15286053 more ... |
| clozapine | affects metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein affects the metabolism of Clozapine | CTD | PMID:15883149 more ... |
| clozapine | increases metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 gene SNP results in increased metabolism of Clozapine | CTD | PMID:15206669 PMID:11763009 |
| clozapine | affects metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein affects the metabolism of Clozapine | CTD | PMID:15949157 more ... |
| clozapine | increases metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 gene SNP results in increased metabolism of Clozapine | CTD | PMID:11763009 PMID:15206669 |
| clozapine | decreases metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 gene SNP results in decreased metabolism of Clozapine | CTD | PMID:12919186 |
| clozapine | decreases response to substance | ISO | RGD:735711 | 6480464 | CYP1A2 gene SNP results in decreased susceptibility to Clozapine | CTD | PMID:11763009 |
| clozapine | affects response to substance | ISO | RGD:735711 | 6480464 | CYP1A2 gene SNP affects the susceptibility to Clozapine | CTD | PMID:15206669 |
| clozapine | affects metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 gene polymorphism affects the metabolism of Clozapine | CTD | PMID:16044115 |
| clozapine | multiple interactions | ISO | RGD:735711 | 6480464 | Clozapine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | CTD | PMID:18493746 |
| clozapine | multiple interactions | ISO | RGD:735711 | 6480464 | [Ciprofloxacin results in decreased activity of CYP1A2 protein] which results in increased abundance of Clozapine | CTD | PMID:11151749 |
| clozapine | multiple interactions | EXP | | 6480464 | Clozapine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | CTD | PMID:18493746 |
| clozapine | increases metabolic processing | ISO | RGD:10438 | 6480464 | CYP1A2 protein results in increased metabolism of Clozapine | CTD | PMID:12969762 |
| clozapine | increases expression | ISO | RGD:10438 | 6480464 | Clozapine results in increased expression of CYP1A2 mRNA | CTD | PMID:12969762 |
| clozapine | increases metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased metabolism of Clozapine | CTD | PMID:16044115 |
| clozapine | affects metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein polymorphism affects the metabolism of Clozapine | CTD | PMID:15949157 |
| clozapine | multiple interactions | ISO | RGD:735711 | 6480464 | Smoke affects the reaction [CYP1A2 gene polymorphism affects the metabolism of Clozapine]; more ... | CTD | PMID:16044115 |
| copper atom | multiple interactions | ISO | RGD:735711 | 6480464 | [CYP1A2 protein co-treated with Copper] results in increased activity of Eugenol | CTD | PMID:15576237 |
| copper(0) | multiple interactions | ISO | RGD:735711 | 6480464 | [CYP1A2 protein co-treated with Copper] results in increased activity of Eugenol | CTD | PMID:15576237 |
| copper(2+) sulfate | decreases expression | ISO | RGD:735711 | 6480464 | Copper Sulfate results in decreased expression of CYP1A2 mRNA | CTD | PMID:19549813 |
| coumarin | decreases expression | EXP | | 6480464 | coumarin results in decreased expression of CYP1A2 mRNA | CTD | PMID:18480146 |
| coumarin | affects expression | EXP | | 6480464 | coumarin affects the expression of CYP1A2 mRNA | CTD | PMID:16963487 |
| curcumin | decreases activity | ISO | RGD:735711 | 6480464 | Curcumin results in decreased activity of CYP1A2 protein | CTD | PMID:15841493 |
| curcumin | multiple interactions | EXP | | 6480464 | Curcumin inhibits the reaction [Carbon Tetrachloride results in decreased activity of CYP1A2 protein] | CTD | PMID:16288784 |
| curcumin | multiple interactions | ISO | RGD:10438 | 6480464 | Curcumin inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA]; more ... | CTD | PMID:18321868 |
| cycloheximide | multiple interactions | ISO | RGD:10438 | 6480464 | Cycloheximide affects the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] | CTD | PMID:1849469 |
| cyhalothrin | increases activity | ISO | RGD:735711 | 6480464 | cyhalothrin results in increased activity of CYP1A2 protein | CTD | PMID:22310298 |
| dacarbazine | increases metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased metabolism of Dacarbazine metabolite | CTD | PMID:11751525 |
| dacarbazine | multiple interactions | ISO | RGD:735711 | 6480464 | O(6)-benzylguanine inhibits the reaction [CYP1A2 protein results in increased metabolism of Dacarbazine metabolite] | CTD | PMID:11751525 |
| dantrolene | multiple interactions | ISO | RGD:735711 | 6480464 | Dantrolene inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | CTD | PMID:18493746 |
| desogestrel | decreases activity | ISO | RGD:735711 | 6480464 | Desogestrel results in decreased activity of CYP1A2 protein | CTD | PMID:18816299 |
| dexamethasone | multiple interactions | ISO | RGD:735711 | 6480464 | [Dexamethasone co-treated with Mifepristone] results in increased activity of CYP1A2 protein; more ... | CTD | PMID:19022236 |
| dexamethasone | decreases expression | EXP | | 6480464 | Dexamethasone results in decreased expression of CYP1A2 mRNA | CTD | PMID:11328961 more ... |
| dexamethasone | decreases expression | EXP | | 6480464 | Dexamethasone results in decreased expression of CYP1A2 mRNA | CTD | PMID:20832446 more ... |
| dexamethasone | decreases expression | EXP | | 6480464 | Dexamethasone results in decreased expression of CYP1A2 mRNA | CTD | PMID:20832446 more ... |
| dexamethasone | decreases expression | EXP | | 6480464 | Dexamethasone results in decreased expression of CYP1A2 mRNA | CTD | PMID:20607812 more ... |
| dexamethasone | increases expression | EXP | | 6480464 | Dexamethasone results in increased expression of CYP1A2 mRNA | CTD | PMID:15607757 |
| dexamethasone | multiple interactions | EXP | | 6480464 | Dexamethasone promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA]; more ... | CTD | PMID:17690134 |
| dexamethasone | affects expression | EXP | | 6480464 | Dexamethasone affects the expression of CYP1A2 mRNA | CTD | PMID:15102944 |
| dexamethasone | decreases activity | ISO | RGD:735711 | 6480464 | Dexamethasone results in decreased activity of CYP1A2 protein | CTD | PMID:19022236 |
| dexamethasone | decreases expression | ISO | RGD:735711 | 6480464 | Dexamethasone results in decreased expression of CYP1A2 protein | CTD | PMID:19022236 |
| dexmedetomidine | multiple interactions | EXP | | 6480464 | atipamezole inhibits the reaction [Dexmedetomidine promotes the reaction [Benzo(a)pyrene results in increased expression of and results in increased activity of CYP1A2 protein]]; more ... | CTD | PMID:16510159 |
| dextromethorphan | affects metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein affects the metabolism of Dextromethorphan | CTD | PMID:15199075 |
| diallyl disulfide | increases expression | EXP | | 6480464 | diallyl disulfide results in increased expression of CYP1A2 protein | CTD | PMID:16000231 |
| diazinon | affects metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein affects the metabolism of Diazinon | CTD | PMID:15764407 PMID:15557345 |
| diazinon | affects metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein affects the metabolism of Diazinon | CTD | PMID:15557345 PMID:15764407 |
| diazinon | multiple interactions | EXP | | 6480464 | [Streptozocin results in increased expression of CYP1A2 protein] which results in increased metabolism of Diazinon | CTD | PMID:17442507 |
| diazinon | increases expression | ISO | RGD:735711 | 6480464 | Diazinon results in increased expression of CYP1A2 mRNA; more ... | CTD | PMID:21784029 |
| diazinon | multiple interactions | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased metabolism of and results in increased activity of Diazinon | CTD | PMID:11708902 |
| diazinon | multiple interactions | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in decreased sulfation of and results in increased activity of Diazinon | CTD | PMID:15764407 |
| diazoxide | multiple interactions | EXP | | 6480464 | Isoproterenol inhibits the reaction [Lipopolysaccharides results in decreased activity of CYP1A2 protein]; more ... | CTD | PMID:15710352 |
| diazoxide | multiple interactions | ISO | RGD:735711 | 6480464 | Isoproterenol inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | CTD | PMID:18493746 |
| dibenz[a,h]anthracene | multiple interactions | ISO | RGD:735711 | 6480464 | [CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of 1,2,5,6-dibenzanthracene; more ... | CTD | PMID:8961944 |
| dibenz[a,h]anthracene | multiple interactions | EXP | | 6480464 | [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of CYP1A2 mRNA; more ... | CTD | PMID:18711122 |
| dibenz[a,h]anthracene | multiple interactions | ISO | RGD:735711 | 6480464 | [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of CYP1A2 mRNA | CTD | PMID:17690111 |
| dibenz[a,h]anthracene | increases expression | ISO | RGD:735711 | 6480464 | 1,2,5,6-dibenzanthracene results in increased expression of CYP1A2 mRNA | CTD | PMID:16269432 PMID:17253728 |
| dibenz[a,h]anthracene | decreases activity | ISO | RGD:735711 | 6480464 | 1,2,5,6-dibenzanthracene results in decreased activity of CYP1A2 protein | CTD | PMID:11162773 |
| dibenz[a,h]anthracene | multiple interactions | ISO | RGD:10438 | 6480464 | [CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of 1,2,5,6-dibenzanthracene; more ... | CTD | PMID:8961944 |
| dibenz[a,h]anthracene | multiple interactions | ISO | RGD:735711 | 6480464 | alyssin inhibits the reaction [1,2,5,6-dibenzanthracene results in increased activity of CYP1A2 protein]; more ... | CTD | PMID:19362136 |
| dibenz[a,h]anthracene | multiple interactions | ISO | RGD:735711 | 6480464 | [CYP1A2 protein results in increased metabolism of 1,2,5,6-dibenzanthracene] which results in increased chemical synthesis of dibenzoanthracene-1,2-dihydrodiol; more ... | CTD | PMID:8638931 |
| dibenz[a,h]anthracene | increases metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased metabolism of 1,2,5,6-dibenzanthracene | CTD | PMID:8638931 |
| dibenz[a,h]anthracene | increases activity | ISO | RGD:735711 | 6480464 | 1,2,5,6-dibenzanthracene results in increased activity of CYP1A2 protein | CTD | PMID:19362136 |
| dibenzo[a,l]pyrene | increases activity | ISO | RGD:10438 | 6480464 | CYP1A2 protein results in increased activity of dibenzo(a,l)pyrene | CTD | PMID:15606143 |
| dibenzo[a,l]pyrene | multiple interactions | EXP | | 6480464 | [1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of CYP1A2 mRNA; more ... | CTD | PMID:18711122 |
| dibenzo[a,l]pyrene | increases expression | ISO | RGD:735711 | 6480464 | dibenzo(a,l)pyrene results in increased expression of CYP1A2 mRNA | CTD | PMID:16269432 |
| dibenzo[a,l]pyrene | multiple interactions | ISO | RGD:735711 | 6480464 | [Benzo(a)pyrene co-treated with dibenzo(a,l)pyrene] affects the expression of CYP1A2 mRNA | CTD | PMID:17690111 |
| dibenzofuran | increases activity | ISO | RGD:10438 | 6480464 | dibenzofuran results in increased activity of CYP1A2 protein | CTD | PMID:8001243 |
| dibenzofuran | multiple interactions | ISO | RGD:10438 | 6480464 | [acenaphthylene co-treated with acenaphthene co-treated with dibenzofuran co-treated with fluorene co-treated with phenanthrene co-treated with anthracene] results in increased expression of CYP1A2 mRNA | CTD | PMID:7750161 |
| diclofenac | increases expression | ISO | RGD:735711 | 6480464 | Diclofenac results in increased expression of CYP1A2 mRNA; more ... | CTD | PMID:21784029 |
| dicofol | increases expression | EXP | | 6480464 | Dicofol results in increased expression of CYP1A2 mRNA | CTD | PMID:19595748 |
| dieldrin | increases expression | EXP | | 6480464 | Dieldrin results in increased expression of CYP1A2 mRNA | CTD | PMID:10910964 |
| diethylstilbestrol | affects response to substance | ISO | RGD:735711 | 6480464 | CYP1A2 protein affects the susceptibility to Diethylstilbestrol | CTD | PMID:8242868 |
| dihydrocapsaicin | decreases activity | ISO | RGD:735711 | 6480464 | dihydrocapsaicin results in decreased activity of CYP1A2 protein | CTD | PMID:22375877 |
| dimethyl sulfoxide | affects expression | ISO | RGD:735711 | 6480464 | Dimethyl Sulfoxide affects the expression of CYP1A2 mRNA | CTD | PMID:12843640 |
| dimethylarsinic acid | increases expression | EXP | | 6480464 | Cacodylic Acid results in increased expression of CYP1A2 mRNA | CTD | PMID:17481689 |
| dimethylmercury | decreases expression | EXP | | 6480464 | dimethyl mercury results in decreased expression of CYP1A2 protein | CTD | PMID:21424224 |
| dimethylmercury | multiple interactions | EXP | | 6480464 | [Acetylcysteine co-treated with Zinc co-treated with Selenium] inhibits the reaction [dimethyl mercury results in decreased expression of CYP1A2 protein] | CTD | PMID:21424224 |
| dioxygen | decreases expression | ISO | RGD:735711 | 6480464 | Oxygen deficiency results in decreased expression of CYP1A2 mRNA | CTD | PMID:19695866 |
| dioxygen | increases activity | ISO | RGD:10438 | 6480464 | Oxygen results in increased activity of CYP1A2 protein | CTD | PMID:21745492 |
| dioxygen | multiple interactions | ISO | RGD:10438 | 6480464 | beta-Naphthoflavone promotes the reaction [Oxygen results in increased expression of CYP1A2 mRNA]; more ... | CTD | PMID:21745492 |
| diuron | increases expression | ISO | RGD:735711 | 6480464 | Diuron results in increased expression of CYP1A2 mRNA; more ... | CTD | PMID:21784029 |
| diuron | increases expression | ISO | RGD:735711 | 6480464 | Diuron results in increased expression of CYP1A2 mRNA | CTD | PMID:21784029 PMID:22310298 |
| domperidone | increases hydroxylation | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased hydroxylation of Domperidone | CTD | PMID:15327587 |
| doxorubicin | multiple interactions | ISO | RGD:735711 | 6480464 | Doxorubicin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | CTD | PMID:18493746 |
| doxorubicin | multiple interactions | EXP | | 6480464 | Doxorubicin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | CTD | PMID:18493746 |
| duloxetine | multiple interactions | EXP | | 6480464 | [furafylline results in decreased activity of CYP1A2 protein] which results in decreased glutathionylation of duloxetine; more ... | CTD | PMID:20669986 |
| elemental selenium | multiple interactions | EXP | | 6480464 | [Acetylcysteine co-treated with Zinc co-treated with Selenium] inhibits the reaction [dimethyl mercury results in decreased expression of CYP1A2 protein] | CTD | PMID:21424224 |
| enoxacin | multiple interactions | ISO | RGD:735711 | 6480464 | Enoxacin inhibits the reaction [CYP1A2 protein affects the metabolism of Fluvoxamine] | CTD | PMID:15905806 |
| enoxacin | multiple interactions | EXP | | 6480464 | Enoxacin inhibits the reaction [CYP1A2 protein results in increased metabolism of Phenacetin] | CTD | PMID:8905919 |
| enoxacin | affects binding | EXP | | 6480464 | Enoxacin binds to CYP1A2 protein | CTD | PMID:8905919 |
| enoxacin | decreases activity | ISO | RGD:735711 | 6480464 | Enoxacin results in decreased activity of CYP1A2 protein | CTD | PMID:15905806 |
| estrone | multiple interactions | ISO | RGD:735711 | 6480464 | CYP1A2 protein promotes the reaction [Estrone binds to Deoxyguanosine] | CTD | PMID:21907773 |
| etodolac | decreases activity | ISO | RGD:735711 | 6480464 | Etodolac results in decreased activity of CYP1A2 protein | CTD | PMID:18816299 |
| etoricoxib | decreases activity | ISO | RGD:735711 | 6480464 | etoricoxib results in decreased activity of CYP1A2 protein | CTD | PMID:18816299 |
| eugenol | multiple interactions | ISO | RGD:735711 | 6480464 | [CYP1A2 protein co-treated with Copper] results in increased activity of Eugenol | CTD | PMID:15576237 |
| farnesol | increases activity | EXP | | 6480464 | Farnesol results in increased activity of CYP1A2 protein | CTD | PMID:15840382 |
| felbamate | decreases expression | EXP | | 6480464 | felbamate results in decreased expression of CYP1A2 mRNA | CTD | PMID:17381134 |
| fenitrothion | increases expression | ISO | RGD:735711 | 6480464 | Fenitrothion results in increased expression of CYP1A2 mRNA | CTD | PMID:22310298 |
| fenofibrate | affects expression | EXP | | 6480464 | Fenofibrate affects the expression of CYP1A2 mRNA | CTD | PMID:20801182 |
| fenofibrate | multiple interactions | EXP | | 6480464 | [Fenofibrate co-treated with Diethylnitrosamine] results in decreased expression of CYP1A2 mRNA | CTD | PMID:18253720 |
| fenvalerate | increases activity | ISO | RGD:735711 | 6480464 | fenvalerate results in increased activity of CYP1A2 protein | CTD | PMID:22310298 |
| ferulic acid | decreases activity | ISO | RGD:735711 | 6480464 | ferulic acid results in decreased activity of CYP1A2 protein | CTD | PMID:15841493 |
| flavanone | decreases activity | ISO | RGD:735711 | 6480464 | flavanone results in decreased activity of CYP1A2 protein | CTD | PMID:21053930 |
| flavone | multiple interactions | ISO | RGD:735711 | 6480464 | flavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | CTD | PMID:17090139 |
| flavone | decreases activity | ISO | RGD:735711 | 6480464 | flavone results in decreased activity of CYP1A2 protein | CTD | PMID:21053930 |
| flavonol | decreases activity | ISO | RGD:735711 | 6480464 | 3-hydroxyflavone results in decreased activity of CYP1A2 protein | CTD | PMID:21053930 |
| fluconazole | increases expression | ISO | RGD:10438 | 6480464 | Fluconazole results in increased expression of CYP1A2 mRNA | CTD | PMID:16730040 |
| fluoranthene | increases expression | ISO | RGD:735711 | 6480464 | fluoranthene results in increased expression of CYP1A2 mRNA | CTD | PMID:12107646 PMID:21784029 |
| fluoranthene | multiple interactions | EXP | | 6480464 | [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of CYP1A2 mRNA; more ... | CTD | PMID:18711122 |
| fluoranthene | multiple interactions | ISO | RGD:10438 | 6480464 | [fluoranthene co-treated with pyrene co-treated with benz(a)anthracene co-treated with chrysene co-treated with benzo(b)fluoranthene co-treated with benzo(k)fluoranthene co-treated with Benzo(a)pyrene] results in increased expression of CYP1A2 mRNA | CTD | PMID:7750161 |
| fluoranthene | increases expression | ISO | RGD:735711 | 6480464 | fluoranthene results in increased expression of CYP1A2 mRNA | CTD | PMID:21784029 PMID:12107646 |
| fluorene | increases activity | ISO | RGD:10438 | 6480464 | fluorene results in increased activity of CYP1A2 protein | CTD | PMID:8001243 |
| fluorene | multiple interactions | ISO | RGD:10438 | 6480464 | [acenaphthylene co-treated with acenaphthene co-treated with dibenzofuran co-treated with fluorene co-treated with phenanthrene co-treated with anthracene] results in increased expression of CYP1A2 mRNA | CTD | PMID:7750161 |
| fluvoxamine | multiple interactions | ISO | RGD:735711 | 6480464 | CYP1A2 protein binds to and affects the metabolism of Fluvoxamine; more ... | CTD | PMID:15905806 |
| fluvoxamine | multiple interactions | ISO | RGD:735711 | 6480464 | [Fluvoxamine results in decreased activity of CYP1A2 protein] which results in decreased chemical synthesis of 16-O-demethylaconitine metabolite; more ... | CTD | PMID:21277363 |
| fluvoxamine | decreases activity | ISO | RGD:735711 | 6480464 | Fluvoxamine results in decreased activity of CYP1A2 protein | CTD | PMID:11763009 more ... |
| fluvoxamine | decreases activity | ISO | RGD:735711 | 6480464 | Fluvoxamine results in decreased activity of CYP1A2 protein | CTD | PMID:15545309 more ... |
| fluvoxamine | decreases activity | ISO | RGD:735711 | 6480464 | Fluvoxamine results in decreased activity of CYP1A2 protein | CTD | PMID:18816299 more ... |
| fluvoxamine | decreases activity | ISO | RGD:735711 | 6480464 | Fluvoxamine results in decreased activity of CYP1A2 protein | CTD | PMID:18816299 more ... |
| fluvoxamine | multiple interactions | ISO | RGD:735711 | 6480464 | Fluvoxamine inhibits the reaction [CYP1A2 protein affects the metabolism of Theophylline] | CTD | PMID:9029748 |
| fluvoxamine | decreases activity | ISO | RGD:735711 | 6480464 | Fluvoxamine results in decreased activity of CYP1A2 protein | CTD | PMID:15545309 more ... |
| fluvoxamine | decreases activity | ISO | RGD:735711 | 6480464 | Fluvoxamine results in decreased activity of CYP1A2 protein | CTD | PMID:18816299 more ... |
| fluvoxamine | decreases activity | ISO | RGD:735711 | 6480464 | Fluvoxamine results in decreased activity of CYP1A2 protein | CTD | PMID:11763009 more ... |
| fluvoxamine | multiple interactions | ISO | RGD:735711 | 6480464 | Fluvoxamine inhibits the reaction [CYP1A2 protein affects the metabolism of olanzapine] | CTD | PMID:15545309 |
| fonofos | multiple interactions | ISO | RGD:735711 | 6480464 | Fonofos inhibits the reaction [CYP1A2 protein results in increased chemical synthesis of 2-hydroxyestradiol]; more ... | CTD | PMID:16790556 |
| fonofos | decreases activity | ISO | RGD:735711 | 6480464 | Fonofos results in decreased activity of CYP1A2 protein | CTD | PMID:16790556 |
| gadolinium trichloride | multiple interactions | EXP | | 6480464 | gadolinium chloride inhibits the reaction [Styrene results in increased expression of CYP1A2 protein] | CTD | PMID:18202523 |
| galangin | multiple interactions | ISO | RGD:735711 | 6480464 | galangin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | CTD | PMID:17090139 |
| galangin | decreases activity | ISO | RGD:735711 | 6480464 | galangin results in decreased activity of CYP1A2 protein | CTD | PMID:20806393 PMID:21053930 |
| galangin | decreases activity | ISO | RGD:735711 | 6480464 | galangin results in decreased activity of CYP1A2 protein | CTD | PMID:21053930 |
| gamma-hexachlorocyclohexane | increases activity | EXP | | 6480464 | Lindane results in increased activity of CYP1A2 protein | CTD | PMID:16641539 PMID:12842176 |
| gamma-hexachlorocyclohexane | increases expression | EXP | | 6480464 | Lindane results in increased expression of CYP1A2 mRNA | CTD | PMID:17919674 more ... |
| gamma-hexachlorocyclohexane | multiple interactions | EXP | | 6480464 | Lindane results in increased expression of and results in increased activity of CYP1A2 protein; more ... | CTD | PMID:18486174 |
| gamma-hexachlorocyclohexane | increases expression | EXP | | 6480464 | Lindane results in increased expression of CYP1A2 protein | CTD | PMID:12842176 PMID:17919674 |
| gamma-hexachlorocyclohexane | increases expression | EXP | | 6480464 | Lindane results in increased expression of CYP1A2 mRNA | CTD | PMID:17984293 |
| gamma-hexachlorocyclohexane | increases activity | EXP | | 6480464 | Lindane results in increased activity of CYP1A2 protein | CTD | PMID:12842176 PMID:16641539 |
| gamma-hexachlorocyclohexane | increases expression | EXP | | 6480464 | Lindane results in increased expression of CYP1A2 protein | CTD | PMID:12842176 |
| gamma-valerolactone | decreases activity | ISO | RGD:735711 | 6480464 | gamma-valerolactone results in decreased activity of CYP1A2 protein | CTD | PMID:15916432 |
| genistein | increases chemical synthesis | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased chemical synthesis of Genistein | CTD | PMID:12814970 |
| genistein | decreases activity | ISO | RGD:735711 | 6480464 | Genistein results in decreased activity of CYP1A2 protein | CTD | PMID:20806393 PMID:21053930 |
| genistein | decreases activity | ISO | RGD:735711 | 6480464 | Genistein results in decreased activity of CYP1A2 protein | CTD | PMID:21053930 |
| genistein | increases metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased metabolism of Genistein | CTD | PMID:12814970 |
| genistein | increases hydroxylation | EXP | | 6480464 | CYP1A2 protein results in increased hydroxylation of Genistein | CTD | PMID:15587933 |
| glucoerucin | increases expression | EXP | | 6480464 | glucoerucin results in increased expression of CYP1A2 protein | CTD | PMID:20833222 |
| glutathione | multiple interactions | ISO | RGD:735711 | 6480464 | [CYP1A2 protein co-treated with NADP co-treated with Glutathione] results in increased glutathionylation of and results in increased activity of 7-methoxy-N-((6-(3-methylisothiazol-5-yl)-(1,2,4)triazolo(4,3-b)pyridazin-3-yl)methyl)-1,5-naphthyridin-4-amine | CTD | PMID:20825217 |
| glycyrrhetinate | multiple interactions | EXP | | 6480464 | [brucine co-treated with Glycyrrhetinic Acid] results in decreased activity of CYP1A2 protein | CTD | PMID:21800547 |
| glycyrrhetinic acid | multiple interactions | EXP | | 6480464 | [brucine co-treated with Glycyrrhetinic Acid] results in decreased activity of CYP1A2 protein | CTD | PMID:21800547 |
| griseofulvin | affects expression | ISO | RGD:10438 | 6480464 | Griseofulvin affects the expression of CYP1A2 mRNA | CTD | PMID:12735108 |
| griseofulvin | multiple interactions | ISO | RGD:735711 | 6480464 | Griseofulvin promotes the reaction [CYP1A2 protein affects the metabolism of Theophylline] | CTD | PMID:9029748 |
| guanethidine | multiple interactions | EXP | | 6480464 | Guanethidine inhibits the reaction [Benzo(a)pyrene results in increased activity of CYP1A2 protein] | CTD | PMID:16510159 |
| hemin | multiple interactions | EXP | | 6480464 | Hemin inhibits the reaction [arsenite inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein]] | CTD | PMID:22159698 |
| hexachlorobenzene | increases expression | EXP | | 6480464 | Hexachlorobenzene results in increased expression of CYP1A2 mRNA | CTD | PMID:2856071 |
| hexachlorobenzene | increases expression | EXP | | 6480464 | Hexachlorobenzene results in increased expression of CYP1A2 protein | CTD | PMID:10696772 more ... |
| hexachlorobenzene | increases expression | EXP | | 6480464 | Hexachlorobenzene results in increased expression of CYP1A2 protein | CTD | PMID:2539049 more ... |
| hexachlorobenzene | increases expression | EXP | | 6480464 | Hexachlorobenzene results in increased expression of CYP1A2 protein | CTD | PMID:10696772 more ... |
| hexachlorobenzene | increases expression | EXP | | 6480464 | Hexachlorobenzene results in increased expression of CYP1A2 protein | CTD | PMID:2845946 more ... |
| hexachlorobenzene | increases expression | EXP | | 6480464 | Hexachlorobenzene results in increased expression of CYP1A2 protein | CTD | PMID:9630449 more ... |
| hexachlorobenzene | increases expression | EXP | | 6480464 | Hexachlorobenzene results in increased expression of CYP1A2 protein | CTD | PMID:9630449 more ... |
| hexachlorobenzene | increases expression | EXP | | 6480464 | Hexachlorobenzene results in increased expression of CYP1A2 protein | CTD | PMID:2539049 more ... |
| hexane | increases hydroxylation | EXP | | 6480464 | CYP1A2 protein results in increased hydroxylation of n-hexane | CTD | PMID:16484137 |
| hydralazine | multiple interactions | ISO | RGD:735711 | 6480464 | Hydralazine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | CTD | PMID:18493746 |
| hydralazine | multiple interactions | EXP | | 6480464 | Hydralazine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | CTD | PMID:18493746 |
| imipramine | affects metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein affects the metabolism of Imipramine | CTD | PMID:15286053 |
| imipramine | multiple interactions | ISO | RGD:735711 | 6480464 | Imipramine inhibits the reaction [resveratrol results in decreased activity of CYP1A2 protein] | CTD | PMID:11714871 |
| imipramine | increases metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased metabolism of Imipramine | CTD | PMID:11714871 |
| imipramine | multiple interactions | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in decreased methylation of and results in increased activity of Imipramine; more ... | CTD | PMID:15922009 |
| imperatorin | increases expression | ISO | RGD:10438 | 6480464 | imperatorin results in increased expression of CYP1A2 protein | CTD | PMID:18692084 |
| indane | decreases activity | ISO | RGD:735711 | 6480464 | indan results in decreased activity of CYP1A2 protein | CTD | PMID:15916432 |
| indole-3-methanol | increases expression | EXP | | 6480464 | indole-3-carbinol results in increased expression of CYP1A2 | CTD | PMID:9806166 |
| indole-3-methanol | increases expression | EXP | | 6480464 | indole-3-carbinol results in increased expression of CYP1A2 protein | CTD | PMID:8384853 |
| indole-3-methanol | increases expression | EXP | | 6480464 | indole-3-carbinol results in increased expression of CYP1A2 | CTD | PMID:22328411 PMID:9806166 |
| indole-3-methanol | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CYP1A2 mRNA] | CTD | PMID:22129741 |
| indole-3-methanol | increases expression | ISO | RGD:10438 | 6480464 | indole-3-carbinol results in increased expression of CYP1A2 | CTD | PMID:22328411 |
| indole-3-methanol | affects expression | EXP | | 6480464 | indole-3-carbinol affects the expression of CYP1A2 mRNA | CTD | PMID:21396975 |
| indole-3-methanol | increases activity | EXP | | 6480464 | indole-3-carbinol results in increased activity of CYP1A2; more ... | CTD | PMID:12147290 |
| indomethacin | multiple interactions | ISO | RGD:10438 | 6480464 | TLR4 protein affects the reaction [Indomethacin results in decreased activity of CYP1A2 protein] | CTD | PMID:12927920 |
| indomethacin | decreases expression | EXP | | 6480464 | Indomethacin results in decreased expression of CYP1A2 mRNA | CTD | PMID:16771604 |
| indoxyl sulfate | increases expression | ISO | RGD:735711 | 6480464 | Indican results in increased expression of CYP1A2 mRNA | CTD | PMID:20000589 |
| isopimpinellin | increases expression | ISO | RGD:10438 | 6480464 | isopimpinellin results in increased expression of CYP1A2 protein | CTD | PMID:18692084 |
| isoprenaline | multiple interactions | ISO | RGD:735711 | 6480464 | Isoproterenol inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | CTD | PMID:18493746 |
| isoprenaline | multiple interactions | EXP | | 6480464 | Propranolol inhibits the reaction [Isoproterenol inhibits the reaction [Lipopolysaccharides results in decreased activity of CYP1A2 protein]] | CTD | PMID:15710352 |
| kaempferol | increases expression | ISO | RGD:735711 | 6480464 | kaempferol results in increased expression of CYP1A2 mRNA | CTD | PMID:19034627 |
| kaempferol | decreases activity | ISO | RGD:735711 | 6480464 | kaempferol results in decreased activity of CYP1A2 protein | CTD | PMID:20806393 PMID:21053930 |
| kaempferol | multiple interactions | ISO | RGD:735711 | 6480464 | kaempferol inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] | CTD | PMID:21256954 |
| kaempferol | decreases activity | ISO | RGD:735711 | 6480464 | kaempferol results in decreased activity of CYP1A2 protein | CTD | PMID:21053930 |
| kaempferol | increases expression | EXP | | 6480464 | kaempferol results in increased expression of CYP1A2 mRNA | CTD | PMID:18421621 |
| kaempferol | multiple interactions | EXP | | 6480464 | kaempferol results in increased expression of and results in increased activity of CYP1A2 protein | CTD | PMID:18421621 |
| L-ascorbic acid | increases expression | EXP | | 6480464 | Ascorbic Acid deficiency results in increased expression of CYP1A2 mRNA; more ... | CTD | PMID:8269614 |
| lansoprazole | increases expression | ISO | RGD:735711 | 6480464 | lansoprazole results in increased expression of CYP1A2 mRNA | CTD | PMID:12623754 |
| lansoprazole | increases expression | EXP | | 6480464 | lansoprazole results in increased expression of CYP1A2 protein | CTD | PMID:14550749 PMID:9152597 |
| lansoprazole | increases expression | ISO | RGD:735711 | 6480464 | lansoprazole results in increased expression of CYP1A2 protein | CTD | PMID:9744552 PMID:8169844 |
| lansoprazole | increases expression | EXP | | 6480464 | lansoprazole results in increased expression of CYP1A2 protein | CTD | PMID:9152597 PMID:14550749 |
| lansoprazole | increases expression | ISO | RGD:735711 | 6480464 | lansoprazole results in increased expression of CYP1A2 protein | CTD | PMID:8169844 PMID:9744552 |
| lidocaine | affects metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein affects the metabolism of Lidocaine | CTD | PMID:15447735 |
| lipoic acid | multiple interactions | ISO | RGD:10438 | 6480464 | [CYP1A1 protein co-treated with CYP1A2 protein] affects the reaction [[Thioctic Acid results in decreased activity of POR protein] inhibits the reaction [aristolochic acid I results in increased abundance of [7-(deoxyadenosin-N(6)-yl)aristolactam I co-treated with 7-(deoxyguanosin-N(2)-yl)aristolactam I co-treated with 7-(deoxyadenosin-N(6)--yl)aristolactam II]]] | CTD | PMID:21932800 |
| loxapine | increases metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 results in increased metabolism of Loxapine | CTD | PMID:21826677 |
| m-xylene | decreases activity | EXP | | 6480464 | 3-xylene results in decreased activity of CYP1A2 protein | CTD | PMID:8598570 |
| m-xylene | multiple interactions | ISO | RGD:735711 | 6480464 | furafylline inhibits the reaction [CYP1A2 protein results in increased metabolism of 3-xylene] | CTD | PMID:8558417 |
| m-xylene | increases metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased metabolism of 3-xylene | CTD | PMID:8558417 |
| malathion | affects metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein affects the metabolism of Malathion | CTD | PMID:15557345 |
| malathion | increases expression | ISO | RGD:735711 | 6480464 | Malathion results in increased expression of CYP1A2 mRNA | CTD | PMID:22310298 |
| maneb | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [[Paraquat co-treated with Maneb] results in increased expression of CYP1A2 mRNA]; more ... | CTD | PMID:23159886 |
| mangiferin | decreases activity | EXP | | 6480464 | mangiferin results in decreased activity of CYP1A2 protein | CTD | PMID:18053976 |
| mangiferin | decreases activity | ISO | RGD:735711 | 6480464 | mangiferin results in decreased activity of CYP1A2 protein | CTD | PMID:22815239 |
| mangiferin | increases expression | ISO | RGD:735711 | 6480464 | mangiferin results in increased expression of CYP1A2 mRNA | CTD | PMID:22815239 |
| mebendazole | increases expression | ISO | RGD:735711 | 6480464 | Mebendazole results in increased expression of CYP1A2 protein | CTD | PMID:12841937 |
| mebendazole | increases expression | EXP | | 6480464 | Mebendazole results in increased expression of CYP1A2 protein | CTD | PMID:12841937 |
| melatonin | decreases methylation | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in decreased methylation of Melatonin | CTD | PMID:15616152 |
| melatonin | affects metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein affects the metabolism of Melatonin | CTD | PMID:15626586 PMID:15824912 |
| melatonin | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with oxfendazole co-treated with Melatonin] results in increased expression of CYP1A2 mRNA | CTD | PMID:20033131 |
| melatonin | decreases activity | ISO | RGD:735711 | 6480464 | Melatonin results in decreased activity of CYP1A2 protein | CTD | PMID:19919601 |
| melatonin | increases metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased metabolism of Melatonin | CTD | PMID:17565714 |
| melatonin | multiple interactions | ISO | RGD:735711 | 6480464 | Melatonin inhibits the reaction [CYP1A2 protein results in increased hydrolysis of Benzo(a)pyrene] | CTD | PMID:19919601 |
| melatonin | increases hydroxylation | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased hydroxylation of Melatonin | CTD | PMID:15616152 |
| melatonin | affects metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein affects the metabolism of Melatonin | CTD | PMID:15824912 PMID:15626586 |
| melphalan | multiple interactions | EXP | | 6480464 | Melphalan inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | CTD | PMID:18493746 |
| melphalan | multiple interactions | ISO | RGD:735711 | 6480464 | Melphalan inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | CTD | PMID:18493746 |
| menadione | multiple interactions | ISO | RGD:735711 | 6480464 | Vitamin K 3 inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | CTD | PMID:18493746 |
| menadione | increases expression | EXP | | 6480464 | Vitamin K 3 results in increased expression of CYP1A2 mRNA | CTD | PMID:15603920 |
| menadione | increases activity | EXP | | 6480464 | Vitamin K 3 results in increased activity of CYP1A2 protein | CTD | PMID:15603920 |
| menadione | multiple interactions | EXP | | 6480464 | Vitamin K 3 inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | CTD | PMID:18493746 |
| mercury atom | multiple interactions | ISO | RGD:10438 | 6480464 | Mercury inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein]; more ... | CTD | PMID:22579925 |
| mercury atom | increases activity | ISO | RGD:10438 | 6480464 | Mercury results in increased activity of CYP1A2 protein | CTD | PMID:22579925 |
| mercury dichloride | decreases activity | ISO | RGD:735711 | 6480464 | Mercuric Chloride results in decreased activity of CYP1A2 protein | CTD | PMID:11162773 |
| mercury(0) | multiple interactions | ISO | RGD:10438 | 6480464 | Mercury inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein]; more ... | CTD | PMID:22579925 |
| mercury(0) | increases activity | ISO | RGD:10438 | 6480464 | Mercury results in increased activity of CYP1A2 protein | CTD | PMID:22579925 |
| metformin | increases expression | ISO | RGD:735711 | 6480464 | Metformin results in increased expression of CYP1A2 mRNA | CTD | PMID:19022234 |
| methamphetamine | affects metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein affects the metabolism of Methamphetamine metabolite | CTD | PMID:16038959 |
| methotrexate | multiple interactions | ISO | RGD:735711 | 6480464 | Methotrexate inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | CTD | PMID:18493746 |
| methotrexate | decreases expression | EXP | | 6480464 | Methotrexate results in decreased expression of CYP1A2 mRNA | CTD | PMID:15120968 |
| methoxsalen | decreases activity | EXP | | 6480464 | Methoxsalen results in decreased activity of CYP1A2 protein | CTD | PMID:12814958 PMID:15879494 |
| methoxsalen | decreases activity | EXP | | 6480464 | Methoxsalen results in decreased activity of CYP1A2 protein | CTD | PMID:15879494 PMID:12814958 |
| methoxsalen | decreases activity | ISO | RGD:735711 | 6480464 | Methoxsalen results in decreased activity of CYP1A2 protein | CTD | PMID:8819299 |
| methoxychlor | decreases methylation | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in decreased methylation of Methoxychlor | CTD | PMID:9733665 |
| methoxychlor | multiple interactions | EXP | | 6480464 | Methoxychlor results in increased expression of and results in increased activity of CYP1A2 protein | CTD | PMID:12919727 |
| methoxychlor | increases expression | ISO | RGD:10438 | 6480464 | Methoxychlor results in increased expression of CYP1A2 mRNA | CTD | PMID:21252393 |
| methoxychlor | increases hydroxylation | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased hydroxylation of Methoxychlor | CTD | PMID:9047321 |
| methoxychlor | multiple interactions | ISO | RGD:10438 | 6480464 | ESR1 protein promotes the reaction [Methoxychlor results in increased expression of CYP1A2 mRNA] | CTD | PMID:21252393 |
| methylarsonic acid | increases expression | EXP | | 6480464 | monomethylarsonic acid results in increased expression of CYP1A2 mRNA | CTD | PMID:17481689 |
| miconazole | increases expression | EXP | | 6480464 | Miconazole results in increased expression of CYP1A2 mRNA | CTD | PMID:22262564 |
| microcystin-LR | increases expression | ISO | RGD:10438 | 6480464 | cyanoginosin LR results in increased expression of CYP1A2 mRNA | CTD | PMID:17383702 |
| mifepristone | multiple interactions | ISO | RGD:735711 | 6480464 | [Dexamethasone co-treated with Mifepristone] promotes the reaction [Methylcholanthrene results in increased activity of CYP1A2 protein]; more ... | CTD | PMID:19022236 |
| mifepristone | multiple interactions | EXP | | 6480464 | Mifepristone inhibits the reaction [Dexamethasone promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA]] | CTD | PMID:17690134 |
| mitomycin C | decreases activity | EXP | | 6480464 | Mitomycin results in decreased activity of CYP1A2 protein | CTD | PMID:15696929 |
| monocrotophos | increases expression | EXP | | 6480464 | Monocrotophos results in increased expression of CYP1A2 protein | CTD | PMID:21445290 |
| N,N-diethyl-m-toluamide | increases metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased metabolism of DEET | CTD | PMID:11854147 |
| N,N-dimethylformamide | decreases expression | EXP | | 6480464 | Dimethylformamide results in decreased expression of CYP1A2 protein | CTD | PMID:10547960 |
| N-acetyl-1,4-benzoquinone imine | multiple interactions | ISO | RGD:10438 | 6480464 | CYP1A2 protein results in increased chemical synthesis of and results in increased abundance of N-acetyl-4-benzoquinoneimine | CTD | PMID:19679878 |
| N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | [Acetylcysteine co-treated with Zinc co-treated with Selenium] inhibits the reaction [dimethyl mercury results in decreased expression of CYP1A2 protein] | CTD | PMID:21424224 |
| N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [Paraquat results in increased expression of and results in increased activity of CYP1A2 protein]; more ... | CTD | PMID:23159886 |
| N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CYP1A2 mRNA] | CTD | PMID:22129741 |
| N-desmethylclozapine | multiple interactions | ISO | RGD:735711 | 6480464 | [Ciprofloxacin results in decreased activity of CYP1A2 protein] which results in increased abundance of norclozapine | CTD | PMID:11151749 |
| N-desmethylclozapine | increases metabolic processing | ISO | RGD:10438 | 6480464 | CYP1A2 protein results in increased metabolism of norclozapine | CTD | PMID:12969762 |
| N-isopropyl-2-chloroacetanilide | increases activity | ISO | RGD:735711 | 6480464 | propachlor results in increased activity of CYP1A2 protein | CTD | PMID:10813365 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:10438 | 6480464 | [dicyclanil co-treated with Diethylnitrosamine] results in increased expression of CYP1A2 mRNA; more ... | CTD | PMID:20118626 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CYP1A2 mRNA] | CTD | PMID:22129741 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Omeprazole co-treated with Diethylnitrosamine] results in increased expression of CYP1A2 mRNA | CTD | PMID:22687989 |
| N-nitrosodiethylamine | decreases expression | EXP | | 6480464 | Diethylnitrosamine results in decreased expression of CYP1A2 mRNA | CTD | PMID:19638242 PMID:20360939 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CYP1A2 mRNA | CTD | PMID:20045035 PMID:18164116 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [oxfendazole co-treated with Diethylnitrosamine] results in increased expression of CYP1A2 mRNA | CTD | PMID:18754104 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Fenofibrate co-treated with Diethylnitrosamine] results in decreased expression of CYP1A2 mRNA | CTD | PMID:18253720 |
| N-nitrosodiethylamine | decreases expression | EXP | | 6480464 | Diethylnitrosamine results in decreased expression of CYP1A2 mRNA | CTD | PMID:20360939 PMID:19638242 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with oxfendazole co-treated with isoquercitrin] results in increased expression of CYP1A2 mRNA; more ... | CTD | PMID:20033131 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of CYP1A2 mRNA | CTD | PMID:20360939 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CYP1A2 mRNA | CTD | PMID:18164116 PMID:20045035 |
| N-nitrosodimethylamine | decreases expression | EXP | | 6480464 | Dimethylnitrosamine results in decreased expression of CYP1A2 mRNA | CTD | PMID:17072980 |
| N-nitrosodimethylamine | decreases expression | EXP | | 6480464 | Dimethylnitrosamine results in decreased expression of CYP1A2 protein | CTD | PMID:16997515 |
| NADP zwitterion | multiple interactions | ISO | RGD:735711 | 6480464 | [CYP1A2 protein co-treated with NADP co-treated with Glutathione] results in increased glutathionylation of and results in increased activity of 7-methoxy-N-((6-(3-methylisothiazol-5-yl)-(1,2,4)triazolo(4,3-b)pyridazin-3-yl)methyl)-1,5-naphthyridin-4-amine | CTD | PMID:20825217 |
| NADP zwitterion | multiple interactions | ISO | RGD:735711 | 6480464 | NADP promotes the reaction [resveratrol results in decreased activity of CYP1A2 protein] | CTD | PMID:11714871 |
| NADP(+) | multiple interactions | ISO | RGD:735711 | 6480464 | [CYP1A2 protein co-treated with NADP co-treated with Glutathione] results in increased glutathionylation of and results in increased activity of 7-methoxy-N-((6-(3-methylisothiazol-5-yl)-(1,2,4)triazolo(4,3-b)pyridazin-3-yl)methyl)-1,5-naphthyridin-4-amine | CTD | PMID:20825217 |
| NADP(+) | multiple interactions | ISO | RGD:735711 | 6480464 | NADP promotes the reaction [resveratrol results in decreased activity of CYP1A2 protein] | CTD | PMID:11714871 |
| naphthalene | decreases activity | ISO | RGD:735711 | 6480464 | naphthalene analog results in decreased activity of CYP1A2 protein | CTD | PMID:15916432 |
| naphthalene | decreases activity | ISO | RGD:735711 | 6480464 | naphthalene results in decreased activity of CYP1A2 protein | CTD | PMID:16790556 PMID:15916432 |
| naphthalene | decreases activity | ISO | RGD:735711 | 6480464 | naphthalene results in decreased activity of CYP1A2 protein | CTD | PMID:15916432 PMID:16790556 |
| naphthalene | multiple interactions | ISO | RGD:735711 | 6480464 | naphthalene inhibits the reaction [CYP1A2 protein results in increased chemical synthesis of 2-hydroxyestradiol]; more ... | CTD | PMID:16790556 |
| naringin | decreases activity | ISO | RGD:735711 | 6480464 | naringin results in decreased activity of CYP1A2 protein | CTD | PMID:21053930 |
| nickel dichloride | decreases expression | ISO | RGD:735711 | 6480464 | nickel chloride results in decreased expression of CYP1A2 protein | CTD | PMID:21784029 |
| nifedipine | decreases activity | ISO | RGD:735711 | 6480464 | Nifedipine results in decreased activity of CYP1A2 protein | CTD | PMID:10805063 |
| nifedipine | multiple interactions | EXP | | 6480464 | Nifedipine inhibits the reaction [CYP1A2 protein results in increased metabolism of 3-cyano-7-ethoxycoumarin] | CTD | PMID:19858067 |
| nitrofurantoin | multiple interactions | ISO | RGD:735711 | 6480464 | Nitrofurantoin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | CTD | PMID:18493746 |
| norfloxacin | affects binding | EXP | | 6480464 | Norfloxacin binds to CYP1A2 protein | CTD | PMID:8905919 |
| norfloxacin | multiple interactions | EXP | | 6480464 | Norfloxacin inhibits the reaction [CYP1A2 protein results in increased metabolism of Phenacetin] | CTD | PMID:8905919 |
| norgestimate | multiple interactions | ISO | RGD:735711 | 6480464 | [Ethinyl Estradiol co-treated with norgestimate] results in decreased activity of CYP1A2 protein | CTD | PMID:16291717 |
| nortriptyline | increases metabolic processing | ISO | RGD:735711 | 6480464 | Nortriptyline results in increased metabolism of CYP1A2 protein | CTD | PMID:18359012 |
| ochratoxin A | increases response to substance | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased susceptibility to ochratoxin A | CTD | PMID:11189750 |
| ochratoxin A | increases response to substance | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased susceptibility to ochratoxin A | CTD | PMID:11189750 more ... |
| ochratoxin A | increases expression | ISO | RGD:735711 | 6480464 | ochratoxin A results in increased expression of CYP1A2 mRNA | CTD | PMID:21834667 |
| ochratoxin A | increases response to substance | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased susceptibility to ochratoxin A | CTD | PMID:21781659 PMID:11189750 |
| ofloxacin | multiple interactions | ISO | RGD:735711 | 6480464 | [Ofloxacin co-treated with Clarithromycin] inhibits the reaction [CYP1A2 protein results in increased metabolism of Theophylline] | CTD | PMID:11408986 |
| olanzapine | affects metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein affects the metabolism of olanzapine | CTD | PMID:15545309 PMID:15883149 |
| olanzapine | affects metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein affects the metabolism of olanzapine | CTD | PMID:15883149 PMID:15545309 |
| olanzapine | multiple interactions | ISO | RGD:735711 | 6480464 | Fluvoxamine inhibits the reaction [CYP1A2 protein affects the metabolism of olanzapine] | CTD | PMID:15545309 |
| oleanolic acid | multiple interactions | ISO | RGD:735711 | 6480464 | Oleanolic Acid inhibits the reaction [CYP1A2 protein results in increased metabolism of Phenacetin] | CTD | PMID:15043991 |
| oleanolic acid | decreases expression | EXP | | 6480464 | Oleanolic Acid results in decreased expression of CYP1A2 mRNA | CTD | PMID:18706400 |
| oleanolic acid | decreases activity | ISO | RGD:735711 | 6480464 | Oleanolic Acid results in decreased activity of CYP1A2 protein | CTD | PMID:15043991 |
| omeprazole | increases activity | ISO | RGD:735711 | 6480464 | Omeprazole results in increased activity of CYP1A2 promoter | CTD | PMID:18502397 |
| omeprazole | multiple interactions | EXP | | 6480464 | [Omeprazole co-treated with Diethylnitrosamine] results in increased expression of CYP1A2 mRNA | CTD | PMID:22687989 |
| omeprazole | increases expression | ISO | RGD:735711 | 6480464 | Omeprazole results in increased expression of CYP1A2 mRNA | CTD | PMID:12040753 more ... |
| omeprazole | increases activity | ISO | RGD:735711 | 6480464 | Omeprazole results in increased activity of CYP1A2 protein | CTD | PMID:19118567 PMID:19230594 |
| omeprazole | increases expression | ISO | RGD:735711 | 6480464 | Omeprazole results in increased expression of CYP1A2 mRNA | CTD | PMID:21784029 more ... |
| omeprazole | increases expression | EXP | | 6480464 | Omeprazole results in increased expression of CYP1A2 mRNA | CTD | PMID:19118567 |
| omeprazole | increases expression | ISO | RGD:735711 | 6480464 | Omeprazole results in increased expression of CYP1A2 protein | CTD | PMID:9744552 more ... |
| omeprazole | increases expression | ISO | RGD:735711 | 6480464 | Omeprazole results in increased expression of CYP1A2 mRNA | CTD | PMID:12040753 more ... |
| omeprazole | increases expression | ISO | RGD:735711 | 6480464 | Omeprazole results in increased expression of CYP1A2 mRNA | CTD | PMID:15802389 more ... |
| omeprazole | increases expression | ISO | RGD:735711 | 6480464 | Omeprazole results in increased expression of CYP1A2 mRNA | CTD | PMID:21784029 more ... |
| omeprazole | increases expression | ISO | RGD:735711 | 6480464 | Omeprazole results in increased expression of CYP1A2 protein | CTD | PMID:12841937 more ... |
| omeprazole | increases expression | ISO | RGD:735711 | 6480464 | Omeprazole results in increased expression of CYP1A2 mRNA | CTD | PMID:17954527 more ... |
| omeprazole | increases activity | ISO | RGD:735711 | 6480464 | Omeprazole results in increased activity of CYP1A2 protein | CTD | PMID:19230594 |
| omeprazole | multiple interactions | ISO | RGD:735711 | 6480464 | AHR protein affects the susceptibility to [Omeprazole results in increased expression of CYP1A2 mRNA] | CTD | PMID:20171196 |
| omeprazole | increases expression | ISO | RGD:735711 | 6480464 | Omeprazole results in increased expression of CYP1A2 protein | CTD | PMID:12841937 more ... |
| omeprazole | increases expression | EXP | | 6480464 | Omeprazole results in increased expression of CYP1A2 protein | CTD | PMID:9152597 |
| omeprazole | increases expression | ISO | RGD:735711 | 6480464 | Omeprazole results in increased expression of CYP1A2 mRNA | CTD | PMID:21784029 more ... |
| omeprazole | multiple interactions | ISO | RGD:735711 | 6480464 | Omeprazole results in increased expression of and results in increased activity of CYP1A2 protein | CTD | PMID:15802389 |
| omeprazole | decreases activity | ISO | RGD:735711 | 6480464 | Omeprazole results in decreased activity of CYP1A2 protein | CTD | PMID:16035375 |
| orphenadrine | multiple interactions | ISO | RGD:735711 | 6480464 | Orphenadrine inhibits the reaction [CYP1A2 protein results in decreased ethylation of 7-ethoxy-4-trifluoromethylcoumarin]; more ... | CTD | PMID:9241656 |
| orphenadrine | decreases activity | ISO | RGD:735711 | 6480464 | Orphenadrine results in decreased activity of CYP1A2 protein | CTD | PMID:9241656 |
| orphenadrine | multiple interactions | EXP | | 6480464 | Orphenadrine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | CTD | PMID:18493746 |
| oxfendazole | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with oxfendazole co-treated with isoquercitrin] results in increased expression of CYP1A2 mRNA; more ... | CTD | PMID:20033131 |
| oxfendazole | multiple interactions | EXP | | 6480464 | [oxfendazole co-treated with Diethylnitrosamine] results in increased expression of CYP1A2 mRNA | CTD | PMID:18754104 |
| ozone | multiple interactions | ISO | RGD:735711 | 6480464 | AHR protein affects the reaction [Ozone results in increased expression of CYP1A2 mRNA]; more ... | CTD | PMID:19536146 |
| ozone | decreases expression | ISO | RGD:10438 | 6480464 | Ozone results in decreased expression of CYP1A2 mRNA | CTD | PMID:16183385 |
| ozone | increases expression | ISO | RGD:735711 | 6480464 | Ozone results in increased expression of CYP1A2 mRNA; more ... | CTD | PMID:19536146 |
| p-cresol | increases metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased metabolism of 4-cresol | CTD | PMID:16174805 |
| paclitaxel | increases expression | EXP | | 6480464 | Paclitaxel results in increased expression of CYP1A2 mRNA | CTD | PMID:15585946 |
| paclitaxel | decreases activity | ISO | RGD:735711 | 6480464 | Paclitaxel results in decreased activity of CYP1A2 protein | CTD | PMID:19909766 |
| pantoprazole | increases expression | EXP | | 6480464 | pantoprazole results in increased expression of CYP1A2 protein | CTD | PMID:9152597 |
| paracetamol | increases chemical synthesis | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased chemical synthesis of Acetaminophen | CTD | PMID:15155557 PMID:12401345 |
| paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of CYP1A2 mRNA | CTD | PMID:12969438 PMID:21807079 |
| paracetamol | increases response to substance | ISO | RGD:10438 | 6480464 | CYP1A2 protein results in increased susceptibility to Acetaminophen | CTD | PMID:16557553 more ... |
| paracetamol | increases expression | ISO | RGD:10438 | 6480464 | Acetaminophen results in increased expression of CYP1A2 mRNA | CTD | PMID:14978233 more ... |
| paracetamol | decreases expression | ISO | RGD:10438 | 6480464 | Acetaminophen results in decreased expression of CYP1A2 mRNA | CTD | PMID:15576447 PMID:16611625 |
| paracetamol | increases response to substance | ISO | RGD:10438 | 6480464 | CYP1A2 protein results in increased susceptibility to Acetaminophen | CTD | PMID:19679878 more ... |
| paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of CYP1A2 mRNA | CTD | PMID:11245408 PMID:17366322 |
| paracetamol | increases response to substance | ISO | RGD:10438 | 6480464 | CYP1A2 protein results in increased susceptibility to Acetaminophen | CTD | PMID:16557553 more ... |
| paracetamol | increases metabolic processing | ISO | RGD:10438 | 6480464 | CYP1A2 protein results in increased metabolism of Acetaminophen | CTD | PMID:19002106 PMID:10977129 |
| paracetamol | increases expression | ISO | RGD:10438 | 6480464 | Acetaminophen results in increased expression of CYP1A2 mRNA | CTD | PMID:12958197 more ... |
| paracetamol | multiple interactions | EXP | | 6480464 | Choline deficiency inhibits the reaction [Acetaminophen results in increased expression of CYP1A2 protein] | CTD | PMID:18798224 |
| paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of CYP1A2 protein | CTD | PMID:18798224 |
| paracetamol | multiple interactions | EXP | | 6480464 | [EGF protein co-treated with HGF protein] promotes the reaction [Acetaminophen results in decreased expression of CYP1A2 mRNA] | CTD | PMID:12969438 |
| paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of CYP1A2 mRNA | CTD | PMID:12969438 |
| paracetamol | multiple interactions | EXP | | 6480464 | Acetaminophen inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | CTD | PMID:18493746 |
| paracetamol | multiple interactions | ISO | RGD:10438 | 6480464 | SLC13A1 protein affects the reaction [Acetaminophen results in increased expression of CYP1A2 mRNA] | CTD | PMID:16729303 |
| paracetamol | multiple interactions | ISO | RGD:10438 | 6480464 | RXRA protein promotes the reaction [Acetaminophen results in increased expression of CYP1A2 mRNA] | CTD | PMID:14978233 |
| paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of CYP1A2 mRNA | CTD | PMID:17366322 PMID:11245408 |
| paracetamol | multiple interactions | ISO | RGD:10438 | 6480464 | PPARA protein affects the reaction [Acetaminophen results in increased expression of CYP1A2 mRNA] | CTD | PMID:12958197 |
| paracetamol | multiple interactions | ISO | RGD:10438 | 6480464 | NR1I2 protein affects the reaction [Acetaminophen results in increased expression of CYP1A2 mRNA] | CTD | PMID:16141365 |
| paracetamol | multiple interactions | ISO | RGD:10438 | 6480464 | IL1A protein inhibits the reaction [Acetaminophen results in increased expression of CYP1A2 protein] | CTD | PMID:19002106 |
| paracetamol | increases response to substance | ISO | RGD:10438 | 6480464 | CYP1A2 protein results in increased susceptibility to Acetaminophen | CTD | PMID:19679878 more ... |
| paracetamol | multiple interactions | ISO | RGD:10438 | 6480464 | CYP1A2 protein results in increased metabolism of and affects the susceptibility to Acetaminophen | CTD | PMID:11376689 |
| paracetamol | increases metabolic processing | ISO | RGD:10438 | 6480464 | CYP1A2 protein results in increased metabolism of Acetaminophen | CTD | PMID:10977129 PMID:19002106 |
| paracetamol | increases abundance | ISO | RGD:10438 | 6480464 | CYP1A2 protein results in increased abundance of Acetaminophen | CTD | PMID:10445756 |
| paracetamol | increases expression | ISO | RGD:10438 | 6480464 | Acetaminophen results in increased expression of CYP1A2 protein | CTD | PMID:19002106 |
| paracetamol | multiple interactions | ISO | RGD:10438 | 6480464 | CYP1A2 protein affects the metabolism of and results in decreased abundance of Acetaminophen | CTD | PMID:19679878 |
| paracetamol | increases expression | ISO | RGD:10438 | 6480464 | Acetaminophen results in increased expression of CYP1A2 mRNA | CTD | PMID:16141365 more ... |
| paracetamol | decreases expression | ISO | RGD:10438 | 6480464 | Acetaminophen results in decreased expression of CYP1A2 protein | CTD | PMID:15576447 |
| paracetamol | decreases expression | ISO | RGD:10438 | 6480464 | Acetaminophen results in decreased expression of CYP1A2 mRNA | CTD | PMID:16611625 PMID:15576447 |
| paracetamol | affects expression | ISO | RGD:10438 | 6480464 | Acetaminophen affects the expression of CYP1A2 mRNA | CTD | PMID:17562736 |
| paracetamol | multiple interactions | ISO | RGD:735711 | 6480464 | [CYP1A2 protein results in increased metabolism of Phenacetin] which results in increased chemical synthesis of Acetaminophen | CTD | PMID:19135037 |
| paracetamol | increases oxidation | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased oxidation of Acetaminophen | CTD | PMID:10811468 |
| paracetamol | increases chemical synthesis | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased chemical synthesis of Acetaminophen | CTD | PMID:12401345 PMID:15155557 |
| paracetamol | decreases expression | ISO | RGD:10438 | 6480464 | Acetaminophen results in decreased expression of CYP1A2 protein | CTD | PMID:21329376 PMID:15576447 |
| paracetamol | increases metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 results in increased metabolism of Acetaminophen | CTD | PMID:20566340 |
| paracetamol | increases expression | ISO | RGD:10438 | 6480464 | Acetaminophen results in increased expression of CYP1A2 mRNA | CTD | PMID:16141365 more ... |
| paracetamol | decreases expression | ISO | RGD:10438 | 6480464 | Acetaminophen results in decreased expression of CYP1A2 protein | CTD | PMID:15576447 PMID:21329376 |
| paracetamol | increases response to substance | ISO | RGD:10438 | 6480464 | CYP1A2 protein results in increased susceptibility to Acetaminophen | CTD | PMID:16141365 more ... |
| paracetamol | multiple interactions | ISO | RGD:10438 | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of CYP1A2 mRNA; more ... | CTD | PMID:17585979 |
| paracetamol | increases expression | ISO | RGD:10438 | 6480464 | Acetaminophen results in increased expression of CYP1A2 mRNA | CTD | PMID:12958197 more ... |
| paraquat | increases activity | EXP | | 6480464 | Paraquat results in increased activity of CYP1A2 protein | CTD | PMID:20888808 |
| paraquat | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [Paraquat results in increased expression of and results in increased activity of CYP1A2 protein]; more ... | CTD | PMID:23159886 |
| paraquat | increases expression | EXP | | 6480464 | Paraquat results in increased expression of CYP1A2 mRNA | CTD | PMID:20888808 PMID:23159886 |
| paraquat | increases expression | EXP | | 6480464 | Paraquat results in increased expression of CYP1A2 mRNA; more ... | CTD | PMID:20888808 |
| parathion | affects metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein affects the metabolism of Parathion | CTD | PMID:15557345 more ... |
| parathion | affects metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein affects the metabolism of Parathion | CTD | PMID:12669189 more ... |
| parathion | affects metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein affects the metabolism of Parathion | CTD | PMID:17079358 more ... |
| parathion | affects metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein affects the metabolism of Parathion | CTD | PMID:15557345 more ... |
| parathion | affects metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein affects the metabolism of Parathion | CTD | PMID:12669189 more ... |
| pentachlorobenzene | increases expression | EXP | | 6480464 | pentachlorobenzene results in increased expression of CYP1A2 protein | CTD | PMID:10696772 |
| pentobarbital | increases expression | ISO | RGD:10438 | 6480464 | Pentobarbital results in increased expression of CYP1A2 mRNA | CTD | PMID:10064569 |
| perfluorooctane-1-sulfonic acid | multiple interactions | ISO | RGD:735711 | 6480464 | perfluorooctane sulfonic acid inhibits the reaction [CYP1A2 protein results in increased oxidation of Oxazines] | CTD | PMID:21964418 |
| perfluorooctane-1-sulfonic acid | increases expression | ISO | RGD:10438 | 6480464 | perfluorooctane sulfonic acid results in increased expression of CYP1A2 mRNA | CTD | PMID:20936131 |
| perfluorooctanoic acid | affects expression | ISO | RGD:10438 | 6480464 | perfluorooctanoic acid affects the expression of CYP1A2 mRNA | CTD | PMID:18281256 |
| perfluorooctanoic acid | decreases expression | EXP | | 6480464 | perfluorooctanoic acid results in decreased expression of CYP1A2 mRNA | CTD | PMID:16221955 PMID:19162173 |
| perfluorooctanoic acid | decreases expression | EXP | | 6480464 | perfluorooctanoic acid results in decreased expression of CYP1A2 mRNA | CTD | PMID:19162173 PMID:16221955 |
| perfluorooctanoic acid | multiple interactions | ISO | RGD:10438 | 6480464 | PPARA promotes the reaction [perfluorooctanoic acid results in increased expression of CYP1A2 mRNA] | CTD | PMID:20118188 |
| perfluorooctanoic acid | decreases expression | ISO | RGD:10438 | 6480464 | perfluorooctanoic acid results in decreased expression of CYP1A2 mRNA | CTD | PMID:20118188 |
| perhexiline | multiple interactions | ISO | RGD:735711 | 6480464 | Perhexiline inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | CTD | PMID:18493746 |
| permethrin | increases expression | ISO | RGD:735711 | 6480464 | Permethrin results in increased expression of CYP1A2 mRNA; more ... | CTD | PMID:21784029 |
| phenacetin | multiple interactions | ISO | RGD:735711 | 6480464 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine inhibits the reaction [CYP1A2 protein results in decreased ethylation of Phenacetin] | CTD | PMID:8020169 |
| phenacetin | affects metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein affects the metabolism of Phenacetin | CTD | PMID:11751525 more ... |
| phenacetin | increases metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased metabolism of Phenacetin | CTD | PMID:12401345 more ... |
| phenacetin | increases oxidation | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased oxidation of Phenacetin | CTD | PMID:10985777 more ... |
| phenacetin | decreases ethylation | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in decreased ethylation of Phenacetin | CTD | PMID:11303964 more ... |
| phenacetin | increases metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased metabolism of Phenacetin | CTD | PMID:15370959 more ... |
| phenacetin | decreases ethylation | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in decreased ethylation of Phenacetin | CTD | PMID:14725854 more ... |
| phenacetin | affects metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein affects the metabolism of Phenacetin | CTD | PMID:11751525 more ... |
| phenacetin | increases metabolic processing | EXP | | 6480464 | CYP1A2 protein results in increased metabolism of Phenacetin | CTD | PMID:17651725 more ... |
| phenacetin | affects metabolic processing | EXP | | 6480464 | CYP1A2 protein affects the metabolism of Phenacetin | CTD | PMID:15231049 more ... |
| phenacetin | increases oxidation | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased oxidation of Phenacetin | CTD | PMID:19053182 more ... |
| phenacetin | decreases ethylation | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in decreased ethylation of Phenacetin | CTD | PMID:14563787 more ... |
| phenacetin | increases metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased metabolism of Phenacetin | CTD | PMID:15155557 more ... |
| phenacetin | affects metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein affects the metabolism of Phenacetin | CTD | PMID:15801540 more ... |
| phenacetin | decreases ethylation | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in decreased ethylation of Phenacetin | CTD | PMID:8020169 more ... |
| phenacetin | increases metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased metabolism of Phenacetin | CTD | PMID:17702393 more ... |
| phenacetin | increases oxidation | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased oxidation of Phenacetin | CTD | PMID:18032064 more ... |
| phenacetin | affects metabolic processing | EXP | | 6480464 | CYP1A2 protein affects the metabolism of Phenacetin | CTD | PMID:15801540 more ... |
| phenacetin | increases metabolic processing | EXP | | 6480464 | CYP1A2 protein results in increased metabolism of Phenacetin | CTD | PMID:12222751 more ... |
| phenacetin | increases oxidation | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased oxidation of Phenacetin | CTD | PMID:10985777 more ... |
| phenacetin | decreases ethylation | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in decreased ethylation of Phenacetin | CTD | PMID:12433797 more ... |
| phenacetin | increases metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased metabolism of Phenacetin | CTD | PMID:19135037 more ... |
| phenacetin | affects metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein affects the metabolism of Phenacetin | CTD | PMID:3577206 more ... |
| phenacetin | decreases ethylation | EXP | | 6480464 | CYP1A2 protein results in decreased ethylation of Phenacetin | CTD | PMID:11911841 PMID:12064368 |
| phenacetin | increases metabolic processing | EXP | | 6480464 | CYP1A2 protein results in increased metabolism of Phenacetin | CTD | PMID:8905919 more ... |
| phenacetin | increases oxidation | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased oxidation of Phenacetin | CTD | PMID:18032064 more ... |
| phenacetin | decreases ethylation | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in decreased ethylation of Phenacetin | CTD | PMID:8020169 more ... |
| phenacetin | increases metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased metabolism of Phenacetin | CTD | PMID:16124035 more ... |
| phenacetin | multiple interactions | EXP | | 6480464 | Enoxacin inhibits the reaction [CYP1A2 protein results in increased metabolism of Phenacetin]; more ... | CTD | PMID:8905919 |
| phenacetin | increases metabolic processing | EXP | | 6480464 | CYP1A2 protein results in increased metabolism of Phenacetin | CTD | PMID:12222751 more ... |
| phenacetin | affects metabolic processing | EXP | | 6480464 | CYP1A2 protein affects the metabolism of Phenacetin | CTD | PMID:15879494 more ... |
| phenacetin | increases expression | ISO | RGD:10438 | 6480464 | Phenacetin results in increased expression of CYP1A2 protein | CTD | PMID:15742976 |
| phenacetin | decreases ethylation | EXP | | 6480464 | CYP1A2 protein results in decreased ethylation of Phenacetin | CTD | PMID:12064368 PMID:11911841 |
| phenacetin | multiple interactions | ISO | RGD:10438 | 6480464 | Phenacetin inhibits the reaction [CYP1A2 protein results in increased oxidation of Uroporphyrinogens] | CTD | PMID:1567206 |
| phenacetin | increases metabolic processing | ISO | RGD:10438 | 6480464 | CYP1A2 protein results in increased metabolism of Phenacetin | CTD | PMID:10445756 |
| phenacetin | affects metabolic processing | ISO | RGD:10438 | 6480464 | CYP1A2 protein affects the metabolism of Phenacetin | CTD | PMID:15742976 |
| phenacetin | multiple interactions | ISO | RGD:735711 | 6480464 | Oleanolic Acid inhibits the reaction [CYP1A2 protein results in increased metabolism of Phenacetin] | CTD | PMID:15043991 |
| phenacetin | multiple interactions | ISO | RGD:735711 | 6480464 | zileuton inhibits the reaction [CYP1A2 protein results in increased metabolism of Phenacetin] | CTD | PMID:14570767 |
| phenacetin | increases activity | ISO | RGD:735711 | 6480464 | Phenacetin results in increased activity of CYP1A2 protein | CTD | PMID:15802386 |
| phenacetin | multiple interactions | ISO | RGD:735711 | 6480464 | O(6)-benzylguanine inhibits the reaction [CYP1A2 protein affects the metabolism of Phenacetin] | CTD | PMID:11751525 |
| phenacetin | multiple interactions | ISO | RGD:735711 | 6480464 | furafylline inhibits the reaction [CYP1A2 protein results in increased metabolism of Phenacetin] | CTD | PMID:16049126 |
| phenacetin | increases oxidation | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased oxidation of Phenacetin analog | CTD | PMID:11284709 |
| phenacetin | increases oxidation | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased oxidation of Phenacetin | CTD | PMID:10985777 more ... |
| phenacetin | multiple interactions | ISO | RGD:735711 | 6480464 | [CYP1A2 protein results in increased metabolism of Phenacetin] which results in increased chemical synthesis of Acetaminophen | CTD | PMID:19135037 |
| phenacetin | increases metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased metabolism of Phenacetin | CTD | PMID:17702393 more ... |
| phenacetin | decreases ethylation | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in decreased ethylation of Phenacetin | CTD | PMID:14725854 more ... |
| phenacetin | affects metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein affects the metabolism of Phenacetin | CTD | PMID:15801540 more ... |
| phenacetin | multiple interactions | ISO | RGD:735711 | 6480464 | 8-phenyltheophylline inhibits the reaction [CYP1A2 protein results in decreased ethylation of Phenacetin] | CTD | PMID:11465391 |
| phenacetin | multiple interactions | ISO | RGD:735711 | 6480464 | 4-amino-2-phenoxymethanesulfonanilide promotes the reaction [CYP1A2 protein results in increased oxidation of Phenacetin] | CTD | PMID:19053182 |
| phenanthrene | increases activity | ISO | RGD:10438 | 6480464 | phenanthrene results in increased activity of CYP1A2 protein | CTD | PMID:8001243 |
| phenanthrene | multiple interactions | ISO | RGD:10438 | 6480464 | [acenaphthylene co-treated with acenaphthene co-treated with dibenzofuran co-treated with fluorene co-treated with phenanthrene co-treated with anthracene] results in increased expression of CYP1A2 mRNA | CTD | PMID:7750161 |
| phenanthrene | multiple interactions | ISO | RGD:10438 | 6480464 | CYP1A2 protein results in increased metabolism of and results in increased activity of phenanthrene | CTD | PMID:19766613 |
| phenanthrene | multiple interactions | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased metabolism of and results in increased activity of phenanthrene | CTD | PMID:19766613 |
| phenethyl isothiocyanate | decreases activity | ISO | RGD:735711 | 6480464 | phenethyl isothiocyanate results in decreased activity of CYP1A2 mRNA | CTD | PMID:20442190 |
| phenethyl isothiocyanate | increases expression | EXP | | 6480464 | phenethyl isothiocyanate results in increased expression of CYP1A2 mRNA | CTD | PMID:22664424 |
| phenethyl isothiocyanate | multiple interactions | EXP | | 6480464 | phenethyl isothiocyanate results in increased activity of [CYP1A1 protein co-treated with CYP1A2 protein] | CTD | PMID:22664424 |
| phenethyl isothiocyanate | decreases expression | ISO | RGD:735711 | 6480464 | phenethyl isothiocyanate results in decreased expression of CYP1A2 protein | CTD | PMID:20025923 |
| phenethyl isothiocyanate | decreases expression | EXP | | 6480464 | phenethyl isothiocyanate results in decreased expression of CYP1A2 protein | CTD | PMID:20025923 |
| phenethyl isothiocyanate | increases expression | ISO | RGD:735711 | 6480464 | phenethyl isothiocyanate results in increased expression of CYP1A2 mRNA | CTD | PMID:20442190 PMID:15672752 |
| phenethyl isothiocyanate | increases expression | ISO | RGD:735711 | 6480464 | phenethyl isothiocyanate results in increased expression of CYP1A2 mRNA | CTD | PMID:15672752 PMID:20442190 |
| phenobarbital | multiple interactions | ISO | RGD:735711 | 6480464 | Meclizine inhibits the reaction [[Phenobarbital results in increased activity of NR1I3 protein] which results in increased expression of CYP1A2 mRNA] | CTD | PMID:15272053 |
| phenobarbital | multiple interactions | EXP | | 6480464 | Phenobarbital promotes the reaction [Lindane results in increased expression of and results in increased activity of CYP1A2 protein] | CTD | PMID:18486174 |
| phenobarbital | increases expression | EXP | | 6480464 | Phenobarbital results in increased expression of CYP1A2 mRNA | CTD | PMID:20226384 PMID:8849338 |
| phenobarbital | increases expression | ISO | RGD:735711 | 6480464 | Phenobarbital results in increased expression of CYP1A2 mRNA | CTD | PMID:19118567 PMID:22310298 |
| phenobarbital | decreases expression | EXP | | 6480464 | Phenobarbital results in decreased expression of CYP1A2 mRNA | CTD | PMID:11328961 more ... |
| phenobarbital | decreases activity | ISO | RGD:735711 | 6480464 | Phenobarbital results in decreased activity of CYP1A2 protein | CTD | PMID:19909766 |
| phenobarbital | increases expression | ISO | RGD:10438 | 6480464 | Phenobarbital results in increased expression of CYP1A2 mRNA | CTD | PMID:10064569 more ... |
| phenobarbital | increases expression | ISO | RGD:735711 | 6480464 | Phenobarbital results in increased expression of CYP1A2 mRNA | CTD | PMID:19118567 |
| phenobarbital | increases activity | ISO | RGD:735711 | 6480464 | Phenobarbital results in increased activity of CYP1A2 protein | CTD | PMID:19118567 |
| phenobarbital | decreases expression | EXP | | 6480464 | Phenobarbital results in decreased expression of CYP1A2 mRNA | CTD | PMID:20607812 more ... |
| phenobarbital | increases expression | ISO | RGD:10438 | 6480464 | Phenobarbital results in increased expression of CYP1A2 mRNA | CTD | PMID:9397191 more ... |
| phenobarbital | decreases expression | EXP | | 6480464 | Phenobarbital results in decreased expression of CYP1A2 mRNA | CTD | PMID:15596064 more ... |
| phenobarbital | increases expression | ISO | RGD:10438 | 6480464 | Phenobarbital results in increased expression of CYP1A2 mRNA | CTD | PMID:20403969 more ... |
| phenobarbital | decreases expression | EXP | | 6480464 | Phenobarbital results in decreased expression of CYP1A2 mRNA | CTD | PMID:17381134 more ... |
| phenobarbital | increases expression | ISO | RGD:10438 | 6480464 | Phenobarbital results in increased expression of CYP1A2 protein | CTD | PMID:10064569 PMID:18692084 |
| phenobarbital | increases expression | ISO | RGD:10438 | 6480464 | Phenobarbital results in increased expression of CYP1A2 mRNA | CTD | PMID:17962186 more ... |
| phenobarbital | multiple interactions | ISO | RGD:10438 | 6480464 | ciprofibrate inhibits the reaction [Phenobarbital results in increased expression of CYP1A2 mRNA]; more ... | CTD | PMID:17962186 |
| phenobarbital | increases expression | ISO | RGD:10438 | 6480464 | Phenobarbital results in increased expression of CYP1A2 mRNA | CTD | PMID:10064569 more ... |
| phenobarbital | increases expression | ISO | RGD:10438 | 6480464 | Phenobarbital results in increased expression of CYP1A2 mRNA | CTD | PMID:20403969 more ... |
| phenobarbital | decreases expression | EXP | | 6480464 | Phenobarbital results in decreased expression of CYP1A2 mRNA | CTD | PMID:17381134 PMID:15596064 |
| phenobarbital | increases expression | EXP | | 6480464 | Phenobarbital results in increased expression of CYP1A2 mRNA | CTD | PMID:20226384 |
| phenobarbital | multiple interactions | EXP | | 6480464 | Choline deficiency promotes the reaction [Phenobarbital results in increased expression of CYP1A2 protein] | CTD | PMID:18798224 |
| phenobarbital | increases expression | ISO | RGD:10438 | 6480464 | Phenobarbital results in increased expression of CYP1A2 mRNA | CTD | PMID:20403969 more ... |
| phenobarbital | increases expression | ISO | RGD:10438 | 6480464 | Phenobarbital results in increased expression of CYP1A2 protein | CTD | PMID:18692084 PMID:10064569 |
| phenobarbital | multiple interactions | ISO | RGD:10438 | 6480464 | MED1 protein promotes the reaction [Phenobarbital results in increased expression of CYP1A2 mRNA] | CTD | PMID:16109766 |
| phenobarbital | increases activity | ISO | RGD:10438 | 6480464 | Phenobarbital results in increased activity of CYP1A2 protein | CTD | PMID:10064569 |
| phenol | affects response to substance | ISO | RGD:735711 | 6480464 | CYP1A2 protein affects the susceptibility to Phenol | CTD | PMID:8242868 |
| phenthoate | increases expression | ISO | RGD:735711 | 6480464 | phenthoate results in increased expression of CYP1A2 mRNA | CTD | PMID:22310298 |
| phenylephrine | multiple interactions | EXP | | 6480464 | Phenylephrine promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA]; more ... | CTD | PMID:16510159 |
| phlorizin | decreases expression | ISO | RGD:10438 | 6480464 | Phlorhizin results in decreased expression of CYP1A2 mRNA | CTD | PMID:22538082 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:735711 | 6480464 | Tetradecanoylphorbol Acetate promotes the reaction [FOS protein binds to CYP1A2 enhancer]; more ... | CTD | PMID:10620351 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:10438 | 6480464 | Tetradecanoylphorbol Acetate inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | CTD | PMID:1313028 |
| pimobendan | decreases methylation | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in decreased methylation of pimobendan | CTD | PMID:10611143 |
| piperonyl butoxide | increases expression | ISO | RGD:735711 | 6480464 | Piperonyl Butoxide results in increased expression of CYP1A2 mRNA; more ... | CTD | PMID:21784029 |
| piperonyl butoxide | increases expression | EXP | | 6480464 | Piperonyl Butoxide results in increased expression of CYP1A2 mRNA | CTD | PMID:18544911 PMID:20735435 |
| piperonyl butoxide | increases expression | ISO | RGD:10438 | 6480464 | Piperonyl Butoxide results in increased expression of CYP1A2 mRNA | CTD | PMID:8722114 PMID:9233375 |
| piperonyl butoxide | increases expression | ISO | RGD:10438 | 6480464 | Piperonyl Butoxide results in increased expression of CYP1A2 protein | CTD | PMID:9233375 |
| piperonyl butoxide | multiple interactions | EXP | | 6480464 | Triterpenes promotes the reaction [Piperonyl Butoxide results in increased expression of CYP1A2 mRNA] | CTD | PMID:18544911 |
| piperonyl butoxide | increases expression | EXP | | 6480464 | Piperonyl Butoxide results in increased expression of CYP1A2 mRNA | CTD | PMID:18544911 |
| piperonyl butoxide | increases expression | ISO | RGD:10438 | 6480464 | Piperonyl Butoxide results in increased expression of CYP1A2 mRNA | CTD | PMID:8722114 |
| pirinixic acid | multiple interactions | ISO | RGD:10438 | 6480464 | [pirinixic acid co-treated with PPARA] results in decreased expression of CYP1A2 mRNA | CTD | PMID:20813756 |
| pirinixic acid | decreases expression | ISO | RGD:10438 | 6480464 | pirinixic acid results in decreased expression of CYP1A2 mRNA | CTD | PMID:17962186 more ... |
| pirinixic acid | decreases expression | ISO | RGD:10438 | 6480464 | pirinixic acid results in decreased expression of CYP1A2 mRNA | CTD | PMID:18467677 more ... |
| pirinixic acid | decreases expression | ISO | RGD:10438 | 6480464 | pirinixic acid results in decreased expression of CYP1A2 mRNA | CTD | PMID:20813756 more ... |
| pirinixic acid | decreases expression | ISO | RGD:10438 | 6480464 | pirinixic acid results in decreased expression of CYP1A2 mRNA | CTD | PMID:20059764 more ... |
| pirinixic acid | multiple interactions | ISO | RGD:10438 | 6480464 | pirinixic acid inhibits the reaction [Phenobarbital results in increased expression of CYP1A2 mRNA] | CTD | PMID:17962186 |
| pirinixic acid | decreases expression | ISO | RGD:10438 | 6480464 | pirinixic acid results in decreased expression of CYP1A2 mRNA | CTD | PMID:20813756 more ... |
| pirinixic acid | multiple interactions | ISO | RGD:10438 | 6480464 | PPARA protein promotes the reaction [pirinixic acid results in decreased expression of CYP1A2 mRNA] | CTD | PMID:18467677 PMID:20059764 |
| pirinixic acid | decreases expression | ISO | RGD:10438 | 6480464 | pirinixic acid results in decreased expression of CYP1A2 mRNA | CTD | PMID:20059764 more ... |
| pirinixic acid | decreases expression | EXP | | 6480464 | pirinixic acid results in decreased expression of CYP1A2 mRNA | CTD | PMID:19162173 |
| pirinixic acid | multiple interactions | ISO | RGD:10438 | 6480464 | PPARA protein promotes the reaction [pirinixic acid results in decreased expression of CYP1A2 mRNA] | CTD | PMID:20059764 PMID:18467677 |
| pirinixic acid | decreases expression | ISO | RGD:10438 | 6480464 | pirinixic acid results in decreased expression of CYP1A2 mRNA | CTD | PMID:18467677 more ... |
| pirinixic acid | multiple interactions | ISO | RGD:735711 | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of CYP1A2 mRNA | CTD | PMID:19710929 |
| poly(styrene) | multiple interactions | ISO | RGD:735711 | 6480464 | styrofoam analog promotes the reaction [Cimetidine results in decreased activity of CYP1A2 protein] | CTD | PMID:19909766 |
| poly(styrene) | affects activity | ISO | RGD:735711 | 6480464 | styrofoam analog affects the activity of CYP1A2 protein | CTD | PMID:19909766 |
| prazosin | multiple interactions | EXP | | 6480464 | Prazosin inhibits the reaction [Phenylephrine promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA]]; more ... | CTD | PMID:16510159 |
| pregnenolone 16alpha-carbonitrile | decreases expression | EXP | | 6480464 | Pregnenolone Carbonitrile results in decreased expression of CYP1A2 mRNA | CTD | PMID:19162173 PMID:15596064 |
| pregnenolone 16alpha-carbonitrile | decreases expression | EXP | | 6480464 | Pregnenolone Carbonitrile results in decreased expression of CYP1A2 mRNA | CTD | PMID:15596064 PMID:19162173 |
| primaquine | increases activity | ISO | RGD:735711 | 6480464 | Primaquine results in increased activity of CYP1A2 promoter | CTD | PMID:18502397 |
| primaquine | increases expression | ISO | RGD:735711 | 6480464 | Primaquine results in increased expression of CYP1A2 mRNA | CTD | PMID:12623754 more ... |
| primaquine | increases metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased metabolism of Primaquine | CTD | PMID:19616568 |
| primaquine | multiple interactions | ISO | RGD:735711 | 6480464 | [CYP1A2 protein results in increased expression of HBG2 protein] which affects the susceptibility to Primaquine | CTD | PMID:19616568 |
| primaquine | increases expression | ISO | RGD:735711 | 6480464 | Primaquine results in increased expression of CYP1A2 mRNA | CTD | PMID:17954527 more ... |
| primaquine | increases expression | ISO | RGD:735711 | 6480464 | Primaquine results in increased expression of CYP1A2 mRNA | CTD | PMID:12623754 more ... |
| primaquine | increases expression | ISO | RGD:735711 | 6480464 | Primaquine results in increased expression of CYP1A2 mRNA | CTD | PMID:12451431 more ... |
| primaquine | affects metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein affects the metabolism of Primaquine | CTD | PMID:12920490 |
| profenofos | increases expression | ISO | RGD:735711 | 6480464 | profenofos results in increased expression of CYP1A2 mRNA | CTD | PMID:22310298 |
| propiconazole | increases expression | ISO | RGD:735711 | 6480464 | propiconazole results in increased expression of CYP1A2 mRNA | CTD | PMID:19409404 |
| propiconazole | increases expression | ISO | RGD:10438 | 6480464 | propiconazole results in increased expression of CYP1A2 mRNA | CTD | PMID:16730040 more ... |
| propiconazole | increases expression | EXP | | 6480464 | propiconazole results in increased expression of CYP1A2 mRNA | CTD | PMID:16643972 PMID:15603923 |
| propiconazole | increases expression | ISO | RGD:10438 | 6480464 | propiconazole results in increased expression of CYP1A2 mRNA | CTD | PMID:16730040 PMID:19010342 |
| propiconazole | increases expression | EXP | | 6480464 | propiconazole results in increased expression of CYP1A2 protein | CTD | PMID:7986207 |
| propiconazole | increases expression | EXP | | 6480464 | propiconazole results in increased expression of CYP1A2 mRNA | CTD | PMID:15603923 PMID:16643972 |
| propiconazole | increases activity | EXP | | 6480464 | propiconazole results in increased activity of CYP1A2 protein | CTD | PMID:3190755 |
| propiconazole | increases expression | ISO | RGD:10438 | 6480464 | propiconazole results in increased expression of CYP1A2 mRNA | CTD | PMID:19010342 PMID:16730040 |
| propranolol | affects metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein affects the metabolism of Propranolol | CTD | PMID:15286053 |
| propranolol | increases expression | ISO | RGD:10438 | 6480464 | Propranolol results in increased expression of CYP1A2 protein | CTD | PMID:15618653 |
| propranolol | multiple interactions | EXP | | 6480464 | Propranolol inhibits the reaction [Clenbuterol inhibits the reaction [Lipopolysaccharides results in decreased activity of CYP1A2 protein]]; more ... | CTD | PMID:15710352 |
| protopine | increases expression | ISO | RGD:735711 | 6480464 | protopine results in increased expression of CYP1A2 mRNA | CTD | PMID:21419197 |
| pterostilbene | decreases activity | ISO | RGD:10438 | 6480464 | pterostilbene results in decreased activity of CYP1A2 protein | CTD | PMID:16684708 |
| purpurin | decreases activity | ISO | RGD:735711 | 6480464 | 1,2,4-trihydroxy-9,10-anthracenedione results in decreased activity of CYP1A2 protein | CTD | PMID:12379470 |
| pyrene | increases hydroxylation | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased hydroxylation of pyrene | CTD | PMID:15016593 |
| pyrene | increases expression | ISO | RGD:10438 | 6480464 | pyrene results in increased expression of CYP1A2 mRNA | CTD | PMID:17618724 |
| pyrene | multiple interactions | ISO | RGD:10438 | 6480464 | pyrene results in increased expression of and results in increased activity of CYP1A2 protein | CTD | PMID:17618724 |
| pyrene | multiple interactions | ISO | RGD:10438 | 6480464 | [fluoranthene co-treated with pyrene co-treated with benz(a)anthracene co-treated with chrysene co-treated with benzo(b)fluoranthene co-treated with benzo(k)fluoranthene co-treated with Benzo(a)pyrene] results in increased expression of CYP1A2 mRNA | CTD | PMID:7750161 |
| pyridine | increases activity | EXP | | 6480464 | pyridine results in increased activity of CYP1A2 protein | CTD | PMID:10413312 more ... |
| pyridine | increases activity | EXP | | 6480464 | pyridine results in increased activity of CYP1A2 protein | CTD | PMID:1857340 more ... |
| pyridine | increases expression | EXP | | 6480464 | pyridine results in increased expression of CYP1A2 mRNA | CTD | PMID:10463385 more ... |
| pyridine | increases activity | EXP | | 6480464 | pyridine results in increased activity of CYP1A2 protein | CTD | PMID:10413312 more ... |
| pyridine | increases expression | EXP | | 6480464 | pyridine results in increased expression of CYP1A2 protein | CTD | PMID:10463385 more ... |
| pyridine | increases expression | EXP | | 6480464 | pyridine results in increased expression of CYP1A2 mRNA | CTD | PMID:7493548 more ... |
| pyridine | increases activity | EXP | | 6480464 | pyridine results in increased activity of CYP1A2 protein | CTD | PMID:1857340 more ... |
| pyridine | increases expression | EXP | | 6480464 | pyridine results in increased expression of CYP1A2 protein | CTD | PMID:10413312 more ... |
| pyridine | increases expression | EXP | | 6480464 | pyridine results in increased expression of CYP1A2 mRNA | CTD | PMID:10463385 more ... |
| pyridine | increases expression | EXP | | 6480464 | pyridine results in increased expression of CYP1A2 protein | CTD | PMID:10413312 more ... |
| pyridine | increases expression | EXP | | 6480464 | pyridine results in increased expression of CYP1A2 mRNA | CTD | PMID:1857340 more ... |
| pyrogallol | increases expression | ISO | RGD:10438 | 6480464 | Pyrogallol results in increased expression of CYP1A2 mRNA | CTD | PMID:18789925 |
| pyrogallol | multiple interactions | ISO | RGD:10438 | 6480464 | resveratrol inhibits the reaction [Pyrogallol results in increased expression of CYP1A2 mRNA]; more ... | CTD | PMID:18789925 |
| pyrogallol | increases activity | ISO | RGD:10438 | 6480464 | Pyrogallol results in increased activity of CYP1A2 protein | CTD | PMID:18789925 |
| quercetin | multiple interactions | ISO | RGD:735711 | 6480464 | Quercetin inhibits the reaction [CYP1A2 protein results in increased oxidation of 3,3'-diindolylmethane] | CTD | PMID:16544949 |
| quercetin | multiple interactions | ISO | RGD:735711 | 6480464 | Quercetin inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] | CTD | PMID:21256954 |
| quercetin | increases expression | ISO | RGD:735711 | 6480464 | Quercetin results in increased expression of CYP1A2 mRNA | CTD | PMID:19034627 PMID:21256954 |
| quercetin | affects activity | ISO | RGD:735711 | 6480464 | Quercetin affects the activity of CYP1A2 protein | CTD | PMID:21053930 |
| quercetin | decreases activity | ISO | RGD:735711 | 6480464 | Quercetin results in decreased activity of CYP1A2 protein | CTD | PMID:15916432 PMID:12949046 |
| quercetin | increases expression | EXP | | 6480464 | Quercetin results in increased expression of CYP1A2 mRNA | CTD | PMID:18421621 |
| quercetin | multiple interactions | EXP | | 6480464 | Quercetin results in increased expression of and results in increased activity of CYP1A2 protein | CTD | PMID:18421621 |
| quercetin | multiple interactions | EXP | | 6480464 | Quercetin inhibits the reaction [CYP1A2 results in increased activity of 2-amino-3-methylimidazo(4,5-f)quinoline] | CTD | PMID:11752233 |
| quercetin | increases expression | ISO | RGD:735711 | 6480464 | Quercetin results in increased expression of CYP1A2 mRNA | CTD | PMID:19034627 |
| quercetin | decreases activity | ISO | RGD:735711 | 6480464 | Quercetin results in decreased activity of CYP1A2 protein | CTD | PMID:12949046 PMID:15916432 |
| quercetin | multiple interactions | ISO | RGD:735711 | 6480464 | Quercetin promotes the reaction [JUND protein binds to CYP1A2 enhancer]; more ... | CTD | PMID:10620351 |
| quercetin 3-O-beta-D-glucoside | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with oxfendazole co-treated with isoquercitrin] results in increased expression of CYP1A2 mRNA | CTD | PMID:20033131 |
| quinidine | multiple interactions | ISO | RGD:735711 | 6480464 | Quinidine affects the reaction [CYP1A2 protein results in increased oxidation of 4-amino-2-phenoxymethanesulfonanilide] | CTD | PMID:19053182 |
| quinidine | decreases activity | ISO | RGD:735711 | 6480464 | Quinidine results in decreased activity of CYP1A2 protein | CTD | PMID:15916432 |
| quinine | increases expression | ISO | RGD:735711 | 6480464 | Quinine results in increased expression of CYP1A2 mRNA | CTD | PMID:12451431 |
| quinoline | decreases activity | ISO | RGD:735711 | 6480464 | quinoline analog results in decreased activity of CYP1A2 protein | CTD | PMID:15916432 |
| rabeprazole sodium | increases expression | ISO | RGD:735711 | 6480464 | rabeprazole results in increased expression of CYP1A2 mRNA | CTD | PMID:12623754 |
| reserpine | multiple interactions | EXP | | 6480464 | Reserpine promotes the reaction [Benzo(a)pyrene results in increased expression of and results in increased activity of CYP1A2 protein]; more ... | CTD | PMID:16510159 |
| resveratrol | multiple interactions | ISO | RGD:735711 | 6480464 | resveratrol inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] | CTD | PMID:10496959 |
| resveratrol | multiple interactions | ISO | RGD:735711 | 6480464 | Imipramine inhibits the reaction [resveratrol results in decreased activity of CYP1A2 protein]; more ... | CTD | PMID:11714871 |
| resveratrol | multiple interactions | ISO | RGD:10438 | 6480464 | resveratrol inhibits the reaction [Pyrogallol results in increased expression of CYP1A2 mRNA]; more ... | CTD | PMID:18789925 |
| resveratrol | multiple interactions | ISO | RGD:735711 | 6480464 | resveratrol promotes the reaction [CYP1A2 protein results in increased metabolism of Caffeine] | CTD | PMID:20716633 |
| resveratrol | decreases activity | ISO | RGD:735711 | 6480464 | resveratrol results in decreased activity of CYP1A2 protein | CTD | PMID:11714871 |
| resveratrol | multiple interactions | ISO | RGD:735711 | 6480464 | resveratrol inhibits the reaction [15,16-dihydrotanshinone I results in increased expression of CYP1A2 mRNA]; more ... | CTD | PMID:21262253 |
| resveratrol | decreases activity | ISO | RGD:10438 | 6480464 | resveratrol analog results in decreased activity of CYP1A2 protein | CTD | PMID:16684708 |
| resveratrol | multiple interactions | ISO | RGD:735711 | 6480464 | resveratrol inhibits the reaction [CYP1A2 protein results in increased oxidation of 3,3'-diindolylmethane] | CTD | PMID:16544949 |
| resveratrol | multiple interactions | ISO | RGD:735711 | 6480464 | resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | CTD | PMID:19376845 |
| resveratrol | multiple interactions | ISO | RGD:735711 | 6480464 | resveratrol inhibits the reaction [anthra(1,9-cd)pyrazol-6(2H)-one results in increased expression of CYP1A2 mRNA] | CTD | PMID:17959153 |
| resveratrol | affects metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein affects the metabolism of resveratrol | CTD | PMID:15276085 |
| rifampicin | multiple interactions | ISO | RGD:735711 | 6480464 | Rifampin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | CTD | PMID:18493746 |
| rifampicin | increases expression | ISO | RGD:735711 | 6480464 | Rifampin results in increased expression of CYP1A2 protein | CTD | PMID:17590308 PMID:15977188 |
| rifampicin | multiple interactions | EXP | | 6480464 | Rifampin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | CTD | PMID:18493746 |
| rifampicin | increases expression | ISO | RGD:735711 | 6480464 | Rifampin results in increased expression of CYP1A2 protein | CTD | PMID:15977188 PMID:17590308 |
| rifampicin | increases expression | ISO | RGD:735711 | 6480464 | Rifampin results in increased expression of CYP1A2 mRNA | CTD | PMID:15977188 |
| salicylamide | multiple interactions | ISO | RGD:735711 | 6480464 | salicylamide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | CTD | PMID:14729655 |
| scutellarein | affects metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein affects the metabolism of scutellarein | CTD | PMID:19666078 |
| secobarbital | increases expression | ISO | RGD:10438 | 6480464 | Secobarbital results in increased expression of CYP1A2 mRNA | CTD | PMID:10064569 |
| selenium atom | multiple interactions | EXP | | 6480464 | [Acetylcysteine co-treated with Zinc co-treated with Selenium] inhibits the reaction [dimethyl mercury results in decreased expression of CYP1A2 protein] | CTD | PMID:21424224 |
| simazine | increases activity | EXP | | 6480464 | Simazine results in increased activity of CYP1A2 protein | CTD | PMID:9711812 |
| simazine | increases expression | EXP | | 6480464 | Simazine results in increased expression of CYP1A2 protein | CTD | PMID:9711812 |
| sodium dichromate | multiple interactions | ISO | RGD:10438 | 6480464 | [Benzo(a)pyrene co-treated with sodium bichromate] results in decreased expression of CYP1A2 mRNA | CTD | PMID:22613061 |
| sodium fluoride | decreases expression | ISO | RGD:10438 | 6480464 | Sodium Fluoride results in decreased expression of CYP1A2 mRNA | CTD | PMID:21340527 |
| sterigmatocystin | multiple interactions | ISO | RGD:735711 | 6480464 | [CYP1A2 protein results in increased glutathionylation of and results in increased hydroxylation of Sterigmatocystin] which results in increased chemical synthesis of Sterigmatocystin metabolite | CTD | PMID:20929267 |
| streptozocin | decreases expression | ISO | RGD:10438 | 6480464 | Streptozocin results in decreased expression of CYP1A2 protein | CTD | PMID:12700423 |
| streptozocin | multiple interactions | EXP | | 6480464 | [Streptozocin results in increased expression of CYP1A2 protein] which results in increased metabolism of Diazinon | CTD | PMID:17442507 |
| streptozocin | increases expression | EXP | | 6480464 | Streptozocin results in increased expression of CYP1A2 protein | CTD | PMID:17442507 |
| styrene | increases expression | EXP | | 6480464 | Styrene results in increased expression of CYP1A2 mRNA; more ... | CTD | PMID:16418063 PMID:18202523 |
| styrene | increases expression | EXP | | 6480464 | Styrene results in increased expression of CYP1A2 mRNA; more ... | CTD | PMID:18202523 PMID:16418063 |
| styrene | multiple interactions | EXP | | 6480464 | gadolinium chloride inhibits the reaction [Styrene results in increased expression of CYP1A2 protein] | CTD | PMID:18202523 |
| Sudan I | multiple interactions | ISO | RGD:735711 | 6480464 | CYB5A protein promotes the reaction [CYP1A2 protein results in increased oxidation of 1-phenylazo-2-naphthol] | CTD | PMID:17159775 |
| Sudan I | increases oxidation | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased oxidation of 1-phenylazo-2-naphthol | CTD | PMID:17159775 |
| sulforaphane | increases expression | EXP | | 6480464 | sulforafan results in increased expression of CYP1A2 protein | CTD | PMID:15906351 |
| sulforaphane | multiple interactions | EXP | | 6480464 | sulforafan results in decreased activity of [CYP1A2 protein co-treated with CYP1A1 protein] | CTD | PMID:22664424 |
| sulforaphane | multiple interactions | ISO | RGD:735711 | 6480464 | sulforafan inhibits the reaction [Benzo(a)pyrene results in increased activity of CYP1A2 protein] | CTD | PMID:19202560 |
| sulforaphane | multiple interactions | ISO | RGD:735711 | 6480464 | sulforafan inhibits the reaction [anthracene results in increased activity of CYP1A2 protein]; more ... | CTD | PMID:19362136 |
| sulforaphane | decreases expression | ISO | RGD:735711 | 6480464 | sulforafan results in decreased expression of CYP1A2 mRNA | CTD | PMID:20442190 |
| sulfur dioxide | decreases activity | EXP | | 6480464 | Sulfur Dioxide results in decreased activity of CYP1A2 protein | CTD | PMID:16023800 |
| sulfur dioxide | decreases expression | EXP | | 6480464 | Sulfur Dioxide results in decreased expression of CYP1A2 mRNA | CTD | PMID:16023800 |
| sulindac | increases expression | ISO | RGD:735711 | 6480464 | Sulindac results in increased expression of CYP1A2 mRNA | CTD | PMID:17985343 |
| sulindac | increases expression | EXP | | 6480464 | Sulindac results in increased expression of CYP1A2 mRNA | CTD | PMID:16531450 |
| suramin | decreases activity | ISO | RGD:735711 | 6480464 | Suramin results in decreased activity of CYP1A2 protein | CTD | PMID:11124226 |
| tacrine | multiple interactions | ISO | RGD:735711 | 6480464 | Tacrine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | CTD | PMID:18493746 |
| tacrine | multiple interactions | EXP | | 6480464 | Tacrine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] | CTD | PMID:18493746 |
| tacrine | decreases activity | EXP | | 6480464 | Tacrine results in decreased activity of CYP1A2 protein | CTD | PMID:15258105 |
| tacrine | affects metabolic processing | EXP | | 6480464 | CYP1A2 protein affects the metabolism of Tacrine | CTD | PMID:15258105 |
| tamoxifen | increases hydroxylation | EXP | | 6480464 | CYP1A2 protein results in increased hydroxylation of Tamoxifen | CTD | PMID:15587933 |
| tangeretin | multiple interactions | ISO | RGD:735711 | 6480464 | tangeretin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | CTD | PMID:17090139 |
| tegaserod | decreases activity | ISO | RGD:735711 | 6480464 | tegaserod results in decreased activity of CYP1A2 protein | CTD | PMID:11560869 |
| terbutryn | increases metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased metabolism of terbutryne | CTD | PMID:8971136 |
| terbutryn | multiple interactions | ISO | RGD:735711 | 6480464 | POR protein promotes the reaction [CYP1A2 protein results in increased metabolism of terbutryne] | CTD | PMID:8971136 |
| tetrachloroethene | increases metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased metabolism of Tetrachloroethylene | CTD | PMID:11684365 |
| tetrachloromethane | decreases expression | ISO | RGD:10438 | 6480464 | Carbon Tetrachloride results in decreased expression of CYP1A2 mRNA | CTD | PMID:18038451 PMID:17084009 |
| tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of CYP1A2 protein | CTD | PMID:17606319 PMID:20930465 |
| tetrachloromethane | multiple interactions | EXP | | 6480464 | [2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline co-treated with Carbon Tetrachloride] results in increased expression of CYP1A2 mRNA; more ... | CTD | PMID:20930465 |
| tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of CYP1A2 mRNA | CTD | PMID:16239168 PMID:14706259 |
| tetrachloromethane | decreases activity | EXP | | 6480464 | Carbon Tetrachloride results in decreased activity of CYP1A2 protein | CTD | PMID:14706259 PMID:16288784 |
| tetrachloromethane | decreases expression | ISO | RGD:10438 | 6480464 | Carbon Tetrachloride results in decreased expression of CYP1A2 mRNA | CTD | PMID:17084009 PMID:18038451 |
| tetrachloromethane | increases metabolic processing | EXP | | 6480464 | CYP1A2 protein results in increased metabolism of Carbon Tetrachloride | CTD | PMID:15988118 |
| tetrachloromethane | multiple interactions | EXP | | 6480464 | Curcumin inhibits the reaction [Carbon Tetrachloride results in decreased activity of CYP1A2 protein] | CTD | PMID:16288784 |
| tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of CYP1A2 protein | CTD | PMID:17606319 |
| tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of CYP1A2 mRNA | CTD | PMID:14706259 PMID:16239168 |
| tetrachloromethane | decreases activity | EXP | | 6480464 | Carbon Tetrachloride results in decreased activity of CYP1A2 protein | CTD | PMID:16288784 PMID:14706259 |
| tetrachloromethane | affects expression | EXP | | 6480464 | Carbon Tetrachloride affects the expression of CYP1A2 mRNA | CTD | PMID:15963342 |
| tetrachloromethane | multiple interactions | ISO | RGD:10438 | 6480464 | CYP2E1 gene mutant form inhibits the reaction [Carbon Tetrachloride results in decreased expression of CYP1A2 mRNA] | CTD | PMID:17084009 |
| tetrachloromethane | decreases expression | ISO | RGD:10438 | 6480464 | Carbon Tetrachloride results in decreased expression of CYP1A2 protein | CTD | PMID:16445600 |
| tetraphene | multiple interactions | ISO | RGD:735711 | 6480464 | [CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of benz(a)anthracene; more ... | CTD | PMID:8961944 |
| tetraphene | increases expression | ISO | RGD:735711 | 6480464 | benz(a)anthracene results in increased expression of CYP1A2 mRNA | CTD | PMID:17253728 PMID:9783729 |
| tetraphene | decreases activity | ISO | RGD:735711 | 6480464 | benz(a)anthracene results in decreased activity of CYP1A2 protein | CTD | PMID:11162773 |
| tetraphene | affects response to substance | EXP | | 6480464 | CYP1A2 protein affects the susceptibility to benz(a)anthracene | CTD | PMID:21384493 |
| tetraphene | increases expression | EXP | | 6480464 | benz(a)anthracene results in increased expression of CYP1A2 mRNA | CTD | PMID:21384493 |
| tetraphene | increases expression | ISO | RGD:735711 | 6480464 | benz(a)anthracene results in increased expression of CYP1A2 mRNA | CTD | PMID:9783729 |
| tetraphene | multiple interactions | ISO | RGD:10438 | 6480464 | [fluoranthene co-treated with pyrene co-treated with benz(a)anthracene co-treated with chrysene co-treated with benzo(b)fluoranthene co-treated with benzo(k)fluoranthene co-treated with Benzo(a)pyrene] results in increased expression of CYP1A2 mRNA | CTD | PMID:7750161 |
| tetraphene | multiple interactions | ISO | RGD:10438 | 6480464 | [CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of benz(a)anthracene; more ... | CTD | PMID:8961944 |
| tetraphene | increases expression | ISO | RGD:10438 | 6480464 | benz(a)anthracene results in increased expression of CYP1A2 mRNA | CTD | PMID:17825862 |
| tetraphene | multiple interactions | ISO | RGD:10438 | 6480464 | [andrographolide co-treated with benz(a)anthracene] results in increased expression of CYP1A2 mRNA | CTD | PMID:17825862 |
| theobromine | increases metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased metabolism of Theobromine | CTD | PMID:10215755 |
| theobromine | increases chemical synthesis | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased chemical synthesis of Theobromine | CTD | PMID:1302044 |
| theobromine | multiple interactions | ISO | RGD:735711 | 6480464 | furafylline affects the reaction [CYP1A2 protein results in increased metabolism of Theobromine] | CTD | PMID:10215755 |
| theophylline | increases metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased metabolism of Theophylline | CTD | PMID:9701106 PMID:11483122 |
| theophylline | affects metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein affects the metabolism of Theophylline | CTD | PMID:12732846 more ... |
| theophylline | affects metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein affects the metabolism of Theophylline | CTD | PMID:15692829 more ... |
| theophylline | affects metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein affects the metabolism of Theophylline | CTD | PMID:16841220 more ... |
| theophylline | affects metabolic processing | EXP | | 6480464 | CYP1A2 protein affects the metabolism of Theophylline | CTD | PMID:15985363 PMID:15720787 |
| theophylline | multiple interactions | ISO | RGD:735711 | 6480464 | Griseofulvin promotes the reaction [CYP1A2 protein affects the metabolism of Theophylline]; more ... | CTD | PMID:9029748 |
| theophylline | increases chemical synthesis | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased chemical synthesis of Theophylline | CTD | PMID:1302044 |
| theophylline | affects metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein affects the metabolism of Theophylline | CTD | PMID:15692829 more ... |
| theophylline | affects response to substance | ISO | RGD:735711 | 6480464 | CYP1A2 gene SNP affects the susceptibility to Theophylline | CTD | PMID:12732846 |
| theophylline | affects metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein affects the metabolism of Theophylline | CTD | PMID:16841220 more ... |
| theophylline | affects hydroxylation | ISO | RGD:735711 | 6480464 | CYP1A2 promoter SNP affects the hydroxylation of Theophylline | CTD | PMID:16841220 |
| theophylline | affects metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 gene SNP affects the metabolism of Theophylline | CTD | PMID:20797314 |
| theophylline | increases metabolic processing | EXP | | 6480464 | CYP1A2 protein results in increased metabolism of Theophylline | CTD | PMID:20096675 |
| theophylline | multiple interactions | EXP | | 6480464 | andrographolide affects the reaction [CYP1A2 protein results in increased metabolism of Theophylline]; more ... | CTD | PMID:20096675 |
| theophylline | increases metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased metabolism of Theophylline | CTD | PMID:11483122 PMID:9701106 |
| theophylline | affects metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein affects the metabolism of Theophylline | CTD | PMID:15948934 more ... |
| theophylline | multiple interactions | EXP | | 6480464 | rutecarpine promotes the reaction [CYP1A2 protein affects the metabolism of Theophylline] | CTD | PMID:15720787 |
| theophylline | affects metabolic processing | ISO | RGD:10438 | 6480464 | CYP1A2 protein affects the metabolism of Theophylline | CTD | PMID:15970798 |
| theophylline | affects metabolic processing | EXP | | 6480464 | CYP1A2 protein affects the metabolism of Theophylline | CTD | PMID:15720787 PMID:15985363 |
| theophylline | multiple interactions | ISO | RGD:735711 | 6480464 | zafirlukast inhibits the reaction [CYP1A2 protein results in increased metabolism of Theophylline] | CTD | PMID:9701106 |
| theophylline | decreases activity | ISO | RGD:735711 | 6480464 | Theophylline results in decreased activity of CYP1A2 protein | CTD | PMID:11465391 |
| theophylline | multiple interactions | ISO | RGD:735711 | 6480464 | [Ofloxacin co-treated with Clarithromycin] inhibits the reaction [CYP1A2 protein results in increased metabolism of Theophylline] | CTD | PMID:11408986 |
| theophylline | affects metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein affects the metabolism of Theophylline | CTD | PMID:15970798 more ... |
| thiabendazole | multiple interactions | ISO | RGD:735711 | 6480464 | beta-Naphthoflavone promotes the reaction [CYP1A2 protein affects the metabolism of Thiabendazole] | CTD | PMID:10936227 |
| thiabendazole | increases expression | EXP | | 6480464 | Thiabendazole results in increased expression of CYP1A2 mRNA | CTD | PMID:15110098 PMID:18539377 |
| thiabendazole | decreases activity | ISO | RGD:735711 | 6480464 | Thiabendazole results in decreased activity of CYP1A2 protein | CTD | PMID:16261361 PMID:11124226 |
| thiabendazole | affects metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein affects the metabolism of Thiabendazole | CTD | PMID:10936227 PMID:12920490 |
| thiabendazole | increases expression | EXP | | 6480464 | Thiabendazole results in increased expression of CYP1A2 protein | CTD | PMID:15110098 |
| thiabendazole | increases expression | EXP | | 6480464 | Thiabendazole results in increased expression of CYP1A2 mRNA | CTD | PMID:18539377 PMID:15110098 |
| thiabendazole | increases expression | ISO | RGD:735711 | 6480464 | Thiabendazole results in increased expression of CYP1A2 mRNA | CTD | PMID:18570159 |
| thiabendazole | decreases activity | ISO | RGD:735711 | 6480464 | Thiabendazole results in decreased activity of CYP1A2 protein | CTD | PMID:11124226 PMID:16261361 |
| thiabendazole | affects metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein affects the metabolism of Thiabendazole | CTD | PMID:12920490 PMID:10936227 |
| thioridazine | multiple interactions | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased metabolism of and results in increased activity of Thioridazine | CTD | PMID:19482014 |
| ticlopidine | multiple interactions | ISO | RGD:735711 | 6480464 | Ticlopidine inhibits the reaction [CYP1A2 protein results in increased oxidation of 4-amino-2-phenoxymethanesulfonanilide] | CTD | PMID:19053182 |
| ticlopidine | multiple interactions | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased oxidation of and results in increased cleavage of Ticlopidine metabolite | CTD | PMID:19170597 |
| ticlopidine | decreases activity | ISO | RGD:735711 | 6480464 | Ticlopidine results in decreased activity of CYP1A2 protein | CTD | PMID:10759690 |
| tizanidine | multiple interactions | ISO | RGD:735711 | 6480464 | Ciprofloxacin inhibits the reaction [CYP1A2 protein affects the metabolism of tizanidine] | CTD | PMID:15592331 |
| tizanidine | affects metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein affects the metabolism of tizanidine | CTD | PMID:16198659 PMID:15592331 |
| tizanidine | multiple interactions | ISO | RGD:735711 | 6480464 | rofecoxib inhibits the reaction [CYP1A2 protein results in increased metabolism of tizanidine] | CTD | PMID:15834531 PMID:16934051 |
| tizanidine | multiple interactions | ISO | RGD:735711 | 6480464 | rofecoxib inhibits the reaction [CYP1A2 protein results in increased metabolism of tizanidine] | CTD | PMID:16934051 PMID:15834531 |
| tizanidine | multiple interactions | ISO | RGD:735711 | 6480464 | [[Ethinyl Estradiol co-treated with Gestodene] results in decreased activity of CYP1A2 protein] which results in decreased metabolism of tizanidine | CTD | PMID:16198659 |
| tizanidine | increases metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased metabolism of tizanidine | CTD | PMID:17618427 |
| tizanidine | affects metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein affects the metabolism of tizanidine | CTD | PMID:15592331 PMID:16198659 |
| toluene | multiple interactions | EXP | | 6480464 | Acetone promotes the reaction [Toluene results in increased expression of CYP1A2 protein] | CTD | PMID:8996725 |
| toluene | increases expression | EXP | | 6480464 | Toluene results in increased expression of CYP1A2 protein | CTD | PMID:8996725 |
| toluene | multiple interactions | EXP | | 6480464 | Methylcholanthrene promotes the reaction [CYP1A2 protein results in increased oxidation of Toluene] | CTD | PMID:1994898 |
| toluene | increases oxidation | EXP | | 6480464 | CYP1A2 protein results in increased oxidation of Toluene | CTD | PMID:1994898 |
| trans-1,2-dichloroethene | decreases activity | EXP | | 6480464 | 1,2-dichloroethylene results in decreased activity of CYP1A2 protein | CTD | PMID:9671540 |
| trans-1,2-dichloroethene | affects expression | EXP | | 6480464 | 1,2-dichloroethylene affects the expression of CYP1A2 protein | CTD | PMID:9493318 |
| trans-4-coumaric acid | decreases activity | ISO | RGD:735711 | 6480464 | 4-coumaric acid results in decreased activity of CYP1A2 protein | CTD | PMID:15841493 |
| trans-resveratrol | multiple interactions | ISO | RGD:735711 | 6480464 | resveratrol inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] | CTD | PMID:10496959 |
| trans-resveratrol | multiple interactions | ISO | RGD:735711 | 6480464 | Imipramine inhibits the reaction [resveratrol results in decreased activity of CYP1A2 protein]; more ... | CTD | PMID:11714871 |
| trans-resveratrol | multiple interactions | ISO | RGD:10438 | 6480464 | resveratrol inhibits the reaction [Pyrogallol results in increased expression of CYP1A2 mRNA]; more ... | CTD | PMID:18789925 |
| trans-resveratrol | multiple interactions | ISO | RGD:735711 | 6480464 | resveratrol promotes the reaction [CYP1A2 protein results in increased metabolism of Caffeine] | CTD | PMID:20716633 |
| trans-resveratrol | decreases activity | ISO | RGD:735711 | 6480464 | resveratrol results in decreased activity of CYP1A2 protein | CTD | PMID:11714871 |
| trans-resveratrol | multiple interactions | ISO | RGD:735711 | 6480464 | resveratrol inhibits the reaction [15,16-dihydrotanshinone I results in increased expression of CYP1A2 mRNA]; more ... | CTD | PMID:21262253 |
| trans-resveratrol | decreases activity | ISO | RGD:10438 | 6480464 | resveratrol analog results in decreased activity of CYP1A2 protein | CTD | PMID:16684708 |
| trans-resveratrol | multiple interactions | ISO | RGD:735711 | 6480464 | resveratrol inhibits the reaction [CYP1A2 protein results in increased oxidation of 3,3'-diindolylmethane] | CTD | PMID:16544949 |
| trans-resveratrol | multiple interactions | ISO | RGD:735711 | 6480464 | resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | CTD | PMID:19376845 |
| trans-resveratrol | multiple interactions | ISO | RGD:735711 | 6480464 | resveratrol inhibits the reaction [anthra(1,9-cd)pyrazol-6(2H)-one results in increased expression of CYP1A2 mRNA] | CTD | PMID:17959153 |
| trans-resveratrol | affects metabolic processing | ISO | RGD:735711 | 6480464 | CYP1A2 protein affects the metabolism of resveratrol | CTD | PMID:15276085 |
| trichloroethene | increases expression | ISO | RGD:10438 | 6480464 | Trichloroethylene results in increased expression of CYP1A2 mRNA | CTD | PMID:19254012 |
| trichostatin A | multiple interactions | ISO | RGD:735711 | 6480464 | trichostatin A promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] | CTD | PMID:12927368 |
| trichostatin A | multiple interactions | ISO | RGD:10438 | 6480464 | Tetrachlorodibenzodioxin inhibits the reaction [trichostatin A results in increased expression of CYP1A2 mRNA] | CTD | PMID:15252868 |
| trichostatin A | increases expression | ISO | RGD:10438 | 6480464 | trichostatin A results in increased expression of CYP1A2 mRNA | CTD | PMID:15252868 |
| trichostatin A | increases expression | ISO | RGD:735711 | 6480464 | trichostatin A results in increased expression of CYP1A2 mRNA | CTD | PMID:12927368 |
| trimethylarsine oxide | increases expression | EXP | | 6480464 | trimethylarsine oxide results in increased expression of CYP1A2 mRNA | CTD | PMID:17481689 |
| valproic acid | affects expression | ISO | RGD:10438 | 6480464 | Valproic Acid affects the expression of CYP1A2 mRNA | CTD | PMID:17292431 |
| valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of CYP1A2 mRNA | CTD | PMID:17381134 |
| vincristine | increases response to substance | ISO | RGD:735711 | 6480464 | CYP1A2 gene SNP results in increased susceptibility to Vincristine | CTD | PMID:20864405 |
| zafirlukast | multiple interactions | ISO | RGD:735711 | 6480464 | zafirlukast inhibits the reaction [CYP1A2 protein results in increased metabolism of Theophylline] | CTD | PMID:9701106 |
| zearalenone | increases hydroxylation | ISO | RGD:735711 | 6480464 | CYP1A2 protein results in increased hydroxylation of Zearalenone | CTD | PMID:19931366 |
| zearalenone | multiple interactions | ISO | RGD:735711 | 6480464 | [CYP1A2 protein results in increased hydroxylation of Zearalenone] which results in increased chemical synthesis of Catechols | CTD | PMID:19931366 |
| zinc atom | multiple interactions | EXP | | 6480464 | [Acetylcysteine co-treated with Zinc co-treated with Selenium] inhibits the reaction [dimethyl mercury results in decreased expression of CYP1A2 protein] | CTD | PMID:21424224 |
| zinc(0) | multiple interactions | EXP | | 6480464 | [Acetylcysteine co-treated with Zinc co-treated with Selenium] inhibits the reaction [dimethyl mercury results in decreased expression of CYP1A2 protein] | CTD | PMID:21424224 |
| zolmitriptan | decreases activity | ISO | RGD:735711 | 6480464 | zolmitriptan results in decreased activity of CYP1A2 protein | CTD | PMID:18816299 |